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 Photoacoustic imaging is a promising tool for disease diagnosis.  The modality uses 
short pulses of laser light to generate ultrasonic waves from tissue.  Photoacoustics can 
take advantage of the optical properties of tissue to differentiate between different tissue 
types.  In addition, photoacoustic imaging is highly complementary with ultrasound 
imaging, which makes it possible to overlay photoacoustic signals with ultrasound signals 
displaying anatomic information.  Applications for photoacoustic imaging include 
improved diagnosis and characterization of primary tumors, cancer metastasis, 
atherosclerosis, arthritis, and other diseases and pathologies.  In this dissertation, 
photoacoustic imaging as a diagnostic tool is advanced in two ways.   
 First, the delivery and distribution of light in tissue is addressed.  Monte Carlo 
simulations of light propagation are used to optimize light delivery (Chapter 3).  A variety 
of tissue types, light wavelengths, species characteristics, and device geometries are 
considered.  Optimal geometries are recommended for researchers depending on whether 
they are imaging mice or humans.  It was found that several times less light will be 
delivered in humans, which has implications for clinical translation of imaging experiments 
conducted in mice.  The simulations were validated using a set of matched simulations and 
experiments.  Next, a new technique is introduced which could make it possible to 
compensate for the decrease in fluence with respect to tissue depth (Chapter 4).  The 
viability of the technique is tested using simulations of a broad range of tissue.  Also, a set 
of simulations mimicking contrast agents in breast tissue is used to estimate the potential 
benefit of the technique.  The results indicate the technique could make it possible to make 
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relative quantitative comparisons of photoacoustic signal from different absorbers deep in 
tissue.  This justifies further experiments ex vivo.    
 Next, the safety of intravascular photoacoustic imaging is evaluated.  Intravascular 
photoacoustics is a catheter based imaging technique meant to identify lipid plaques 
formed from atherosclerosis.  Intravascular photoacoustic imaging can result in the same 
region of tissue being irradiated hundreds of times because the artery must be irradiated 
repeatedly as the catheter is rotated and retracted to produce one 3D image.  This makes 
safety a concern.  In this dissertation, the safety of intravascular photoacoustic imaging is 
evaluated in vitro and in vivo.  Several cell types found in healthy and diseased arteries 
were irradiated in vitro at different dosages (Chapter 5).  The first finding is that cell death 
occurs only at the upper limit of expected light dosages required for intravascular 
photoacoustic imaging.  The second finding is that any damage from photoacoustic 
imaging is likely to be from heat accumulation over many light pulses, rather than from 
optical breakdown caused by high fluences from any single pulse.  Next, in vivo studies 
were conducted on swine (Chapter 6).  Damage was observed at the highest light irradiation 
dosages.  However, there was no vessel wall damage found at dosages that have been used 
to successfully image plaque in vivo in other recent studies.  These results indicate that 
intravascular photoacoustic imaging can be used to identify lipid plaques without damaging 
the vessel wall.   
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CHAPTER 1: SUMMARY OF SPECIFIC AIMS 
1.1 Aim 1: Optimizing light delivery for photoacoustic imaging systems 
The central hypothesis of this aim is that fluence delivery, and thus image quality, can be 
optimized by varying the geometry of one’s experimental setup in a manner dependent on 
the species and tissue type of the imaging target.  In this aim, Monte Carlo modeling was 
conducted to investigate the effect of the light delivery angle, light delivery position, 
imaging target species, tissue type, and laser wavelength on the amount of light delivered 
to the imaging plane.  For each species, tissue type, and light wavelength the fiber position 
and light emission angle that maximized peak fluence was reported.  Matched modeling 
and experiments were conducted to validate the model.  The work in this aim is meant to 
give researchers guidance on the optimal experimental geometry for a variety of 
applications of photoacoustic imaging.  Researchers can choose the optimal optical fiber 
distance and angle for the tissue type and wavelength that most closely matches their 
application.  In addition, the work is meant to give insight into the differences in fluence 
that may occur when transitioning from preclinical studies in mice to clinical use in 
humans.   
1.2 Aim 2: Fluence Compensation in Deep Tissue for Quantitative Photoacoustic 
Imaging 
The central hypothesis of this aim is that it is possible to compensate for fluence variations 
in deeper regions of tissue by using compression to track the change in photoacoustic signal 
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of native absorbers as a function of depth.  In this aim, the viability of this method is 
investigated using Monte Carlo simulations.  First, it is determined that the fluence 
decreases at a exponential rate for homogenous tissue for a wide range of optical properties.  
This establishes that the technique would be viable in most tissue types.  Then, the expected 
improvement in photoacoustic signal from using the technique is evaluated using a 
simulation consisting of several regions of high intensity (contrast agents) in breast tissue 
at 789 nm.  The work is meant to establish the viability and usefulness of this technique, 
which would serve to motivate future ex vivo and in vivo experiments.  Once developed 
and implemented, the technique would make it possible to make quantitative comparisons 
of relative photoacoustic signals.   
1.3 Aim 3: Safety of Intravascular Photoacoustic Imaging – In Vitro Studies 
The central hypothesis of this aim is that a threshold of light dosage for cell death can be 
identified for cells in vitro and that damage at higher IVPA dosages are likely to be caused 
by heating of tissue.  To investigate this, the viability of macrophages, smooth muscle cells, 
and endothelial cell after irradiation with light dosages relevant to IVPA imaging was 
evaluated.  First, cells were irradiated with many pulses of light, similar to the exposure 
from 3D image acquisition during IVPA imaging and at IVPA relevant dosages.  The cells 
were then evaluated for viability.  Second, cells were irradiated with fewer pulses but at 
the highest optical fluence expected during IVPA imaging and again evaluated for viability.  
The first output of this aim is to indicate whether IVPA can be conducted at safe light 
dosages.  Second, it will indicate if the damage mechanism is expected to be heat 
accumulation from many laser pulses or optical breakdown from high peak fluences of 
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single pulses.  Third, it will guide the light dosage decisions chosen for the in vivo 
experiments conducted for aim 4.     
1.4 Aim 4: Safety of Intravascular Photoacoustic Imaging – In Vivo Studies 
The hypothesis of this aim is that IVPA imaging can be conducted at safe laser dosages, 
but there will be limitations on the amount of energy used for safety reasons.  This is the 
first in vivo study on the safety of IVPA imaging the author is aware of that has been 
reported to date.  The carotid arteries of two swine were irradiated using a real-time IVPA 
imaging system at multiple wavelengths and energy dosages.  The tissues were evaluated 
for damage by a pathologist.  The purpose of this aim is to indicate the dosages at which 
IVPA can be safely conducted without causing damage to vessel tissue, which will further 
IVPA imaging on its path toward clinical application.   
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CHAPTER 2: BACKGROUND 
2.1 Photoacoustic Imaging 
2.1.1 Physical Principals 
Photoacoustic imaging is a relatively recent imaging modality in the field of biomedical 
research[1, 2], although the physical effect was first discovered by Alexander Graham Bell[3].  
Photoacoustic signals are induced by the application of short pulses of electromagnetic 
radiation, which for biomedical applications is usually achieved using a short laser pulse 
at a near infrared wavelength.  Chromophores in the tissue absorb the laser light, resulting 
in the sudden absorption of heat.  The consequent thermal expansion and collapse induces 
an ultrasonic disturbance in the form of a photoacoustic wave.  This photoacoustic wave 
can then be detected by an ultrasound transducer.  Importantly, the location of that signal 
can also be inferred from the elapsed time between laser irradiation and photoacoustic 
signal acquisition based on the speed of sound in tissue.   
 Efficient conversion of the absorbed laser light into photoacoustic signal requires 
satisfaction of the thermal and stress confinement conditions.  In practice, this means that 
for biological tissues, photoacoustic signal induction requires lasers with a pulse width on 
the order of several nanometers.  A more detailed description of these conditions can be 
found in the literature[4].   
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 The intensity of the photoacoustic signal at its source is defined by the 
photoacoustic pressure induced by the expansion and compression of the chromophore at 
the location of light absorption (Eq. 1.1)[5].   
 






                   (Eq. 1.2) 
 
 In this equation, the photoacoustic pressure is defined by the term Po.  The other 
terms include the optical absorption coefficient (µa), the fluence (F), and the Grueneisen 
parameter (Γ).  The fluence is defined as the light energy per unit area at the site of 
photoacoustic signal generation.  The Grueneisen parameter is a set of physical properties 
of the tissue that determines how efficiently the heat is converted into photoacoustic 
pressure (Eq. 1.2).  It includes the bulk expansion modulus (β), the speed of sound in tissue 
(vs), and the specific heat capacity (Cp).   
  Several observations can be made from the photoacoustic pressure equation (Eq. 
1.1).  First, all the terms on the right-hand side are linearly proportional to the photoacoustic 
pressure, which can have practical implications.  First, improved light delivery into the 
target tissue will increase the photoacoustic signal.  This will result in improved image 
quality.  Second, the dependence of the absorption coefficient on light wavelength is a 
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mechanism of contrast in photoacoustic imaging.  When irradiating at multiple 
wavelengths, the Grueneisen parameter will not change since it is a physical property of 
the tissue.  For small wavelength changes (i.e., range of wavelengths), the fluence locally 
can also be assumed constant.  As a result, changes in photoacoustic pressure from the 
same absorber in tissue using images taken using different but close laser wavelengths can 
be attributed to the difference in the optical absorption coefficient at these wavelengths.  
Since these values are widely available in the literature, this can be used identify certain 
tissue types, or even contrast agents, in tissue.  Note that although fluence is not accounted 
for directly when comparing between wavelengths, increasing light delivery for each pulse 
is still desirable since a greater number of imaging targets will be detected above the noise 
floor.   
 A final benefit of photoacoustic imaging is that the hardware requirements make it 
a simple process to also acquire ultrasound (US) images.  Since the photoacoustic signal is 
detected by an ultrasound transducer, this same transducer used for anatomical imaging 
can also be used for acquiring the photoacoustic signal.  Thus, any photoacoustic signal 
can be overlaid with the anatomical images produced by ultrasound.  In addition to 
traditional B-mode US which acquires the anatomical images, PA can also be combined 
with flow imaging and elasticity imaging[6].   
 Photoacoustic imaging has been developed for a wide variety of imaging 
applications in the biomedical field over the last several years.  These applications have 
been widely reviewed and include detection of cancers and metastasis to lymph nodes, 
identifying circulating tumor cells, imaging of atherosclerotic plaques, evaluating blood 
oxygenation (SO2) levels, contrast agent imaging, and even measurement of temperature
[7-
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14].  At least one study using a photoacoustic imaging system for breast cancer diagnosis 
has gone through clinical trials[15].   
2.2 Transdermal Photoacoustic Imaging Systems 
Photoacoustic acquisition is most often achieved using a commercial ultrasound array with 
light delivered externally from a pulsed laser using an optical fiber[16, 17] (Figure 2.1).  This 
allows researchers to take advantage of ultrasound transducers developed commercially for 
photoacoustic signal acquisition, rather than systems built custom in the lab.  As stated 
previously, these systems can also easily be used to acquire anatomical information with 
B-mode ultrasound that can then be overlaid with the photoacoustic signal.  A variety of 
studies serve as examples of this method[8, 9, 18, 19].  The system used in clinical studies for 
breast cancer imaging mentioned earlier also used this approach[15].   
 Besides hardware, several factors affect the measured intensity of the photoacoustic 
signal and thus image quality for this type of system.  One is the amount of energy emitted 
from the optical fiber.  This is controlled directly with the laser system.  In fact, the pulse 
energy will vary linearly with fluence, so an increase in the energy irradiated will result in 
a proportional increase in photoacoustic signal (Eq. 1).  However, there is a ceiling on the 
amount of light that can be used based on safety considerations, which limits the fluence 
that can be applied to skin.  A second factor is the positioning and orientation of the optical 
fiber used to deliver light.  Changing these design choices would affect the path light travels 
to the imaging target, and thus the amount of light that reaches the imaging target.  The 
ideal geometry may be dependent on multiple factors, including the optical properties of 
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the tissue and the species of the imaging target.  Determining the ideal geometry which 
maximizes the amount of light that reaches the target for a variety of imaging scenarios 
would be of value to the field.   
 
 
Figure 2.1 Representative image of the experimental setup commonly used for 
combined ultrasound and photoacoustic imaging.  It consists of a linear ultrasound 
transducer array and light delivered from the side externally with bundles of optical 
fibers.    
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2.3 Intravascular Photoacoustics 
2.3.1 Atherosclerosis 
The leading cause of death worldwide is cardiovascular disease[20].  A primary driver of 
these deaths is coronary artery disease, in which lipid plaques grow in the vessel wall[21].  
The biological progression is complex (Figure 2.2).  Growth in the plaque can result in 
vessel occlusion, requiring an intervention to reinstate blood flow that is commonly 
achieved with deployment of a stent[22].  Alternatively, the plaques can suddenly rupture[23-
25] or erode[25-27].  This exposes blood to coagulation inducing factors, resulting in blood 
clot formation.  The clot can block blood flow at the site of the plaque.  It can also block 
flow in downstream tissue if the clot breaks away from the site of the plaque and travels 
with blood in the vessel before eventually becoming lodged in a narrower vessel.  Deaths 
from atherosclerosis commonly result from a heart attack after a clot blocks a coronary 




Figure 2.2 Development of an atherosclerotic plaque.  Endothelial activation leads to 
chemokine production and expression of molecular markers on the surface of 
endothelial cells, which cause migration and adhesion of immune cells, including 
monocytes, to the endothelium.  Increased endothelial permeability enables cells and 
LDL to cross into the vessel wall.  Monocytes differentiate into macrophages, which 
take up modified LDL to form foam cells.  Proinflammatory cytokines promote cell 
recruitment, smooth muscle cell proliferation and neovascularization.  Both foam-
cell formation and smooth-muscle proliferation cause a localized thickening of the 
vessel wall, which becomes a plaque.  The fragile neovessels can bleed, causing 
intraplaque haemorrhage that can accelerate growth.  Hypoxia and oxidative stress 
lead to foam-cell apoptosis and the formation of a lipid-rich necrotic core.  Calcium 
is deposited within the plaque and a fibrous cap forms over the top of the plaque, 
shielding the thrombogenic content of the plaque from the circulation.  As the 
plaque enlarges, it not only causes narrowing of the lumen, but can also lead to 
outward vessel-wall remodeling, a feature of plaques at high risk of rupture.  The 
fibrous cap thins and the plaque eventually ruptures, which can lead to acute 
thrombosis and clinical events.  High levels of inflammatory cells are found in the 
plaque at the time of rupture.  Reproduced from ref [28] with permission from 
Springer Nature.    
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 The progression of atherosclerotic plaques from their earliest stages to those that 
are vulnerable to rupture is biologically complex and not completely understood[29-31].  It 
is an inflammation driven process that involves a number of biological factors[28].  It is 
initiated by endothelial activation, which results in the migration of immune cells, 
especially monocytes, into the vessel wall.  These monocytes take up low density 
lipoprotein (LDL), developing into foam cells.  Focal proliferation of these cells and 
smooth muscle cells cause plaque growth.  Eventually, hypoxia in these regions leads to 
cell death and the growth of a necrotic core.  A fibrous cap at the top of the plaque can be 
formed.  Plaque rupture or erosion arises from multiple factors, with the primary cause(s) 
still being an active subject of research.[23-27, 32-35]   
 Pathohistological studies have been conducted to determine the characteristics that 
differentiate rupture-prone or “vulnerable” plaques for clinical intervention[36-38].  These 
studies identified lipid content, widespread inflammation, and a thin fibrous cap as 
common characteristics of ruptured plaques.  For example, in one histopathologic study a 
fibrous cap thickness <54 µm and a necrotic core area of 3.45 mm2 were specified[37] as 
thresholds that differentiate between rupture prone and non-rupture prone plaques.  These 
specific thresholds suggest that imaging modalities capable of measuring these features in 
vivo could inform clinicians deciding on the best course of intervention.   
 However, the concept of the vulnerable plaque has recently become controversial[39, 
40].  The main criticism is that while these characteristics of plaque are commonly found in 
post-mortem examinations of ruptured plaque, they may not predict if a given plaque will 
rupture in a patient.  Evidence for this is given in the PROSPECT trial[41], in which patients 
underwent coronary angiography, gray-scale ultrasound, and radiofrequency ultrasound 
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imaging following percutaneous coronary intervention after an adverse cardiovascular 
event.  Only 26 out of 595 plaques (< 5%) identified as thin cap fibroatheromas were sites 
of recurrent events at 3.4 year follow up.  Even when plaque burden (70%) and minimal 
lumen area (4.0 mm2) were included, the event rate was only 18.2%.  The study indicated 
that the high incidence of plaques meeting the “vulnerable” standards that did not rupture 
may make these criteria ineffective at directing clinical interventions.   
 It should be noted that there are limitations to this study.  For one, radio frequency 
intravascular ultrasound (virtual histology) has only moderate sensitivity and specificity 
for identifying vulnerable plaque characteristics in vivo[39].  Given the high base incidence 
of plaques that did not meet the criteria of a thin-cap fibroatheroma (only 596 thin cap 
fibroatheroma out of 3160 identified lesions), moderate specificity would have resulted in 
a large proportion of the plaques being misidentified as thin-cap fibroatheromas.  This 
could have artificially lowered the predictive rate of vulnerable plaque features.  In 
addition, the study authors note that about half of the lesions responsible for recurrent 
events were evaluated with angiography but not ultrasound due to the small size of the 
artery, which means they also could have been misidentified at the first time point.   
 Other studies have lent weight to the idea that more accurate characterization of 
plaques could be useful in guiding clinical decisions on intervention.  For example in the 
more recent Lipid Rich Plaque study[42], near-infrared spectroscopy was combined with 
intravascular ultrasound in a prospective study involving over 1500 patients.  Patients with 
suspected coronary artery disease underwent imaging in segments that included non-culprit 
plaques.  Measures of lipid presence were able to improve prediction of future events in 
non-culprit plaques, with a hazard ratio of 2.18 for the endpoint of major adverse 
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cardiovascular events at 2 year follow up.  The study authors suggest that near-infrared 
spectroscopy and ultrasound can be used to inform decisions on intervention, especially in 
larger arteries where side effects from catheterization are less likely.  These studies 
illustrate that it is still possible for improved plaque characterization to be useful for 
guiding clinical intervention, although more work is needed to identify the best features for 
differentiation and develop the imaging modalities to detect them.   
 In addition to plaque characteristics, some have argued that plaque vulnerability 
may need to be combined with other factors related to patient vulnerability.  These include 
characteristics of blood related to thrombosis and the vulnerability of the myocardium 
based on a patient’s prior medical history[40].  Evaluation of widespread inflammation may 
also be needed, as many patients experiencing acute coronary syndrome have multiple 
legions besides the culprit lesion[43].  Overall, other clinical measures may need to be 
incorporated into the decision making process beyond information taken from intravascular 
imaging methods.   
 Identification of clear diagnostic criteria for informing clinical interventions is 
inhibited by the widespread use of retrospective studies of culprit lesions[40].  Diagnostic 
criteria could be determined if additional prospective studies based on plaque 
characterization are conducted.  However, the lack of imaging modalities with high 
sensitivity and specificity for the characteristics of ruptured culprit lesions have made this 
difficult.  The development of imaging modalities that could accurately measure fibrous 
cap thickness, lipid content and area, and the presence of inflammatory markers in vivo 
would make it possible to rectify this shortcoming.    
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2.3.2 Intravascular Photoacoustic Imaging 
Intravascular photoacoustics (IVPA) is a catheter-based system that can detect lipid in 
plaques in vessel walls using photoacoustic imaging.  The technique takes advantage of the 
unique optical properties of lipid, which has absorption peaks at 1210 and 1720 nm[44].  The 
enhanced photoacoustic signal from irradiation at this wavelength can be used to 
differentiate lipid from surrounding tissue.  This imaging technique has the potential to 
more accurately characterize plaque features such as lipid area, depth, and angular extent.  
In addition, the development of contrast agents shows it may be possible to evaluate the 
intensity of expression of biological markers in plaque[45].   
 The catheter design consists of a side firing optical fiber and ultrasound 
transducer[46, 47] (Figure 2.3).  Initial designs used an optical fiber polished at an angle to 
refract light outward through the catheter.  Other more recent designs similarly use a 
reflective mirror at a 45 degree angle to reflect the light[48].  The photoacoustic signal 
induced by the laser irradiation is detected by an ultrasound transducer oriented sideways 
such that its field of view overlaps the light emission from the optical fiber.  The ultrasound 
transducer is also used to acquire ultrasound images.  These can be overlaid with the 
intravascular photoacoustic image to give anatomic information about the location of any 
acquired photoacoustic signal.  In this way, the size and extent of lipid in a plaque can be 
imaged and mapped to its location in the artery.  Catheter designs reported in the literature 




Figure 2.3 Image of a catheter used for real-time in vivo intravascular photoacoustic 
imaging.  The outer shell consists of a hollow housing with the side partially cut 
away for delivery of light and propagation of ultrasonic signals.  The housing is 
welded onto a torque cable to allow fast rotation of the catheter.  The light is 
delivered through an optical fiber shown in the image, which is contained within a 
class cap that is set in place with epoxy, so it does not come into direct contact with 
liquid.  The ultrasound transducer is located in front of the glass cap.  Intravascular 
photoacoustic catheters also have an additional sheath (not shown), make of a 
common plastic such as polyethylene, to prevent damage to the tissue.    
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Figure 2.4 (a) IVUS and (b) combined IVUS/IVPA (1210 nm wavelength) images of 
the atherosclerotic vessel.  The images were acquired at 25°C.  Yellow arrows in 
these images indicate the location of atherosclerotic plaques.  (c) Oil red O stain 
confirmed that the imaged aorta had lipid-rich plaques.  The angular position of the 
histological slide was chosen based on the visual correlation of the shape of the 
vessel wall in histology and the IVUS image.   Adapted from reference [49].   
 
 
 Intravascular photoacoustic imaging has seen rapid development over the last 
decade.  It was first illustrated using imaging phantoms and rabbit arteries[46, 47].  Shortly 
afterward, successful imaging of lipid in human[50] arteries was achieved ex vivo.   An 
example of an intravascular photoacoustic image of a human artery showing lipid plaque 
is shown in Figure 2.4.  The ultrasound image does not clearly show plaque (Figure 2.4a), 
although it is detectable in the photoacoustic image (Figure 2.4b).  The histology confirms 
the presence of lipid in the intima and media (Figure 2.4c).  Other techniques were soon 
developed.  For example, spectroscopic imaging of lipid plaque using multiple wavelengths 
of light was shown to enhanced plaque identification[51, 52].  Contrast agents have also been 
used to increase the sensitivity of plaque imaging and indicated the preference of 
macrophage infiltration[53].  Clinical use of IVPA first required the development of a real 
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time imaging system[54].  Finally, real time intravascular photoacoustic imaging of non-
native lipid[55] and adventitial lipid has been achieved[56].  The use of IVPA to identify lipid 
in plaque in real-time in an in vivo swine model of atherosclerosis was only accomplished 
recently[57].  Preclinical development of intravascular photoacoustic imaging has 
demonstrated its potential value as a clinical imaging modality.   
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 Multiple imaging modalities[58] are currently used to assess atherosclerotic plaques 
besides IVPA.  It’s worth discussing the advantages and limitations (Table 2.1) of each to 
understand the unique advantages and limitations of IVPA.  Angiography[59-62] is used to 
detect luminal stenosis and does not require the insertion of a catheter into the vessel.  
Although it is effective at detecting stenosis during acute cardiac events to inform 
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intervention, it gives no information about plaque extent and composition.  Intravascular 
ultrasound (IVUS) is a catheter-based intervention[63, 64].  It has a penetration depth well 
beyond the thickness of the artery and by using radio frequency techniques can give some 
information about plaque composition.  However, its spatial resolution is not sufficient to 
characterize thin cap fibroatheromas[63, 64] and its sensitivity and specificity for evaluating 
plaque composition is moderate[39].  Optical coherence tomography has limited penetration 
depth, but excellent spatial resolution capable of detecting thin fibrous caps[65-72].  It often 
requires the removal of blood through saline flushing or balloon occlusion, which can cause 
negative side effects.   
 Other modalities are currently in development that could contribute to plaque 
identification and characterization.  Intravascular MRI[73, 74] is being developed to assess 
plaque, for example, using the diffusion coefficient of water as a surrogate for assessing 
plaque presence and composition[74].  However, it currently suffers from poor spatial 
resolution and is not conducted in real time.  Raman spectroscopy[58] has poor penetration 
depth and spatial resolution, which would make it ineffective at assessing deep plaques.  
Near-infrared spectroscopy can be used to assess the presence of lipid along the imaging 
direction of the catheter[75-79].  However, the modality is not depth resolved and thus cannot 
assess plaque area or volume.  It is also incapable of assessing fibrous cap thickness.   
 Intravascular photoacoustics has its own set of advantages and limitations.  It has 
excellent penetration depth that can easily evaluate the deepest lesions.  It achieves native 
contrast directly from the presence of lipid, which is a predictor of plaque severity.  Since 
it is depth resolved, it can directly assess plaque area and volume.  This makes it the only 
modality capable of producing a 3D representation of lipid in the artery wall.   
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 Despite the clinical debate surrounding the potential predictors of vulnerable 
plaques, the development of intravascular photoacoustics into a clinical imaging modality 
would have multiple benefits.  Intravascular photoacoustics could be used in prospective 
studies to more accurately assess if lipid area/volume can be used as predictors for adverse 
clinical events.  Additionally, intravascular photoacoustics will be effective at identifying 
plaques that have not caused extreme luminal stenosis due to compensatory vessel 
expansion and remodeling.  Thus, it would be valuable in assessing the “vulnerable patient” 
in addition to the presence of a vulnerable plaque.  The use of contrast agents could make 
it possible to assess the level of inflammation in a plaque, as has been shown in studies in 
which contrast agents preferentially accumulated in activated macrophages[80].  Also, IVPA 
imaging would be able to assess the presence of adventitial lipid, which has been implicated 
in plaque development in multiple studies.  For example, adventitial lipid has been 
connected to the development of atherosclerotic plaques through the release of 
inflammatory factors[81-83].  In humans, the thickness and volume of coronary epicardial 
adipose tissue correlates with coronary artery disease severity[81-83].  Also, the surgical 
removal of adventitial lipid in swine resulted in reduced percent stenosis 3 months later[82], 
indicating a possible causal relationship.  The specificity of intravascular photoacoustic 
imaging to the detection of lipid and its ability to resolve the signal with depth gives IVPA 
a unique advantage in evaluating which plaques require clinical intervention.    
 Beyond its unique advantages, IPVA is compatible with other imaging methods 
used to characterize atherosclerotic plaques.  Researchers have combined IVUS, IVPA, 
and near infrared fluorescence (NIRF) imaging[84].  Others have combined IVUS, IVPA, 
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and OCT[85, 86].  Combining IVPA with other modalities could give clinicians more types 
of actionable information about the characteristics of a specific plaque simultaneously.   
 So far, the discussion of IVPA in this chapter has revolved around the diagnosis of 
atherosclerotic plaque.  However, it is important to consider what role IVPA could play in 
treatment.  Currently, acute atherosclerotic plaques are treated by stent placement using 
percutaneous coronary intervention to relieve blockages or stabilize potentially vulnerable 
plaques[22].  To prevent the development of plaque in patients over longer time periods, 
medications such as statins are commonly prescribed[39].  However, other forms of 
treatment for atherosclerotic plaque are in development that would be complementary with 
IVPA imaging, including photodynamic and photothermal therapy[12].  In both techniques, 
the idea is to arrest the disease state in a targeted manner by subjecting an atherosclerotic 
plaque to fatal insult.   
 Photodynamic therapy is conducted with activation of a light sensitive drug that is 
delivered specifically to the plaque.  The drug is referred to as a photosensitizer.  Upon 
activation, the drug will damage surrounding biological tissue with the formation of 
reactive oxygen species[87, 88].  Photodynamic therapy is already an accepted form of cancer 
treatment[87-89], and research has naturally been conducted to determine if it can be used to 
treat atherosclerotic plaques.  It has been applied successfully to larger animal models of 
atherosclerosis, including rabbits and swine.  It has been shown to eradicate plaques[90] and 
reduce macrophage content[91, 92] in rabbits.  In swine, photodynamic therapy reduced 
intimal thickness at long term time points of 3 and 6 months[93].  A phase I clinical trial in 
humans illustrated the safety of the photosensitizer motexafin lutetium at 6 months with no 
side effects[94] after the photosensitizer was shown to be effective at treating plaque in 
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rabbits[91].  A multi-center study has been funded to conduct studies in which photodynamic 
therapy is used to treat atherosclerotic plaque development in real time with follow up 
monitoring, although the results have yet to be reported[95].  Although not currently an 
accepted treatment method for atherosclerotic plaque, developments in photodynamic 
therapy and photosensitizers are ongoing[88].   
 Photothermal therapy is used to damage biological tissue in plaque from heating.  
Studies in mice using contrast agents to enhance the deposition of heat have been shown 
to result in macrophage death[96] and to reduce plaque formation and lipid storage[97].  It 
has also been shown that gold nanorods can be directly used as temperature sensors using 
photoacoustic imaging, making it possible to deliver the therapy in a targeted manner[98].  
Clinical trials in the NANOM-FIM studies[99] used photothermal therapy which 
successfully reduced atheroma volume.  However, the studies used contrast agents with 
unknown long-term toxicity, and the results have yet to be replicated.   
 Both these therapeutic treatments are highly complementary with intravascular 
photoacoustic imaging, as they are conducted using light.  Intravascular photoacoustic 
imaging could be used to identify plaque using a lipid specific wavelength.  Once plaques 
are identified and stratified based on risk, the intravascular photoacoustic catheter could be 
used to deliver an alternative wavelength of light used to activate a photosensitizer or heat 
the tissue for photothermal therapy.  If photothermal therapy is used, it may even be 
possible to monitor the temperature of the tissue during application of the therapy in real 
time.  Thus, intravascular photoacoustic imaging has a potential role in the treatment of 
atherosclerotic plaques in addition to diagnosis.   
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 However, one area of intravascular photoacoustic imaging that has not been 
explored is safety.  Since IVPA imaging must be acquired with many laser pulses while 
the catheter is rotated and retracted, each region of tissue can be irradiated up to hundreds 
of times.  The effect of this on living artery tissue, and the consequent limitations in energy 
that can safely be used to achieve high image quality, are unknown.  Determining if IVPA 
imaging can be conducted without laser irradiation damaging vessel tissue is one hurdle to 
clinical use of this technology.  No prior work was found which investigated the safety of 
intravascular photoacoustics directly.  Investigating the safety of IVPA imaging is the 
primary objective of the work described in chapters 3 and 4 of this dissertation.  
 23 
CHAPTER 3: OPTIMIZING LIGHT DELIVERY FOR 
PHOTOACOUSTIC IMAGING SYSTEMS 
3.1 Introduction 
This chapter was adapted from: Sowers, T., Yoon, H., and Emelianov. S. Investigation of 
light delivery geometries for photoacoustic applications using Monte Carlo simulations 
with multiple wavelengths, tissue types, and species characteristics J. Biomed. Opt., 2020. 
25(1), 016005, doi: 10.1117/1.JBO.25.1.016005.[100]   
 
3.1.1 Abstract  
Combined ultrasound and photoacoustic imaging systems are being developed for 
biomedical and clinical applications.  One common probe configuration is to use a linear 
transducer array with external light delivery to produce coregistered ultrasound and 
photoacoustic images.  The diagnostic capability of these systems is dependent on the 
effectiveness of light delivery to the imaging target.  In this chapter, Monte Carlo modeling 
is used to investigate the optimal design geometry of an integrated probe.  Simulations are 
conducted with multiple tissue compositions and wavelengths.  The effect of a skin layer 
with the thickness of a mouse or a human is also considered.  The model was validated 
using a tissue-mimicking gelatin phantom and corresponding Monte Carlo simulations.  
The optimal illumination angle is shallower with human skin thickness, whereas 
intermediate angles are ideal with mouse skin thickness.  The effect of skin thickness 
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explains differences in the results of prior work.  The simulations also indicate that even 
with identical hardware and imaging parameters, light delivery will be up to 3x smaller in 
humans than in mice due to the increased scattering from thicker skin.  These findings have 
clear implications for the many researchers using mice to test and develop imaging methods 
for clinical translation.   
 
3.1.2 Background 
Photoacoustic imaging[1, 2, 14, 101-103] is an emergent area of research in biomedical imaging.  
The technique uses nanosecond pulses of light to induce ultrasonic waves from imaging 
targets in tissue, which can then be detected by an ultrasound transducer.  The ultrasonic 
wave is induced by rapid expansion of the target as a result of heat generated from the 
absorbed laser light.  The strength of the ultrasonic wave is dependent on the quantity of 
light delivered, a set of physical properties referred together as the Grueneisen parameter, 
and the optical absorption coefficient of the imaging target[2].  Since the optical absorption 
coefficient is wavelength dependent and has been characterized for a wide variety of tissue 
types, imaging targets can be identified by imaging a single region at multiple wavelengths 
and then comparing the changes in photoacoustic signal intensity with what would be 
predicted based on the known optical absorption coefficients.   
 As explained previously, photoacoustics (PA) is being widely developed for 
applications in the biomedical field, including, for example, the detection of various 
cancers and lymph node metastasis, detection of circulating tumor cells, identification of 
atherosclerotic plaques, evaluation of muscle oxygenation, identification of contrast 
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agents, and temperature sensing[7-14].  A significant benefit of PA is that it can be used 
synergistically with other imaging techniques, including conventional B-mode ultrasound, 
flow imaging, and elasticity imaging[6].  One common technique for PA image acquisition 
is to use a commercial linear ultrasound array with laser light delivered by an optical 
fiber[16, 17].  This method takes advantage of developments in commercial ultrasound 
transducer arrays to detect the ultrasonic PA waves, while making it possible to overlay 
the PA signal with anatomical information obtained from an ultrasound (US) B-mode 
image.  Examples of studies that specifically use commercial ultrasound arrays with 
external light delivery can be found in the literature[8, 9, 18, 19, 104], including one application 
currently in clinical trials for breast cancer diagnosis[15].   
 Since the photoacoustic pressure generated at the imaging target is proportional to 
the laser fluence at that location, increased light delivery into the tissue will result in 
stronger photoacoustic signals from native absorbers.  In addition, improved light delivery 
can enhance the use of photoacoustic contrast agents, which are being developed for 
contrast-enhanced imaging and super-resolution imaging[105, 106].  Various research groups 
have conducted studies to determine the optimal geometrical layout of the fiber bundle and 
transducer to increase light delivery.  Haisch et al.[16] proposed the use of a fiber bundle 
and commercial transducer.  They determined experimentally that a 40-50 degree angle 
between the fiber bundle and transducer is best for imaging depths from 10-25 mm, while 
smaller angles are better at greater depths using artificial tissue phantoms.  The modeling 
of Wang et al.[107] indicates that decreasing the distance between the fiber bundle and the 
transducer imaging plane will increase light delivery.  However, in contrast to the results 
of Haisch et al[16], they found that decreasing the angle between the fiber bundle and 
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transducer will monotonically increase fluence along the imaging plane at depths of 5-30 
mm.  Sivasubramanian et al.[108] modeled different combinations of the fiber bundle to 
transducer distance, fiber bundle to transducer angle, and the transducer to tissue distance 
to optimize the signal-to-noise ratio (SNR), and tested the results experimentally in chicken 
breast tissue without a skin layer.  It was found that different combinations of these 
parameters can result in large differences in SNR.  Finally, Sangha et al.[109] designed a 
motorized system in which the angle of the fiber bundle can be changed on demand during 
an experiment.  This system was used to vary the light emission angle to separately 
optimize imaging of subcutaneous fat and periaortic fat in mice in vivo.  They found 
differences between the optimal angle in their phantom, which had no skin mimicking 
layer, and experiments conducted in mice.   
 In this chapter, these studies are furthered by investigating the differences in the 
optimal design that arise from the presence of skin with the thickness of a human or mouse.  
The hypothesis is that the high scattering in this layer explains differences in the results of 
Haisch et al.[16], Wang et al[107], and Sangha et al[109].  The effect of changing the thickness 
of the skin layer at multiple wavelengths and with multiple soft tissue compositions below 
the skin using Monte Carlo simulations of photon propagation is evaluated.  This is of 
particular interest to researchers, since the use of mice for in vivo validation of preclinical 
techniques is common.  Experiments are conducted in a phantom at 1064 nm and the results 
are compared with simulations from the Monte Carlo software for validation.  The results 
show that different light emission and transducer configurations maximize fluence delivery 
when using the skin thickness of a mouse versus the skin thickness of a human.  
Furthermore, differences in the optimal geometries between species can explain variability 
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in the results of prior work.  Importantly, the results indicate that significant variations in 
fluence can be expected between mice and humans using an identical imaging setup and 
imaging parameters, which serves as a cautionary message to researchers expecting to 
directly translate results in mice to the clinic.   
3.2 Materials and Methods 
3.2.1 Monte Carlo Modeling Software 
MCXLAB, a package within Monte Carlo eXtreme[110-112] that has been developed for use 
with MATLAB and GNU Octave, was used to simulate photon transport.  The software 
simulates photon propagation from a defined source through a volume consisting of cubic 
voxels.  The optical properties at each voxel are defined by the absorption coefficient, µa, 
scattering coefficient, µs, anisotropy, g, and index of refraction, n.  In these simulations, all 
voxels were cubic with a length of 50 µm.  The Monte Carlo software output makes it 
possible to attain the fluence in each voxel, normalized to the total energy from the light 




Figure 3.1 Diagram of the (a) (b) model and (c), (d) experimental setup. (a) A side 
view diagram of the tissue model geometry showing the location and orientation of 
the optical fibers used for light delivery. (b) A top view diagram of the tissue model 
geometry. The optical fibers have a rectangular footprint with dimensions of 25 mm 
× 1.4 mm. In general, two cables of optical fibers are used for light delivery during 
PA imaging experimentally, although only one was needed for our model and 
experiment due to the geometrical symmetry. (c) The experimental setup with the 
location of light emission from the optical fibers separated from the transducer 
array by a distance, D, and at an angle, θ. The distance D covers distance from the 
center of the transducer to the center of the rectangular optical fiber contained in 
the metal housing.  If the angle is changed, the location of the metal housing is 
adjusted horizontally as needed to keep D constant. (d) Graphite rods at various 
depths in the gelatin phantom were used as PA absorbers. The rods all had a length 
of 2 cm and a diameter of 0.5 mm.  Reproduced from Sowers et al.[100]    
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 Combined US/PA systems that use a commercial ultrasound transducer with optical 
fibers for delivery of laser irradiation generally illuminate the imaging target with the distal 
end of the optical fibers positioned on each side of the transducer.  In these simulations, 
the light emission from the distal end of the optical fibers was simulated as a light source 
of uniform fluence with an area of 25 x 1.4 mm2.  The center of the light emission area was 
offset from the center of the simulation space (in practice, the imaging plane of the 
transducer array) by a distance, D (Figure 3.1a,b).  The light was emitted into the simulated 
volume at a uniform angle, θ.  Since the optical fiber and transducer array setup is 
symmetrical across the imaging plane of the ultrasound transducer only one light source 
needed to be simulated.  After the simulation, the average of the fluence output and its 
mirror across the imaging plane was used as the final fluence output.  The boundary 
condition at the edge of the simulation volume was set such that any photons that crossed 
the boundary permanently escaped the simulation volume.   
 
3.2.2 Modeling Parameters 
The mouse and human modeling were simulated using multiple tissue types and 
wavelengths (Table 3.1).  Simulations were conducted using both fibrous[113, 114] and fatty 
tissue[115].  Fibrous tissue is among the least scattering of the tissue types whereas fatty 
tissues are highly scattering.  Thus, both extremes of light scattering, which often dominate 
absorption effects in tissue, are represented.  Simulations were conducted at 700, 800, and 
900 nm, which are commonly used for photoacoustic imaging.  In addition, simulations 
were conducted at 1064 nm which is commonly used due to the ubiquity of the Nd:YAG 
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laser.  To sample the space between tissue types, we also ran simulations at 800 nm in 
which the tissue composition was a linear combination of the fibrous and fatty tissue types 
in 20% increments.  This combination of wavelengths and tissue compositions will allow 
other researchers to use our results as a general guide for their own photoacoustic 
applications.  For example, a researcher evaluating plaque in the carotid artery would likely 
use results from more fibrous tissue, since the neck contains a large proportion of muscle.  
A researcher building a system to diagnose breast cancer, on the other hand, would use 
results from simulations using fatty tissue.  As suggested in the literature, all tissues were 
simulated with an anisotropy coefficient of 0.9[116] and a refractive index of 1.4[115-119].   
 Species specific variations in the fluence distribution between mice and humans 
arising from differences in the thickness of their skin, which is highly scattering, was also 
investigated.  The absorption and scattering properties of skin were taken from Bashkatov 
et al.[115], as the optical properties between the species have been shown to be similar[115, 
120].  The thickness of epidermis and dermis in humans is 1 – 4 mm[115], while in mice it is 
only 0.3 – 0.5 mm[120, 121].  Each tissue type and wavelength combination were simulated 
with a 2 mm skin layer to mimic human skin and a 0.3 mm skin layer to mimic the skin of 
mice.  It was assumed that the fiber bundle was pressed flush with the skin, so neither 
ultrasound gel nor another coupling medium was included in the simulation volume.    
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Table 3.1 List of optical properties for all tissue type and wavelength combinations 
that were simulated.  Reproduced from Sowers et al.[100]   


































1.63, 1.30 0.9 1.4 [113, 114, 116, 118, 119] 
20% Fatty, 
80% Fibrous 




Tissue 800 0.048 5.68 0.9 1.4 
60% Fatty, 
40% Fibrous 
Tissue 800 0.063 7.56 0.9 1.4 
80% Fatty, 
20% Fibrous 














Refraction () References 
Milk 1064 0.02 7 0.7 1.338 [122-125] 
Gelatin 1064 0.012 0.05 0.85 1.5 [126, 127] 
 
 
 For each species, tissue type, and wavelength combination, two sets of simulations 
were conducted.  In the first set, the distance between the location of light emission and the 
center of the transducer, D, was held constant while the angle was varied.  The distance, 
D, was set to 7 mm.  This was chosen because it is close to the minimum possible given 
the size of the transducer used in our experiment and because many other transducers 
would be similarly sized.  The angles were sampled from 20 to 70 degrees in 12.5 degree 
increments, which spans the range of angles likely to be used.  In the second set of 
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simulations, the angle was held constant while the distance between the fiber bundle and 
the center of the transducer was varied.  The angle was set to 45 degrees since it is 
intermediate in the angles used in the prior simulation and because we found from initial 
simulations that it commonly results in the highest fluence in the imaging plane.  The 
distance, D, was varied from 5 to 13 mm.  We used these distances because most 
transducers have a width greater than 10 mm and because we found that the fluence drops 
off significantly beyond 13 mm.  The reported fluence for each simulation was the fluence 
averaged over a 0.5 mm x 20 mm rectangular region at the center of the imaging plane.  A 
cubic volume with a length of 36 mm on each side and 109 photons were used to simulate 
each condition.  Finally, we compared the fluence delivered to the imaging plane when the 
mouse skin thickness was used and when the human skin thickness was used.  This was 
conducted to determine the extent to which the difference in skin thickness contributes to 
lower fluence when translating from mice to humans, even before other factors such as 
greater imaging depth are considered.  The maximum fluence at all fiber angles for the 
simulations in which the distance was held constant was calculated for each tissue type, 
wavelength, and species combination.  The ratio of the maximum fluences between each 
mouse and human skin thickness simulation pair is calculated for each tissue type and 
wavelength combination.     
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3.2.3 Experimental Validation 
3.2.3.1 Experimental Setup and Analysis 
The Verasonics system (Vantage 256TM, Verasonics, Inc., Kirkland, WA) was used for 
ultrasound and photoacoustic signal acquisition.  The previously developed acquisition 
sequence, which incorporates a laser, the Verasonics system, and motorized stages[128, 129] 
was used for acquisition of the US and PA data.  The ultrasonic signals were acquired with 
a 128-element linear array transducer (Verasonics, Inc.; L11-4v) with a frequency 
bandwidth from 4-11 MHz.  For ultrasound imaging, the center frequency was at 8 MHz 
and plane-wave compounding with 15 angles was utilized.  Photoacoustic excitation was 
achieved with a Nd:YAG pumped optical parametric oscillator laser (Opotek Phocus).  The 
laser operated at 10 Hz with 7 ns pulses.  The laser irradiation was delivered to the phantom 
by optically coupling the laser output to a 9 mm diameter optical fiber bundle.  The optical 
fiber bundle terminated in two rectangular bundles with dimensions of 25 mm x 1.4 mm.   
 The phantom used for the experimental validation consisted of multiple 0.5 mm 
diameter graphite rods embedded in a 6% gelatin (Sigma-Aldrich, G2500-1KG) phantom.  
Eleven rods were spaced 5-6 mm horizontally at depth increments of approximately 2 mm 
(Figure 3.1d).  The phantom was irradiated at 1064 nm with 40 mJ per pulse measured out 
of the single optical fiber bundle used in the experiment (Figure 3.1c).  The transducer and 
optical fiber bundle were scanned across the graphite rods using a 3D positioning system 
(Newport; Model ESP301) in 0.2 mm steps, with 1 US and 1 PA image taken at each 
location, which was repeated four times for statistical analysis.  The translation distance 
for three-dimensional scanning was 50 mm, so a total of 251 steps were required.  One 
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optical fiber bundle was sufficient to deliver laser irradiation to the rods (Figure 3.1c), due 
to the symmetry of the dual optical fiber bundle setup commonly found in the literature.  
This acquisition was repeated with the optical fiber bundle at each combination of three 
angles (20°, 40°, and 60°) and at three horizontal distances (7.5, 11.5, and 15.5 mm) from 
the transducer, resulting in a total of 9 acquisitions.  If the angle was changed, the optical 
fiber was translated such that the distance, D, between the center of the transducer array 
and the center of the optical fiber remained constant.  Both the ultrasound transducer and 
the optical fiber bundle output were located 2 mm above the gelatin phantom and coupled 
to the phantom using milk, which approximates the scattering and absorption coefficients 
of skin at 1064 nm[122-125].   
 Images were taken directly above each of the eleven graphite rods.  These were 
used to determine the PA intensity from each rod by averaging the PA signal across the rod 
in each image.  The standard deviation for each of those PA intensities was calculated using 
the four acquisitions taken at each location.  Since the absorption coefficient and 
Grueneisen parameter would be the same for each of the graphite rods, the measured PA 
signal is directly proportional to the fluence at each rod.  Thus, the PA intensity can be 
compared to the average fluence at the depth of each rod in the model.   
 However, in these experiments the effect of ultrasound attenuation, obliquity, and 
the depth dependent transducer focus would vary from rod to rod due to their placement at 
different depths in the phantom.  To account for this, the US images of each rod were used 
to normalize the PA images in a manner similar to the work of Ranasinghesagara et al.[130, 
131].  Given that the rods are nearly identical, the same magnitude of ultrasound should be 
measured at each rod once the ultrasound attenuation, obliquity, and depth dependent 
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transducer focus are taken into account.  Thus, the PA intensities were normalized using 
the US data.  The US intensity for each rod was calculated by averaging the ultrasound 
signal over the rod in each of the eleven images.  The US intensities were then normalized 
so that the maximum US intensity had an intensity of one.  Since the attenuation, obliquity, 
and depth dependent transducer focus would affect the ultrasonic signal twice during US 
acquisition (one for each direction of travel) the square root of the normalized ultrasound 
intensity for each rod was calculated.  Finally, the PA intensity of each rod was normalized 
rod to rod by these values.  These adjusted PA intensities, with their standard deviations, 
were plotted for each combination of angle and fiber distance.   
 
3.2.3.2 Experiment Matched Modeling Parameters 
To simulate the experiment, modeling was performed with parameters chosen to emulate 
the materials used in the experiment (Table 3.1).  Thus, the volume for the Monte Carlo 
simulation consisted of a 2 mm layer with the optical properties of milk while the remainder 
of the volume was assigned the optical properties of water to approximate the optical 
properties of the gelatin phantom.  At 1064 nm, milk has an absorption coefficient near 
0.02 1/mm and a scattering coefficient of 7.0 1/mm[123, 124].  It has a lower anisotropy 
coefficient of 0.7[122, 123] and an index of refraction of 1.34[124, 125].  The absorption[127] and 
scattering coefficients[115, 117] of gelatin were approximated with that of water.  At 1064 
nm, gelatin has an anisotropy coefficient of 0.85 and a refractive index of 1.5[126].  A cubic 
volume with a length of 36 mm on each side and 109 photons were used to simulate each 
condition.   
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 The model was evaluated to determine the fluence as a function of depth along the 
imaging plane of the transducer.  The average fluence across voxels in a 0.5 mm x 20 mm 
area was used for comparison to the experiment since this is equivalent to the cross section 
of the rods.  These values were plotted for each combination of fiber bundle angle and fiber 
distance.   
 
3.2.4 Model Convergence 
Across the imaging plane for each simulation, a 0.5 mm x 0.5 mm kernel was used to 
evaluate the SNR (average fluence divided by the standard deviation of fluence) at each 
voxel.  The SNR values were averaged across the imaging plane for each experimental 
condition to determine the average SNR for each simulation.   
3.3 Results 
3.3.1 Modeling Parameters 
The fluence versus depth along the center of the imaging plane for several simulations with 
the mouse skin and human skin thickness is displayed in Figure 3.2 and Figure 3.3.  Only 
the plots for the 40% fat tissue at 800 nm (Figure 3.2a,b and Figure 3.3a,b), the purely 
fibrous tissue at 700 nm (Figure 3.2c,d and Figure 3.3c,d), and fat tissue at 1064 nm (Figure 
3.2e,f and Figure 3.3e,f) are shown in the body of the text, although the results for all tissue 
types and wavelengths are included in Appendix A.  The results with the mouse skin 
thickness are shown on the left (Figure 3.2a,c,e and Figure 3.3a,c,e) and results with the 
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human skin thickness are shown on the right (Figure 3.2b,d,f and Figure 3.3b,d,f).  The y-
axis is defined as the averaged normalized fluence.  It is averaged because the fluence was 
calculated by averaging across the voxels in a 0.5 mm x 20 mm area at the center of the 
imaging plane.   It is normalized because the MCXLAB software automatically normalizes 
the fluence output by the amount of energy irradiated into the simulation volume.  Fluence 
drops significantly as a function of depth in all simulations.  For the fibrous tissue, it drops 
to zero near 35 mm at the end of the simulation volume, whereas for the highly scattering 
fatty tissue it decreases to nearly zero at a depth of only 15 mm.  As would be expected, 
the depth at which fluence reaches zero decreases monotonically as the fatty tissue 
component increases for the mixed tissue type simulations conducted at 800 nm.  Fatty, 
and thus more highly scattering, bulk tissue results in lower fluences at the imaging plane.  
The peak of maximum fluence occurs between 2 and 6 mm for the majority of conditions 
that were simulated, no matter the angle of the fiber bundle.   
For nearly all simulations, the fluence as a function of depth decreases by over an 
order of magnitude as the distance of the fiber bundle from the imaging plane increases 
(Figure 3.2).  The decrease was smaller in a few simulations (fibrous tissue at 700 and 800 
nm) although the fluence still decreased by at least a factor of 5.  The likely cause is that 
in these simulations, the scattering coefficient of the soft tissue is still low relative to other 
simulated tissue types and the absorption coefficient in fibrous tissue is smaller than at 900 
or 1064 nm.   
 Varying the light emission angle (Figure 3.3) while holding the distance constant 
had a more complex effect on the peak fluence.  For simulations with the fatty tissue, 45 
degrees was optimal for both humans and mice, with 32.5 degrees giving a fluence within 
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several percent of the maximum for all wavelengths.  In fibrous tissue, 45 degrees was 
optimal with the mouse skin thickness while 20 degrees was optimal when the skin had the 
thickness of a human.  For skin with the human thickness, 20 degrees was also the optimal 
angle for most mixed tissue types at 800 nm.  The exception was for 80% fatty tissue, in 
which the optimal angle transitioned to 32.5 degrees.  The variation between 20 degrees 
and 32.5 degrees was only a few percent at these conditions.  For simulations with skin the 
thickness of a mouse, 45 degrees and 32.5 degrees were optimal and gave almost identical 
peak fluences.  Across all the simulations in which angle was changed, the peak fluence 
varied by 10-50% between the angle with the optimal fluence and the angle with the least 
light delivery.  The variation was greatest when the scattering coefficient of the soft tissue 
was small.   
 Perhaps most importantly, there is significant variation in the fluence at the imaging 
plane between simulations with different skin thicknesses when all other conditions are 
held constant.  Using the simulations in which angle was varied, the ratio of maximum 
fluence delivered when the mouse skin thickness was used versus the human skin thickness 
varied from 0.68 to 3.53 (Table 3.2).  The ratio is greatest for the most fibrous tissue and 
increased with greater fibrous tissue content in the simulations with the mixed tissue 
composition.  For the fatty tissue, the ratio dropped below 1 at wavelengths from 700-900 
nm.  Given the optical properties of tissue types commonly used for photoacoustic 
applications, ratios between 1.5 and 2 can be expected.  This has clear implications for the 
translatability of photoacoustic studies conducted in mice, even before other factors, such 
as the greater imaging depth required in humans, are taken into consideration.    
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Figure 3.2 Plots of average normalized fluence versus depth. Simulations with a 
mouse skin thickness are on the left [(a), (c), and (e)], while simulations with the 
human skin thickness are on the right [(b), (d), and (f)]. Results for (a), (b) the 40% 
fat tissue at 800 nm; (c), (d) the purely fibrous tissue at 700 nm; and (e), (f) the 
purely fat tissue at 1064 nm are shown for the mouse and human skin thickness. 
Simulations were run with a constant angle of 45 deg and a variety of distances 
between the location of light emission from the optical fibers and the center of the 
transducer array. As expected, smaller distances between the location of light 
emission and the transducer result in higher fluences. Fluences are noticeably larger 
when the mouse skin thickness is used for the simulation, rather than the human 
skin thickness. Reproduced from Sowers et al.[100]    
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Figure 3.3 Plots of average normalized fluence versus depth. Simulations with a 
mouse skin thickness are on the left [(a), (c), and (e)], while simulations with the 
human skin thickness are on the right [(b), (d), and (f)]. Results for (a), (b) the 40% 
fat tissue at 800 nm; (c), (d) the purely fibrous tissue at 700 nm; and (e), (f) the 
purely fat tissue at 1064 nm are shown for the mouse and human skin thickness. 
Simulations were run with a constant distance of 7 mm between the location of light 
emission and the center of the US transducer, while varying the angle of light 
emission. In addition, shallower angles appear to deliver higher fluence across all 
depths for the human skin, while the optimal light emission angle is usually 45 deg 
when the simulations are run with the mouse skin thickness.  Fluences are 
significantly higher when the mouse thickness is used instead of the human skin 
thickness.  It is also highest for the least fatty tissues.  Reproduced from Sowers et 
al.[100]    
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Table 3.2 Ratios of maximum fluence between the simulations with mouse and 
human skin thicknesses, for simulations in which the distance was held constant at 7 
mm.  Reproduced from Sowers et al.[100]   
Fluence Ratios of Fatty and Fibrous Tissues by Wavelength 
  700 800 900 1064 
Fatty tissue 0.68 0.81 0.92 1.05 
Fibrous tissue 2.49 2.74 3.18 3.53 
Fluence Ratios of Mixed Fatty and Fibrous Tissues by Fat Content 
  20% fat 40% fat 60% fat 80% fat 
Mixed Tissue, 800 nm 2.09 1.74 1.41 1.10 
 
 
3.3.2 Experimental Validation 
Results of the experimental validation and matching simulation are shown in Figure 3.4.  
In both the experiment and the model, fluence varies significantly across all depths as the 
distance between the location of light emission and transducer center is increased.  
However, the change in the fluence is generally greater for the model than for the 
experiments.  For the model, peak fluences between 20 and 60 degrees varied by only about 
25%, with the maximum peak fluence arising at the shallower angle of 20 degrees.  A 
similar difference for peak fluence with respect to light emission angle occurred when the 
location of light emission was farther from the transducer.   
 However, for the experiment the maximum fluence occurred at 40 degrees.  In 
addition, variations in fluence were more significant.  There was a 25% decrease in fluence 
when changing the light emission angle from 40 degrees to 20 degrees in the experiment 
with a 7.5 mm distance between the light emission and transducer center.  At larger 
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distances, the change generally ranged from 10-20%.  A light emission angle of 60 degrees 
resulted in fluences two times smaller than at a 40 degree angle when the distance was 7.5 




Figure 3.4 Comparison between (a)–(c) the experiment matched model and (d)–(f) 
the experimental results using the gelatin and graphite rod phantom. Simulations 
were conducted at 60 deg [(a) and (d)], 40 deg [(b) and (e)], and 20 deg [(c) and (f)]. 
In general, a smaller distance between the location of light emission and the 
transducer center results in higher fluences in both the experiment and simulations. 
Meanwhile, an angle of 20 deg or 40 deg is optimal for the model and experiment, 
respectively.  Reproduced from Sowers et al.[100]    
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3.3.3 Model Convergence 
The average SNR across the imaging plane was evaluated for each simulation.  For the 
position and angle dependence studies in mice and humans, the average SNR across the 
imaging plane was 14.7.  The minimum SNR for all conditions was 4.3.  For the 
experimental phantom simulations, the average SNR was 28.8, with a minimum SNR of 
15.0 for any single condition.  The SNR values indicate that the photon count used for these 
simulations was sufficient.  The smoothness of the processed data is evident in Fig. 2-3.   
3.4 Discussion 
In this chapter, a series of simulations have been conducted with different system 
geometries, tissue types, wavelengths, and species characteristics to optimize fluence 
delivery for a photoacoustic imaging system.  The difference in fluence distributions when 
either a mouse or human skin thickness is used indicate that there are differences in optimal 
design as well as the quantity of fluence that can be expected at a given depth depending 
on the skin thickness.  First, in both models the distance between the location of light 
emission from the optical fibers and the center of the ultrasound transducer has the most 
significant effect on the fluence delivered to the imaging plane.  Minimizing this distance 
increases light delivery to the imaging plane.  Variations of only several millimeters can 
result in changes in fluence of nearly two-fold.   
 Variations in the optimal angle were found to be dependent on the skin thickness 
and tissue composition.  Angle had the greatest effect on fluence when the bulk tissue was 
more fibrous, and thus had a scattering coefficient several times smaller than the skin layer.  
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For simulations with the mouse skin thickness, a 45 degree angle was optimal for most 
conditions with 32.5 degrees often giving almost identical fluence.  However, when the 
human skin thickness was used in the simulations, the optimal angle was instead 20 
degrees, with 32.5 degrees sometimes giving similar results.  The difference is due to the 
more complete scattering of light as it passes through the thicker 2 mm skin layer.  For the 
human skin thickness, light is completely scattered such that the light propagation is 
diffusive rather than ballistic.  This is illustrated in Figure 3.5, which depicts a cross section 
perpendicular to the imaging plane.  Light propagating through the 2 mm thick skin layer 
has lost its directionality despite having an angle of illumination of 60 degrees (Figure 
3.5a).  However, when the skin scattering coefficient is decreased by a factor of 10, the 
angle of illumination is still evident, resulting in more light delivery to the imaging plane 
(Figure 3.5b).  The mouse skin thickness is about 10 times smaller than the human skin 
thickness, so in the simulations the light maintains some of the directionality associated 
with the original illumination angle.  As a result, the 45 degree angle, which directs the 




Figure 3.5 Color map of the fluence in a cross section of the simulation volume 
perpendicular to the center of the imaging plane.  (a) A simulation with light 
emitted at a 60-deg angle through skin with a human skin thickness.  (b) An 
identical simulation geometry with the human skin scattering coefficient decreased 
by a factor of 10.  The difference in the fluence map clearly indicates the scattering 
effect of normal human skin thickness, which causes the photons to lose much of 
their ballistic directionality and instead have a more diffusive transport behavior.  
Reproduced from Sowers et al.[100]   
 
 
 Importantly, the extreme scattering in the thicker human skin layer results in lower 
fluences when the human skin thickness is used, even when using the optimal distance and 
angle configurations (Figure 3.2 and Figure 3.3).  The modeling results indicate that the 
fluence will commonly be 50 to 100% higher in mice than in humans, and over 200% as 
high in fibrous tissue at 900 or 1064 nm.  While this does not matter for imaging techniques 
developed for valuable preclinical applications, this should be strongly considered by 
researchers conducting techniques that are meant to be translated to humans, as most 
preclinical work is done in mouse models.  While alternative methods for light delivery, 
such as using catheters or endoscopes, have been suggested that could circumvent this 
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issue, they are not common[132].  The simulations were conducted using a variety of bulk 
tissue compositions and wavelengths, so that researchers can approximate the extent to 
which this will affect their specific applications.  Researchers should expect that when 
translating their results to the clinic, fluences in human tissue may be several times smaller 
using the same equipment and pulse energies, simply because of the increased scattering 
in human skin.   
 The experimental validation was used to validate the trends found in the model.  
This was done by producing a gelatin phantom containing discrete absorbers at different 
depths and covered by a thin layer of milk which approximates the optical properties of 
human skin.  Then, the results of the experiment were compared to simulations of the 
experiments conducted on this phantom.  In the model, there was a 2-4x difference in 
fluence when the distance between light emission from the optical fiber and the center of 
the ultrasound transducer was changed from 7.5 to 15.5.  In the experiment, changing this 
distance also had the largest effect, with fluence decreasing by a factor of 2-3x.  When 
changing the light emission angle, the model indicated that the fluence would vary by no 
more than 25% across the angles tested.  In the experiment, the difference between 40 and 
20 degrees was 25%.  For the 40- and 60-degree tests, the change in angle had a larger 
effect on fluence at two fold.  One potential source of error in these experiments is that 
some light, especially at extreme angles, could have been scattered upwards and been 
absorbed after hitting the transducer.  This possibility was not incorporated into our 
modeling, as the transducer was not present.  In addition, the optical properties of the 
gelatin were approximated with those of water.  Lastly, our simulations did not consider 
light reflecting off the boundaries of the simulation, which could have been possible at the 
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gelatin-plastic and plastic-air interfaces.  Finally, the light emitted from the optical fiber in 
the experiment would have been emitted at a distribution of angles, depending on the 
acceptance angle of the optical fiber in the milk medium.  The result would have been light 
emitted at more extreme angles than the defined value.  Given the NA of the optical fiber 
(0.22) and the index of refraction in milk (1.34), the maximum angle would have been 
about 10 degrees.  At the 20-degree condition, some light would have been emitted at a 
smaller angle, or even in a direction perpendicular to the imaging plane.  The result would 
be less light reaching the graphite underneath the ultrasound transducer, which could 
explain the lower PA intensity at that condition compared to the model.  At the 70-degree 
condition, some light emitted at larger angles or light emitted perpendicular to the imaging 
plane would have been directed away from the graphite underneath the imaging plane of 
the transducer.  Light emitted at more extreme angles would have also partially reflected 
off the milk/gelatin interface, based off calculations using the Fresnel equations, which 
could explain the low PA signal at that condition.  For example, the percentage of light that 
would reflect off the milk/gelatin interface would be only 6% at 70 degrees but rise to 22% 
at 80 degrees (70-degree emission + 10-degree emission angle).  The Monte Carlo 
simulation software only allowed light to be emitted at a constant angle, so these effects 
could not be replicated in the modeling results.   
 These issues could be addressed in future work.  The optical properties of gelatin 
could be measured so the material could be accurately represented in the model.  The 
shortcomings of the model would be more complex to address.   A different skin layer 
using a solid material could be used instead of milk, so there is no mismatch in the index 
of refraction at the interface.  One solution may be to use a second gelatin layer containing 
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intralipid.  The issue with the unique distribution of light emitted from the optical fiber 
could be addressed with an alternative simulation software, or by introducing a custom 
light source into the code for MCXLAB.  Alternatively, multiple simulations could be run 
with light emitted at a variety of angles within the angle of acceptance from the optical 
fiber.  The fluence distribution of each simulation could be summed in a weighted average 
based on the likelihood of light being emitted at each of these angles.  However, this would 
require a clear understanding of the probability distribution for the angle of light emission 
from the optical fiber, which is not known.  Also, it would be expensive in terms of 
simulation time and memory.   
 Multiple researchers have investigated the optimal experimental geometry of 
similar imaging hardware in previous work.  However, findings on the optimal angle for 
light delivery have varied.  For example, Haisch et al.[16] found that angles from 40-50 
degrees are optimal for depths from 10-25 mm, but that shallower angles are better for 
deeper targets.  Sivasubramanian et al.[108] found that a combination of the fiber-transducer 
distance, transducer-tissue distance, and light emission angle affect SNR in tissue.  Sangha 
et al.[109] found experimentally in a phantom that deeper focal depths resulted in higher 
depth penetration but at the cost of SNR in regions closer to the phantom surface, but this 
result did not carry over to in vivo experiments using a mouse.  Conversely, Wang et al.[107] 
found that smaller angles will result in monotonically higher fluence in the imaging plane 
at depth ranging from 5 to 30 mm.  The divergent results can be explained by the presence 
or lack of a high scattering layer that replicates skin.  For example, Haisch et al.[16] did not 
include a skin layer in their phantom studies, while Sangha et al.[109] used both a phantom 
without a skin mimicking layer and validated the experimental work in a mouse.  
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Sivasbramanian et al.[108] also did not use a skin mimicking layer.  Thus, their finding that 
angle can be actuated to improve fluence in the imaging plane is consistent with the 
simulations using mouse skin thickness in this work.  In contrast, Wang et al.[107] and other 
researchers[133, 134] included a 2 mm thick skin layer in their simulations and the results of 
those studies therefore correspond with the results in the human model used here.  Thus, 
the differences in the effect of angle found between these researchers are explainable by 
the presence, or lack, of a scattering skin layer.  Our modeling also indicated that reducing 
the fiber to transducer distance will increase the fluence delivered at the imaging plane.  
This finding was consistent with prior work in the literature[16, 107, 135].   
 In this study, we evaluated the optimal design of an imaging system consisting of 
light emission and a commercial ultrasound transducer using the maximum fluence as the 
criterion for the optimal design.  However, it has been found in the literature that in some 
instances, the increased background signal from other optical absorbers in the tissue can 
result in the optimal distance being farther away from the transducer[133, 136].  This effect is 
complex.  The optimal distance can change, for example, when the transducer offset is 
increased.  Also, studies on bright field designs[137-140] indicate that the increased clutter 
will not always offset the gain in fluence from moving the location of light emission closer 
to the imaging plane.  In addition, the development of clutter removal techniques promises 
to reduce this effect[141-146].  In general, the clutter will be a function of the chromophores 
in the tissue being imaged and the wavelength used for imaging, among other variables, 
which will vary from application to application.  Researchers should carefully consider 
these factors or conduct direct testing when determining if a greater distance is appropriate 
for their application.  Studies in which the fluence is compensated to adjust for the decrease 
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at greater depths were not considered, although techniques exploring this are in 
development[147].   
 Within the scope of this study, only the distance between the location of light 
emission and the center of the ultrasound transducer and the light emission angle were 
examined to optimize light delivery.  However, other parameters are worth mentioning that 
have already been studied.  One method used light reflectors on the transducer face or 
around the end of the optical fibers and transducer to reflect upwardly scattered light back 
into the tissue[135, 148-150].  However, experimental testing of the phenomena showed mixed 
results.  When imaging arteries in mice in vivo, the reflector did not show the improvements 
found from modeling[151], although curved reflectors have given better experimental 
results[148, 150].  Periyasami et al.[135] also considered different arrangements of the fiber 
bundles around the ultrasound transducer.  The variation in fluence along the imaging plane 
was also not considered, as this has been found previously to vary little with the length of 
the optical fiber bundle[107].  Also, the effect of offsetting the fiber bundle from the tissue 
surface was not modeled, as this has already been investigated[135].  Finally, the width of 
the optical fiber bundle was not considered.  This is because a larger width (with the same 
pulse energy) would effectively increase the average distance between the light source and 
the transducer bundle, which the results in this chapter and the results of others[16, 107, 135] 
have consistently shown result in a decrease in fluence.  The other case, where the width 
of the optical fiber bundle is changed but the fluence is held constant rather than the pulse 
energy, results in an increase in depth penetration as has been shown previously[152].   
 Patient to patient or animal to animal variability was not considered in this work, 
since capturing all possible combinations is not possible.  These could include differences 
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in size and anatomy, as well as hair, fur (in mice), and skin pigmentation.  Instead, bulk 
tissue at a variety of tissue compositions and wavelengths were used as optical media to 
achieve generalizable results.  The goal is to give practical guidance to researchers, who 
can use the simulation results that best match the optical properties for their specific 
application as a starting point for designing their own imaging system.     
 In this work, simulations and experimental validation were used to determine the 
optimal design geometry for the optical fiber and ultrasound transducer array combination 
that has become common for combined US and PA imaging.  This work evaluated 
differences in the optimal device designs that would arise from different bulk tissue types, 
wavelengths, and system geometries.  These results can be used by researchers as practical 
guidance for a variety of applications, because of the variety of tissue types and 
wavelengths that were simulated.  Using the depth dependent fluence delivered to the 
imaging plane as the criterion for evaluating the optimal design, it was found that a smaller 
distance between the location of light emission from the optical fiber and the center of the 
transducer array results in the best light delivery for both species.  However, the optimal 
light emission angle is dependent on the thickness of the skin layer and the tissue 
composition, with the former having the largest effect.  The results are compared to the 
literature and it was found that the differences in skin layer thickness can explain variable 
findings for the optimal angles found in prior work.  Perhaps most importantly, this work 
indicates that the same imaging system may deliver fluences several times smaller in 
humans than mice, which serves as a cautionary message for researchers currently 
developing new imaging techniques in mice models with the expectation that they will 
translate to humans.    
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3.5 Conclusions 
In this chapter, experimental work and light transport modeling were completed to 
determine the optimal parameters for the design of a combined US/PA system consisting 
of an ultrasound linear array with external light delivery.  The simulations included a 
variety of tissue compositions, wavelengths, and equipment geometries.  The effect of 
incorporating either a skin layer with the thickness expected in a mouse or with the 
thickness expected in a human was also investigated.  With both skin thickness and all 
tissue type and wavelength combinations, reducing the distance between the light source 
and imaging plane has the largest effect on the light delivery to the imaging plane.  
However, the optimal light emission angle varied depending skin thickness, tissue 
composition, and wavelength.  In humans, shallower angles were found to increase fluence 
in the imaging plane across all depths.  However, in mice an intermediate angle of 45 
degrees was most often optimal.  The difference is shown to be mainly a result of the 
increased scattering of thicker human skin.  The difference in the optimal fiber bundle 
angle between simulations with different skin thicknesses also explains variations in the 
results of studies by other researchers.  Perhaps most importantly, these results indicate 
that an identical imaging system will deliver significantly less light to the imaging plane in 
humans than in mice because of the scattering effect of the thicker skin layer.   
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CHAPTER 4: FLUENCE COMPENSATION FOR QUANTITATIVE 
PHOTOACOUSTIC IMAGING 
4.1 Introduction 
4.1.1 Abstract  
In this chapter, a new technique is introduced that could be used to compensate for fluence 
variations deep in tissue, such that relative quantitative comparisons of photoacoustic 
signal intensity could be made.  The technique is investigated using modeling methods.  It 
requires slightly compressing tissue while simultaneously recording the photoacoustic 
intensity of native absorbers.  Once acquired, the photoacoustic intensity as a function of 
depth during compression can be fitted exponentially to approximate the attenuation 
coefficient of light in that tissue.  Once determined, the attenuation coefficient can be used 
to compensate the acquired photoacoustic image in the uncompressed state.  The 
simulations run here establish that a constant exponential attenuation coefficient for fluence 
versus depth is expected in most soft tissues at depths near or greater than 1 cm, illustrating 
the viability of the technique.  The expected improvement in measuring the relative 
photoacoustic intensity between five high absorbing regions in a simulation using the 
optical properties of breast tissue at 789 nm is estimated.  The error in relative intensity is 
improved from 51-97% before using the technique to less than 5% afterwards.  The studies 
illustrate the potential usefulness of the technique in clinical applications and justify further 
experimental study.   
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4.1.2 Background  
As explained previously (Eq. 1.1) the magnitude of a photoacoustic signal is linearly 
dependent on the fluence at the target tissue.  However, the true fluence distribution in 
tissue is not known.  Thus, variations in the photoacoustic signal in an image are not solely 
attributable to the absorption coefficient and Grueneisen parameter of tissue which impedes 
identification of the target tissue.  Indeed, fluence in tissue across an imaging depth of 
multiple centimeters can easily vary by more than an order or magnitude (for an example, 
see fluence distributions in Figure 3.2, Figure 3.3, or Appendix A).  It would be desirable 
to compensate for this fluence distribution since it would make target identification more 
accurate and make it possible to quantitatively compare the concentration of absorbers in 
different regions of tissue.   
 Many researchers have developed a diverse set of methods for approaching this 
problem.  Indeed, the subject of fluence compensation is well represented in the literature, 
with multiple reviews covering the prior art in depth[153, 154].  Some common approaches 
will now be discussed, although the reader is referred to the review papers for a more 
complete accounting.   
 Perhaps the most straight forward method for estimating the fluence distribution in 
tissue is to approximate it directly using modeling methods.  Monte Carlo modeling is 
considered the gold standard for approximating light propagation in tissue with known 
optical properties[153, 155].  Multiple researchers have published work in which Monte Carlo 
simulations are used to estimate the fluence distribution in tissue[156-159].  The problem with 
these and other simulation methods is that they require the optical properties of the tissue 
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to be assumed, which is a constant source of inaccuracy.  Often, these are approximated 
using the optical properties of the same tissue type measured and then reported in the 
literature by another researcher.  However, the optical properties of soft tissues can vary 
widely between different specimens even for the same tissue type.  For example, in one 
study that measured the optical properties in chicken breast tissue[114], the absorption 
coefficient of one sample was 2x higher than another while the scattering coefficient was 
1.5x lower across all wavelengths in the range 400-800 nm.   
 Another method of approximation is the use of analytical approximations, such as 
modified forms of the Beer-Lambert law[153, 160].  In unmodified form, this law is valid for 
low scattering media and defines the decrease with an exponential equation where the 
exponential constant is defined as the product of the absorption coefficient and the depth 
in tissue.  However, deep in highly scattering media this approximation breaks down[160] 
because the path highly scattered photons travel to a tissue target is significantly longer 
than the geometrical distance between the light source and the target.  Modified forms of 
Beers law have been formulated and experimentally tested to account for the longer path 
length[160-166].  However, the adjustment terms are dependent on the tissue type and 
experimental geometry, making the results non-generalizable and thus of limited practical 
usefulness.  They also suffer from the fact that the optical properties must be assumed, 
which is a constant source of error.   
 Methods which attempt to explicitly pair photoacoustic acquisition with a method 
for measuring optical properties have also been investigated[167-170].  These methods require 
additional system components, cost, and complexity.  Another set of studies have been 
conducted which use a contrast agent of known optical properties as a detector for fluence 
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in tissue[171].  Other methods use multiple light sources, or a light source focused to 
different regions of the tissue, to extract bulk tissue optical properties[172-178].   
In this chapter, we introduce a new concept that would make it possible to 
compensate for fluence deep in tissue and investigate its usefulness and potential 
effectiveness using Monte Carlo simulations.  The concept requires that the fluence in 
tissue follows a uniform exponential decay in the regions over which the fluence 
compensation method in applied.  The first simulations that are conducted model light 
propagation through a range of tissue compositions and wavelengths to confirm if the 
uniform exponential decay in fluence exists.  These simulations are used to estimate the 
depths at which the technique could be applied, and how the appropriate depth may vary 
depending on tissue type.  Finally, the effectiveness of the fluence compensation technique 
is evaluated using several high absorbing regions of indocyanine green (ICG)-like contrast 
agent, embedded in bulk tissue with the optical properties of breast tissue, to emulate 
potential applications in breast cancer diagnosis.   
4.2 Description of Fluence Compensation Technique 
The technique for fluence compensation proposed in this dissertation takes advantage of 
the fact that fluence decreases in an exponential manner deep in tissue.  The method is 
similar to the multiple illumination method mentioned in the prior section, except that it 
would not require additional hardware and the measurements would be less affected by the 
optical properties of tissue outside of the imaging plane of the transducer.  In effect, the 
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technique would make it possible to make quantitative comparisons of photoacoustic 




Figure 4.1 A schematic illustrating the use of the proposed fluence compensation 
technique.  a) The optical fiber for laser delivery and one half of a linear ultrasound 
array are shown in the uncompressed state in the tissue over the bulk tissue (blue 
region).  b) The same optical setup but after compression.  Compression causes a 
change in the optical path length to the tissue target, and a consequent change in 
fluence that can be determined by comparing the photoacoustic intensity of the 
target at different compression depths.  The attenuation coefficient of fluence can be 
determined by fitting the photoacoustic intensity of the target versus the optical 
path length the optical path length at multiple compression depths.  Once the 
attenuation coefficient is known, it can be used to compensate for the decrease in 
fluence with depth in the photoacoustic image taken in the uncompressed state.    
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 To determine the constant for exponential decay, fluence as a function of depth at 
several locations must be known.  The proposed technique would take advantage of native 
absorbers in the tissue to reconstruct the exponential decay in fluence.  By pressing gently 
on the tissue (Figure 4.1), and causing compression up to several millimeters, the 
photoacoustic intensity of native absorbers could be evaluated as a function of depth.  The 
different photoacoustic signals would be derived from the same native absorber (displaced 
to different depths due to compression) so the Grueneisen parameter and optical absorption 
coefficient would be identical for each photoacoustic acquisition.  Thus, changes in the 
photoacoustic intensity during compression would be attributable only to changes in 
fluence at the new depth.  Fitting the fluence as a function of depth to an exponential curve 
would allow the rate of fluence attenuation to be calculated.   
 Once the exponential rate of attenuation is calculated, the intensity of the 
photoacoustic signal from each absorber in the tissue could be adjusted depending on its 
depth in the uncompressed state.  The result would be a photoacoustic image in which 
quantitative comparisons between absorbers could be made, although only at greater depths 
where the exponential decay in fluence is present.   
4.3 Materials and Methods 
4.3.1 Monte Carlo Modeling Software 
The same open source Monte Carlo simulation software, MCXLAB, used for simulations 
in the prior section was used for the fluence compensation experiments.  Briefly, MCXLAB 
is a package within Monte Carlo Extreme[110-112] that can be set up through MATLAB to 
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simulate photon transport.  The software simulates a volume which is separated into 
equally sized square voxels.  The optical properties required for the simulations include the 
absorption coefficient, µa, scattering coefficient, µs, the anisotropy coefficient, g, and the 
index of refraction, n.  For the simulations in this chapter a voxel length of 50 µm was 
used.  The output of MCXLAB is the flux per voxel.  The flux is automatically normalized 
to the energy input for the simulation.  Since photoacoustic imaging requires a sufficiently 
short pulse that the energy can be assumed to have been deposited in the tissue 
instantaneously[4], the fluence is used to report results in this work. The fluence can be 
calculated simply by multiplying the flux in a voxel by the time length of the Monte Carlo 




Figure 4.2 Schematic and diagrams that show the geometry of the simulations.  A) 
the optical fiber bundles are shown at an angle, theta, with light propagating into 
the skin (2 mm) and bulk tissue (34 mm).  The size of the optical fiber footprint is 
also shown by yellow rectangles in (b).  The optical fibers are spaced a distance, D, 
from the imaging plane of the ultrasound transducer.  Also shown (a,b) is the 
location of the high absorbing regions (red dots) used in the simulations using breast 
tissue at 789 nm.  c) The location of the high absorbing regions in the imaging plane 
of the ultrasound transducer.    
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 For these simulations, we used a common US/PA imaging setup with a linear 
transducer over the center of the simulation space with two optical fiber bundles placed on 
either of the long sides of the transducer to illuminate the tissue for photoacoustic excitation 
(Figure 4.2).  Light was emitted from each of the two optical fibers, which were assumed 
to have a size of 25 x 1.4 mm2.  The center of the optical fibers (point of light emission) 
was offset from the transducer by a distance, D, of 7.5 mm.  This is close to the minimum 
distance you could get the optical fiber to the imaging plane using a standard commercial 
ultrasound linear array.  The light was emitted at a constant angle, θ, of 45 degrees.  Due 
to the symmetry of the optical fiber geometry, light emission from only one optical fiber 
was needed which reduced the simulation time by a factor of 2.  The results were then 
mirrored across the imaging plane and averaged to calculate the fluence distribution in the 
volume from both optical fibers.  The boundary condition at the edge of the simulation was 
set such that any photons that crossed over the boundary permanently left the simulation 
volume.  All simulations were conducted using 109 photons and in a cubic volume with 36 
mm per side.   
 
4.3.2 Modeling Parameters 
Two sets of simulations were conducted to test the viability of the compression method.  
Each set used different optical properties (Table 4.1).  The first set of simulations had two 
purposes.  The first was to evaluate if the fluence follows a uniform exponential decrease 
in the far field from the transducer.  This would be required for the technique to be usable 
in tissue that has sparse PA absorbers and a small (≤ 5 mm) total compression depth.  It 
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was also used to determine the depth the exponential decrease in fluence begins in different 
tissue type and wavelength combinations.  To evaluate the behavior in a wide variety of 
tissue, multiple tissue types and wavelengths were used.  The tissue consisted of various 
percentages of fibrous[113, 114] and fatty[115] tissue components.  The tissue mixtures ranged 
from purely fibrous to purely fatty tissues, with mixtures of each in 20% increments.  
Fibrous tissue is one of the tissue types with the lowest scattering coefficients while fatty 
tissues have high scattering coefficients.  Since scattering is the dominant optical property 
in soft tissue, this represents the extremes of expected optical behavior.  Mixtures of each 
component represented tissue types between those extremes.  The simulations were run at 
700, 800, and 900 nm, which cover the near infrared region commonly used for 
photoacoustic imaging.  In addition, simulations were run at 1064 nm which is often used 
due to the ubiquity of the Nd:YAG laser.  Each tissue mixture was simulated at each of the 
4 wavelengths, for a total of 24 simulations.   
 A 2 mm thick layer with the optical properties of human skin[115] was also placed 
at the surface of the simulation volume.  Light was assumed to enter the tissue at the surface 
of the skin, with no light traveling through a coupling medium such as ultrasound gel.  All 
tissues were simulated with an anisotropy coefficient of 0.9[116] and an index of refraction 




Table 4.1 Optical properties used for simulations related to the fluence 
compensation technique.   
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Figure 4.3 Three plots showing the method for fluence compensation.  a) First, 
simulations are conducted with the high absorbing regions located at their original 
depths (12, 17, 22, 27, 32 mm).  Four additional simulations are conducted with the 
high absorbing regions located 1 mm consecutively closer to the tissue surface.  
Here, the slight variations in the smoothness of the fluence curve illustrate the small 
effect of the high absorbing regions on the fluence distribution.  b) The average 
fluence across each of the high absorbing regions are calculated.  The average for 
each region is shown in a unique color, with the 5 points representing the average at 
each depth.  An exponential fit is applied to each set of 5 points for a unique region 
to determine the attenuation coefficient.  The attenuation coefficient for the 5 
regions are averaged for these simulations, since the bulk tissue is homogenous.  c) A 
plot of the fluence distribution before and after adjustment with the attenuation 
coefficient for fluence.  The adjusted fluence is nearly uniform, which is ideal for 
comparison of photoacoustic intensity between the regions.    
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 The fluence versus depth along the center voxel of the modeling volume (which 
would be equivalent to the fluence versus depth along the center of the imaging plane of 
the ultrasound array in a physical experimental setup) was extracted for each wavelength 
and tissue composition combination.  The uniformity of the exponential decay was 
evaluated by applying an exponential fit across the data in short segments (4 mm) in small 
increments (1 mm) along the fluence versus optical path length curve.  The optical path 
length of the target was calculated with the Pythagorean theorem using the target depth and 
the offset of the optical fiber bundle from the center of the imaging plane.  The segments 
chosen ranged from 90% of the peak fluence to the maximum depth of 36 mm.  The 
constant for the exponential decay was calculated for each segment, and the segments were 
evaluated for uniformity.  The depth of maximum fit was evaluated by manually 
identifying the depth the exponential decay coefficient became constant.   
 The purpose of the second set of simulations was to evaluate and illustrate the 
potential effectiveness of the fluence adjustment technique.  For these simulations, the bulk 
tissue was given the optical properties of fibrous breast tissue (found in older women, who 
would thus be more prone to the development of breast cancer) at 789 nm[179].  Inserted 
into the bulk tissue (Figure 4.2c) were 5 regions of high absorption that would emulate a 
contrast agent with a high absorption near 800 nm, such as indocyanine green.  These 
regions of high absorption were used as the photoacoustic markers to calculate the rate of 
exponential decrease in fluence.  The regions were located at 12, 17, 22, 27, and 32 mm.  
The first, third, and fifth regions were placed in the center of the imaging plane.  The second 
and fourth remained in the imaging plane, but were offset at opposite sides of the center by 
5 mm.  Each region was assigned different relative concentrations by assigning them 
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different absorption coefficients.  The first and fifth region has an absorption coefficient of 
0.1 mm-1, the third region had an absorption coefficient of 0.2 mm-1, while the second and 
fourth region had absorption coefficients 0.05 mm-1.  These are representative of the same 
absorber at relative concentrations of 1, 2, and 0.5, respectively.  A 2 mm skin layer was 
also located at the top of the simulation space, with the light entering directly at the skin 
surface as was done for the first set of simulations in this chapter.  This simulation was 
then repeated with the high absorbing regions at different depths to mimic the effect of 
compression at the tissue surface.  A total of five simulations were run.  The first was with 
the regions at the depth specified above.  Each of the four successive simulations was 
conducted with the regions progressively 1 mm closer to the skin surface (Figure 4.3a).  
Figure 4.3a illustrates this at the centerline, with the slight deviations in the fluence being 
caused by the presence of the high absorbing regions.  The fluence was averaged across 
each of the high absorbing regions in each of the 5 “compressed” simulations.  An 
exponential fit was applied to the average fluence versus optical path length for each of the 
five regions at different “compression” depths.  An example of the average fluence in each 
high absorbing region at all five compression points is shown in Figure 4.3b.  Each set of 
5 points sharing a common color represent the same high absorbing region at the 5 different 
compression points.  The exponential fit parameter was then used to compensate for the 
decay in fluence versus optical path length.  An example of the fluence before and after 
this compensation is given in Figure 4.3c.   
 Evaluating the effectiveness of the compensation technique requires a comparison 
of the relative photoacoustic signals that would be found in this region before and after 
compensation.  What is referred to here as a relative photoacoustic intensity (since the 
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Grueneisen parameter and absorption coefficient are constant because neither would 
change for the same target with “compression” depth) can be calculated by multiplying the 
relative concentration of each high absorbing region with the fluence distribution.  This 
can be done separately with the unadjusted and adjusted fluence, to attain the unadjusted 
and adjusted photoacoustic intensity, respectively.  Each of the unadjusted and adjusted 
relative photoacoustic intensities are then normalized to the intensity of the shallowest high 
absorbing region.  The shallowest region is used because the true relative absorption 
coefficient assigned to the shallowest region in the simulation is 1.0.  The normalized 
intensities before and after adjustment are then compared to the true relative concentrations 
assigned to the voxels in the simulation space.   
4.4 Results 
The effective attenuation coefficient for each of the wavelength and tissue type 
combinations was first calculated using a sliding window in 1 mm increments using 
segments lengths of 4 mm.  The results for the all the tissue composition simulations at 700 
nm are shown in Figure 4.4.  For each simulation, the effective attenuation coefficient of 
each segment was plotted versus the midpoint of that 4 mm segment.  The results show 
that the effective coefficient is low for segments at shallow depth but reaches a constant 
value with increasing depth.  The variation in the effective attenuation coefficient also 
increases for some tissue types at extreme depths, but without any clear upward or 
downward trend.  These behaviors are consistent for simulations at all wavelengths 
(Appendix B).    
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Figure 4.4 A plot of the effective attenuation coefficient of each 4 mm segment taken 
in 1 mm increments.  The results indicate a uniform fluence distribution after a 
finite depth is reached, although there is some noise in the results at greater depths 
due to the low number of photons that reach deeper into fatty tissues.  The depth of 
minimum fit is manually marked for each of the tissue components.   
 
 
 For all the effective attenuation curves, the point at which the effective attenuation 
reaches a constant was visually identified and marked (Figure 4.4).  These points represent 
the minimum depth at which the fitting technique is valid.  The results for all tissue type 
and wavelength combinations are shown in Figure 5.4.  The depth of minimum constant fit 
was 8 mm or lower for all simulations.  The depth of minimum fit also varied by tissue 
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composition, with the use of the technique at smaller depths being possible with fattier 
tissue.  The average depth of minimum fit for the most fibrous tissue was near 7 mm, while 
for the fattiest tissue it was just below 5 mm.  There was no clear pattern in the depth of 
minimum with respect to the wavelength of light used for the simulation.   
 The results of the simulations with 5 high absorbing regions in an optical medium 
that matched breast tissue at 789 nm are shown in Figure 4.6.  The figure shows the true 
agent concentration, the normalized photoacoustic intensity calculated from the unadjusted 
fluence, and the normalized photoacoustic intensity calculated from the adjusted fluence.  
The photoacoustic intensity for all 3 data sets match for the high absorbing region at 12 
mm because of the normalization.  Afterwards, the photoacoustic intensity measured using 
the unadjusted fluence decreases relative to the true value as depth increases.  The percent 
errors as a function of depth for all the high absorbing regions are 0%, 57%, 81%, 93%, 
and 97%.  The percent error using the adjusted fluence were drastically improved.  The 
percent error between the true relative concentrations and the photoacoustic intensities 
using the adjusted fluence were 0%, 2.9%, -1.0%, 4.5%, and 4.4%.  This is a marked 
improvement over the adjusted values and illustrates the potential of the technique for 







Figure 4.5 Plot of the depth of minimum fit for all tissue types and wavelengths.  
The depth of minimum fit ranges from 8 mm in fatty tissue to 5 mm in fibrous 





Figure 4.6 A plot of the normalized photoacoustic intensity versus depth for the high 
absorbing (contrast agent-like) regions.  It includes for comparison the true relative 
concentrations, unadjusted relative concentrations, and relative concentrations after 
applying the technique for fluence compensation.  The relative photoacoustic 
intensity using the unadjusted fluence clearly deviate from the true relative value 
with depth.  This is a result of the decrease in fluence deeper in tissue.  The relative 
photoacoustic intensities calculated after fluence adjustment are greatly improved, 
with errors of 5% or less.   
 
4.5 Discussion 
The simulations at all tissue composition and wavelength combinations showed a 
uniformity of fit at depths beyond 1 cm.  This indicates the viability of the fluence 
compensation technique across most soft tissue types found in biomedical applications.  
The decrease in the effective attenuation coefficient at shallower depths is a consequence 
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of the sampled segment becoming closer to the peak of the fluence distribution.  In this 
region, the fluence distribution is not uniformly exponential.  At greater depths, the 
effective attenuation coefficient had greater variance, although there was no clear upward 
or downward trend across the tissue type and wavelength combinations.  This can be 
explained by the fact that in the Monte Carlo simulations lower fluence, and thus fewer 
photons, were present deeper in tissue.  Due to the random nature of photon propagation 
in Monte Carlo simulations, this would result in a noisy fluence distribution deeper in 
tissue.   
 The depth of minimum fit analysis indicated that this technique will be valid at 
smaller depths in fatty tissue.  This is consistent with the fluence versus depth distribution 
in which the peak fluence occurs at smaller depths in fatty tissue.  A uniform rate of 
fluence decay occurred at depths ranging from 5-8 mm depending on tissue type.  As a 
simple rule of thumb, we propose that this technique be used at depths of 1 cm or greater.  
It should also be noted that in an experimental setting, the validity of the technique at 
depths in the 5-10 mm range could be detected in real time by evaluating the goodness of 
the exponential fit, such as by an R2 value or some other measure, from an imaging target 
found at a depth in that range.   
 Several assumptions were made for this modeling study.  First, we assumed that 
the bulk tissue was homogenous.  In theory, you could deduce different attenuation 
coefficients in layers of tissue with different optical properties if there existed a 
chromophore that could be tracked during compression in each layer.  In addition, the 
presence of these layers could be detected in the first place using ultrasound.  However, 
this was not explicitly tested and will require experimental validation.  Another 
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assumption was that skin compression was negligible, since it is much thinner than the 
bulk tissue.  Finally, we ran simulations with only one optical fiber and ultrasound 
transducer geometry.  The optical fiber was set at a 45-degree angle and the optical fiber 
was placed 7.5 mm from the imaging plane.  We showed in the last section that when 
irradiation is conducted through skin, the optical fiber angle has little effect on fluence.  
In addition, optical fiber distances larger than 7.5 mm are not desirable because they 
would result in less light delivery to the imaging plane.  It is difficult to decrease the 
optical fiber distance because of the size of linear ultrasound arrays.  Because we 
expected deviations from the chosen parameters to be small, we did not investigate the 
effect of changing these extra parameters.   
 It was also assumed that tissue properties do not change when the tissue is pushed 
to induce compression.  Our rationale is that tissue is generally assumed to be 
incompressible, due to high water content[180].  The necessary compression is also small, 
at only a few millimeters.  Thus, it is likely that what appears as compression in the 
images is really a result of tissue being displaced sideways out of the imaging plane.  
Some literature has shown that optical properties of tissues do change with 
compression[181, 182].  However, there were several factors that make these not directly 
comparable to our approach.  First, the experiments were conducted on tissue specimens 
less than 1 mm in thickness that were sandwiched between glass slides and/or mirrors.  
Thus, space for tissue to be displaced sideways was small.  Second, the compression used 
was large, with the tissues compressed to thicknesses 1.5-4x smaller than the 
uncompressed thickness.  This is much larger than the compression that would occur 
from the use of our technique.  Third, there was strong evidence that the change in optical 
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properties was a result of irreversible dehydration (water loss) during the compression 
process.  This would not occur during the use of our technique in vivo.  Thus, we argue 
that this assumption is likely a valid one, although it would take further experimental 
work to prove it conclusively.   
 Another limitation of the technique is that it can provide relative concentrations of 
optical absorbers only.  It is not capable, for example, of indicating the concentration of a 
marker in absolute terms (e.g. µg/mL).  Nonetheless, relative quantitative comparisons of 
concentration within an image would still be highly useful.  Given the large (51-97%) 
percent error in the photoacoustic intensity when the fluence is unadjusted, it would be 
easy to mischaracterize signal deep in tissue.   
A second limitation is that this method is limited when using multi-wavelength 
techniques.  The fluence compensation can only be completed for targets at different 
depths for each wavelength individually.  It cannot compensate between wavelengths.  
The difference in relative fluence between the wavelengths would be limited to whatever 
ratio in fluence is present at the shallowest photoacoustic target since this is the target to 
which each wavelength is normalized.  Fluence compensation between wavelengths 
could theoretically be conducted if a chromophore were identified in tissue in which the 
difference in absorption coefficient between the wavelengths was known.  However, this 
could not be guaranteed in every imaging session.   
 The final limitation is that the study was conducted purely by simulation.  
Experiments will be needed first on phantoms consisting of high scattering liquids or 
gelatin.  Point sources, such as graphite rods, can be tracked as the optical fiber and 
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transducer are pushed into the phantom.  These studies should confirm that the exponential 
decrease in fluence as a function of depth is present by using compression.  If successful, 
several other ex vivo studies would be of value.  First, phantoms could be tested with 
multiple layers having different optical properties, to investigate the effect that 
heterogeneous tissue may have on the effectiveness of the technique.  In addition, future 
work should focus on point absorbers in actual tissue.  The purpose would be to determine 
if any change in optical properties of tissue due to compression is sufficient to make the 
technique ineffective.  For each test, the minimum depth at which the technique becomes 
viable could also be evaluated.  Finally, by using photoacoustic sources with known 
relative concentrations, the effectiveness of the compensation technique in reconstructing 
the true relative photoacoustic intensities could be evaluated.   
4.6 Conclusion 
In this chapter, we introduce a new technique that could be used to compensate fluence 
such that relative quantitative comparisons of photoacoustic signal intensity could be made 
in biological tissue.  The technique involves slightly compressing tissue and recording the 
photoacoustic intensity of native absorbers as the tissue compresses.  The change in 
photoacoustic intensity with depth can be used to determine the exponential attenuation 
coefficient of fluence in the tissue.  Once determined, the attenuation coefficient can be 
used to compensate the acquired photoacoustic image in the uncompressed state.  We 
investigate this technique using modeling methods.  We establish that a constant 
exponential attenuation coefficient for fluence versus depth should be expected in most 
soft tissues at depths near or greater than 1 cm, illustrating the viability of the technique.  
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We estimate the expected improvement in comparisons of photoacoustic intensity between 
five high absorbing regions in a simulation using the optical properties of breast tissue at 
789 nm.  We find that errors are improved from 51-97% before using the technique to less 
than 5% afterwards.  The studies illustrate the potential usefulness of the technique in 
clinical applications and justify further experimental study.   
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CHAPTER 5: SAFETY OF INTRAVASCULAR PHOTOACOUSTIC 
IMAGING – IN VITRO 
5.1 Introduction 
This chapter was adapted from: Sowers, T., et al. Laser threshold and cell damage 
mechanism for intravascular photoacoustic imaging. Lasers Surg Med., 2018. Oct 10. doi: 
10.1002/lsm.23026[183].   
 
5.1.1 Abstract 
Intravascular photoacoustic (IVPA) imaging is being developed to image atherosclerotic 
plaques, a leading cause of morbidity and mortality in the United States.  However, the 
safety of this imaging modality, which requires repeated irradiation with short laser pulses, 
has not yet been investigated.  This chapter has two objectives.  First, determine in vitro 
the limit of cumulative fluence that can be applied to cells before death at IVPA relevant 
wavelengths.  Second, evaluate if high single pulse fluences are a potential cause of cell 
death during IVPA imaging.  Experiments were conducted using endothelial cells, 
macrophages, and smooth muscle cells.  The cumulative fluence experiments were 
conducted at 1064 and 1197 nm, using a high pulse repetition frequency laser.  Cells were 
irradiated with a wide range of cumulative fluences and evaluated for cell death.  The 
thresholds for death were compared to the maximum expected clinical cumulative fluence.  
To evaluate the effect of single pulse fluences, cells were irradiated at 1064, 1210, and 
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1720 nm.  Light was delivered at a range of pulse energies to emulate the fluences that cells 
would be exposed to during clinical IVPA imaging.  At 1064 nm, all three cell types 
remained viable at cumulative fluences above the maximum expected clinical cumulative 
fluence, which is calculated based on common IVPA imaging protocols.  At 1197 nm, cells 
were viable near or just below the maximum expected clinical cumulative fluence, with 
some cell type to cell type variation.  All three cell types remained viable after irradiation 
with high single pulse fluences at all three wavelengths.  The cumulative fluence 
experiments indicate that safety considerations are likely to put constraints on the amount 
of irradiation that can be used in IVPA imaging protocols.  However, these experiments 
also indicates that it will be possible to use IVPA imaging safely, since cumulative fluences 
could be reduced by as much as two orders of magnitude below the maximum expected 
clinical cumulative fluence by varying the imaging protocol, albeit at the expense of image 
quality.  The single pulse fluence experiments indicate that cell death from single pulse 
fluence is not likely during IVPA imaging.  Thus, future studies should focus on heat 
accumulation as the likely mechanism of tissue damage.   
 
5.1.2 Background 
Cardiovascular disease is the leading cause of death worldwide, ahead of cancer and 
chronic lower respiratory disease[20].  Coronary artery disease, which is a subset of 
cardiovascular disease, resulted in an estimated 7.4 million deaths worldwide in 2015 
alone[20].  Coronary artery disease results from lipid plaque formation, causing death either 
by extreme luminal narrowing or more often by coronary thrombus formation from 
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ruptured plaques[184, 185].  Based on histopathologic studies, these rupture prone plaques are 
characterized by large lipid rich necrotic cores, calcification, a thin fibrous cap, and 
erythrocyte infiltration[26, 37, 184, 186, 187].  The growth of these lipid plaques is 
asymptomatic[188], leaving clinicians unable to intervene prior to the development of  
symptoms, which commonly include unstable angina, acute myocardial infarction, or 
sudden coronary death[184].  Once symptoms occur, it is not always clear which plaques 
require intervention.  Thus, a clinical tool capable of identifying and characterizing plaques 
would help clinicians determine the best treatments for culprit and non-culprit plaques, 
ultimately reducing morbidity and mortality.  Patients with a history of heart disease or 
with risk factors associated with plaque progression (e.g. diabetes or hypertension) could 
be ideal candidates for more extensive imaging after an initial cardiac event.  Multiple 
imaging modalities are being developed, and sometimes combined, to meet this need, with 
each modality having its own distinct advantages and disadvantages[189-192].  One such 
modality is intravascular photoacoustics.   
 In the last several years, there have been concerted efforts toward the translation of 
IVPA imaging to the clinic[13, 193].  These include, but are not limited to: continual 
improvements in catheter design[48], improvements in imaging resolution[194], the use of 
contrast agents to target biological markers, such as MMP2, of rupture prone plaques[195], 
combining IVPA with other modalities such as optical coherence tomography[196], real-
time IVPA imaging[54], and in vivo real time imaging of non-native plaque in swine[55].  
However, a review of the literature has shown no study to date that has investigated the 
safety of IVPA imaging.  Since volumetric IVPA imaging requires the acquisition of many 
photoacoustic signals as the catheter is simultaneously rotated and retracted, vessel tissue 
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is subjected to many pulses of laser irradiation.  Standards concerning human exposure to 
laser light (ANSI Z136.1 – Safe Use of Lasers) exist that give guidance for irradiation of 
the skin and eye but not for irradiation of vessel tissue.  The advent of real-time imaging, 
which can require up to thousands of laser pulses in time periods on the order of seconds, 
makes safety studies a necessary prerequisite to clinical translation[54].    
 Studies that investigate cell death from laser irradiation have been conducted.  For 
example, Denton  et al., studied the effect of heat accumulation from laser irradiation on 
cell death[197].  In this study, microthermography was used to relate cell death with 
temperature increases and found a correlation between cell death and an average peak 
temperature of 53°C.  However, the authors were unable to find studies in which cells 
present in vessel tissue were irradiated at IVPA relevant wavelengths.   
 This chapter covers what is to my knowledge the first set of studies focused on the 
issue of IVPA safety.  The response of the main three cell types present in the vessel 
(endothelial cells, macrophages, and smooth muscle cells) to laser irradiation at IVPA 
relevant wavelengths were investigated in vitro.  Cell death by heat accumulation was 
studied with fast, high power lasers by irradiating cells with various levels of cumulative 
fluence based on common IVPA imaging parameters.  These experiments were completed 
near the lipid absorption peak at 1197 nm and at 1064 nm.  The latter was chosen since the 
Nd:YAG laser makes this wavelength easy to use for multiple wavelength imaging.  Next, 
cell death from the mechanism of single pulse fluence was investigated.  In these 
experiments, cells were irradiated at the higher range of single pulse fluences expected in 
clinical IVPA imaging using slow lasers at 1064, 1210, and 1720 nm and then evaluated 
for cell death.   
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5.2 Materials and Methods  
5.2.1 Cell Culture 
5.2.1.1 Cumulative Fluence Experiments  
The cell studies were completed on the main cell types found in both healthy and diseased 
vessels.  These included human coronary artery endothelial cells (HCAEC) (CC-2585, 
Lonza), mouse macrophages (TIB-67, ATCC), and human aortic smooth muscle cells 
(SMC) (C-007-5C, Cascade Biologics).  Passage numbers for the HCAECs, macrophages, 
and SMCs were no higher than 7, 12, and 14, respectively.  The HCAECs were cultured in 
vascular cell basal medium (CC-3156, Lonza) with an endothelial cell growth kit (CC-
4176, Lonza) while the mouse macrophages were cultured in Dulbeco’s Modified Eagle 
Media (10-013-CV, Corning) with 10% Fetal Bovine Serum and 1% Penicillin-
Streptomycin.  The SMCs were cultured in Medium 231 (M231500, Life Technologies) 
with 5% Smooth Muscle Growth Supplement (S00725, Life Technologies) and 1% 
Penicillin-Streptomycin-Glutamine (10378016, Thermo Fisher Scientific).  
 Cell death was used as a marker to determine if any side effects were likely from 
the irradiation dosages used for IVPA imaging.  In addition, cell death in vivo could have 
negative effects.  For example, death of endothelial cells could induce additional 
inflammation, which is a driver of atherosclerotic disease.  At worst, it could also lead to 
the exposure of prothrombogenic factors inside the vessel wall, increasing the chance of 
blood clot formation.  Meanwhile, macrophages and smooth muscle cells both have a role 
in the pathogenesis of atherosclerosis.  Cell death, particularly by necrosis, of either cell 
type in vivo would result in the release of additional inflammatory cytokines.  This could 
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exacerbate the severity of plaques already present or accelerate the development of plaque 
in regions of tissue not covered by plaque in patients suffering from atherosclerosis.  For 
these reasons, cell death is used here as an indicator of potential side effects from IVPA 
imaging.   
 Prior to irradiation cells were plated on a polyethylene cell culture 96 well plate 
(353072, Corning) at 80-90% confluency but with a phenol red free base media (SMCs, 
macrophages: 21063029, Life Technologies; HCAECs: CC-3129, Lonza) since phenol red 
is highly absorbing.  After irradiation, cells were returned to an incubator at 37°C with 5% 
CO2.  Cells were removed from the incubator either 6 or 24 hours after irradiation and 
evaluated for cell viability using an MTT assay (V131154, Life Technologies). Briefly, 
10 µL 12 mM MTT stock solution was added to each well at the appropriate time point 
and incubated at 37°C for 4 hours.  Then, 100 µL of a solution consisting of 1 gm SDS 
dissolved in 10 mL 0.01 M HCl was added to each well and incubated at 37°C for 4-18 
hours.  The absorbance at 570 nm was measured using a plate reader (Synergy HT, 
BioTek).   
 
5.2.1.2 Single Pulse Fluence Experiments  
The polyethylene well plates could not withstand the laser intensities used in the single 
pulse fluence tests without being damaged.  To address this, single pulse fluence tests were 
performed using tissue chamber slides with a borosilicate glass bottom (macrophages, 
SMCs: 155411, Nunc, Inc.).  It was necessary to plate the HCAECs on a tissue culture 
treated glass chamber (543079, Greiner Bio-One) for cell adhesion.  Cells were plated at 
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80-90% confluency as previously described for cumulative fluence experiments.  Passage 
numbers for the HCAECs, macrophages, and SMCs were no higher than 9, 15, and 17, 
respectively.   
 After irradiation, cells were returned to the cell incubator.  Cell viability was 
evaluated using a fluorescence-based assay kit (30002-T, Biotium) instead of with the MTT 
assay because the plate reader used to evaluate the MTT assay was not compatible with the 
tissue chamber slides.  A solution of 1 µM Calcein AM and 2 µM EthD, which respectively 
label live and dead cells, was prepared.  Each well was washed with 100 µL of PBS to 
remove serum esterase activity.  Then, the solution containing Calcein AM and EthD was 
added to each well and incubated at room temperature for 30-45 minutes.  
Photomicrographs were captured using a microscope (DMI3000 B, Leica) and camera 
(DFC290, Leica) at a magnification of 10x (10x/0.22, Leica).  Cell counts of live and dead 
cells in one field of view for each well were performed by the same individual, from which 
the fractional cell viability was calculated for each experimental condition.   
 
5.2.2 Irradiation Parameters 
5.2.2.1 Cumulative Fluence Experiments  
Cells were irradiated at 1064 nm with a Nd:YAG pump laser (SOL40W-1064, 
RPMC Lasers, Inc.) and at 1197 nm with a custom-made Ba(NO3)2–based Raman laser 
pumped with the 1064 Nd:YAG laser.  These lasers had pulse durations of 5-15 ns.  The 
1197 nm wavelength was chosen because it is close to a peak in lipid absorption, relative 
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to water, while 1064 nm was chosen because it is a highly common wavelength that could 
easily be used for spectroscopic or ratiometric imaging of plaque in a clinical IVPA 
imaging system.   
 Constructing a three-dimensional IVPA dataset requires collecting A-lines while 
simultaneously rotating and retracting a side firing catheter.  The spot size of the laser 
irradiation on the tissue is sufficiently large that a given section of tissue is irradiated many 
times.  The number of times a segment of vessel is irradiated is related to the number of A-
lines used to construct each image, the catheter pullback rate, and spot size of irradiation 
on the lumen surface of the vessel.  In these experiments, cells were irradiated such that 
the cumulative fluence experienced by the cells would span a range both above and below 
the cumulative fluence experienced by the vessel wall during IVPA imaging, based on 
common imaging parameters from the literature.  First, an expression was determined that 
can be used to calculate the cumulative fluence on the artery lumen in terms of common 
imaging parameters.  Such an expression is briefly derived below.   
 First, it is assumed that the IVPA catheter is inside a cylindrical artery of constant 
diameter.  It is also assumed that imaging is completed using a constant rate of catheter 
rotation and pullback.  Finally, it is assumed that each location in the vessel will be 
irradiated by many catheter rotations during pullback, such that there is significant overlap 
in the area of vessel that is irradiated by the beam from one A-line to the next.  Any area 
on the vessel wall will be successively irradiated by the entire laser beam but in subsections, 
including areas with hot spots or beam irregularities that may be present in the beam profile.  
As a result, irregularities in beam shape can be ignored, making it possible to use the sum 
of average fluences for the derivation.  Note that this would not be valid in special instances 
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of IVPA imaging, such as imaging without pullback in which energy variation in the laser 
beam profile would cause variation in fluences at different locations on the vessel lumen.  
Given these assumptions, we can arrive at the following expression for the cumulative 
fluence (Eq. 3.1) 
 
𝐶𝐹 =  
𝐸𝑝 𝑁𝐴−𝑙𝑖𝑛𝑒𝑠
𝜋 𝐷 𝐿𝑧
 ×  
𝐿𝑧  𝑃𝑅𝐹
𝑃𝑟 𝑁𝐴−𝑙𝑖𝑛𝑒𝑠
 ,               (Eq. 3.1) 
 
where Ep is the energy per pulse, NA-lines is the number of A-lines per rotation, D is the 
inner diameter of the artery, Lz is the length of the laser spot size in the longitudinal 
direction, PRF is the pulse repetition frequency of the laser, and Pr is the pullback rate of 
the catheter.   
 In Equation (3.1), the cumulative fluence is a product of two terms. The first term 
represents the cumulative fluence irradiated on the tissue during one 360-degree rotation.  
The numerator is the total energy deposited while the denominator represents the 
cylindrical area irradiated on the lumen surface.  In the second term, the length of the laser 
spot size in the longitudinal direction, Lz, divided by the pullback rate of the catheter, Pr, 
is equivalent to the amount of time over which a single location on the lumen will be 
irradiated.  Multiplying this by the frame rate gives the total number of rotations during 
which the catheter will illuminate the same segment of tissue.   Equation (3.1) could be 
further simplified by substituting the pulse repetition frequency, PRF, with the product of 
the number of A-lines, NA-lines, and the imaging frame rate, Fr:  
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𝐶𝐹 =  
𝐸𝑝 𝑃𝑅𝐹
𝜋 𝐷 𝑃𝑟
 =  
𝐸𝑝 𝑁𝐴−𝑙𝑖𝑛𝑒𝑠 𝐹𝑟
𝜋 𝐷 𝑃𝑟
 .                (Eq. 3.2) 
 
The number of A-lines per image and the pullback rates cited in the literature[13, 193] 
generally vary from 64 to 256 and from 0.5 mm/s to 3 mm/s, respectively.  The pulse 
energies used vary from 0.1 – 0.8 mJ per pulse.  The maximum cumulative fluence would 
occur using 256 A-lines per image, a 0.5 mm/s pullback rate, and a pulse energy of 0.8 mJ.   
Assuming a maximum imaging frame rate of 30 Hz and a minimum inner (occluded) 
coronary artery diameter of 2 mm, this would result in a cumulative fluence of 195.6 ≈ 200 
J/cm2.  This will be referred to as the maximum expected clinical cumulative fluence 
(MECCF) throughout this chapter and the next.  It represents the highest amount of 
irradiation that would be reasonably expected in a clinical setting.   
 All three cell types were subjected to irradiation at each wavelength.  Both lasers 
were operated at 7680 Hz, with the spot size equivalent to the well size in a 96 well plate 
(well diameter 6.4 mm).  The pulse energy at 1064 nm was 0.8 mJ, while the pulse energy 
at 1197 nm was 0.08 mJ due to the Raman laser having a lower output.  Seven irradiation 
conditions at various levels of cumulative fluence were used (Error! Reference source n
ot found.).  One control condition that was not irradiated was used so that the change in 
cell viability from irradiation could be determined.  Higher cumulative fluences were 
attained by irradiating over longer time periods.  The number of pulses each well was 
exposed to was tracked using software programmed with LabVIEW (National 
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Instruments).  Once the desired cumulative fluence was achieved, a software-controlled 3D 
positioning system (Parker Hannifin) was used to move the well plate so that a new well 
was irradiated (Figure 5.1).  The cumulative fluences for each condition were lowered by 
a factor of 10 at 1197 nm, due to the lower output of the Raman laser.  However, the lower 
cumulative fluences were still sufficient to cause cell death using 1197 nm for some 
conditions.  This is likely the result of the absorption coefficient of water, which is the 
primary component of cells, being about 10 times higher at this wavelength[198].  The cells 
were placed on a hotplate during irradiation so that they had a steady state temperature near 
the physiological norm (37°C +/- 3°C).  The sample size for each condition was six, which 
was sufficient to attain statistically significant differences in cell viability.   
 
 
Table 5.1 Cumulative fluence dosages at 1064 nm and 1197 nm for all 3 cell types.  
Data reproduced from Sowers et al.[183]   
Cumulative Fluence Dosage (J/cm2) 














Figure 5.1 Photograph of the experimental setup used for the cumulative fluence 
experiments.  The laser beam was elevated up and then down into the well plate, 
using an aperture to regulate the spot size.  The well plate was placed on a hot plate 
that maintained the well temperature at 37°C.  Only wells directly over the hotplate 
were irradiated.  A computer software controlled 3D motor stage was used to 
control the location of the well plate during irradiation.  For the single pulse fluence 
experiments, the laser beam was instead coupled into an optical fiber and delivered 
to the cells as described in the methods section.  Figure reproduced from Sowers et 
al.[183].    
 88 
5.2.2.2 Single Pulse Fluence Experiments  
The single pulse fluence experiments were completed for all three cell types at 1064, 1210, 
and 1720 nm.  The experiments at 1064 and 1210 were completed with a 10 Hz optical 
parametric oscillator (OPO) pumped at 532 nm (Vibrant, Opotek), while the 1720 nm 
experiments were completed using a 10 Hz OPO pumped at 355 nm (FRO-290 Quanta-
Ray, Spectra-Physics) due to its higher output energy at that wavelength.  These lasers had 
pulse durations of 7-10 ns.   
 The single pulse fluence experiments were designed to test for cell damage caused 
by high fluences in a single pulse.  Cells were irradiated using the output of an optical fiber 
with an NA of 0.22 and a core diameter of 300 µm (1068000061, Polymicro Technologies), 
which is similar to those used in IVPA imaging.  The maximum fluence in clinical IVPA 
imaging would occur when the catheter rests against the side of the artery, since the spot 
size will be smallest for a given pulse energy.  The fiber was placed 1 mm above the cell 
adherent chamber slide surface to mimic this condition for a 2 mm diameter catheter and 
sheath.  The optical fiber was then raster scanned across the chamber slide such that all the 
cells were irradiated.  This was completed using a 3D positioning system (Parker Hannifin) 
controlled with software programmed in LabVIEW (National Instruments).  Each location 
on the chamber slide was irradiated with 50 pulses instead of a single pulse during the 
raster scan, to ensure that any damage was detected.  The pulse energies tested were 0.0 
(control), 0.4, 0.8, and 1.2 mJ, which correspond to 0.0, 0.10, 0.21, and 0.31 J/cm2 (300 
µm diameter fiber core with 0.22 NA gives a spot size of 0.7 mm).  The cells were placed 
on a hotplate during irradiation so that they had a steady state temperature near the 
physiological norm (37°C +/- 3°C).    
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5.2.3 Statistics 
All statistical tests were performed in IBM SPSS Statistics.  Levene’s test (p < 0.05) was 
used to evaluate the homogeneity of variances for each cell type/wavelength combination, 
while the Shapiro-Wilkes test (p < 0.05) was used to test for normality, meaning the sample 
came from a normally distributed population.  For data sets in which neither assumption 
was violated, a one way, two-tailed ANOVA with Tukey’s honestly significant difference 
(p < 0.05) post hoc test was used for comparison groups.  Five of the one hundred thirty-
two conditions were found to violate the assumption of normality, but not the homogeneity 
of variances.  However, ANOVA is known to be fairly robust against violations of the 
assumption of normality, and has in fact been shown to perform as well or better than the 
Kruskal-Wallis test for small samples sizes even on non-normal data[199].  Thus, an 
ANOVA with Tukey’s honestly significant difference (p < 0.05) was still used to evaluate 
these data sets.  Data sets that failed Levene’s test for homogeneity of variance (sixteen out 
of one hundred thirty-two) were instead evaluated using the Brown-Forsythe test, since it 
has been shown to perform well for small sample sizes and when the number of populations 
is large[200].  Since Brown-Forsythe has been shown to be robust to violations of 
normality[201, 202], it was used on data sets that failed Levene’s test whether or not they 
passed the Shapiro-Wilkes test for homogeneity of variances.  When Brown-Forsythe 
indicated significance Games-Howell (p < 0.05) was used as the post hoc test.     
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5.3 Results  
Cumulative fluence experiments were first completed at 1064 nm for all three cell types 
(Figure 5.2).  Values of cumulative fluence were chosen that spanned approximately two 
orders of magnitude.  The MECCF of 200 J/cm2 is marked with the vertical red line in 
Figure 5.2.  Significant between group differences were found for each combination of cell 
type and wavelength at some time points.  Cell death was observed at 6 and 24 hours for 
all cell types at 1400 J/cm2.  At 690 J/cm2, HCAECs showed a statistically significant level 
of cell death (p = 0.026) at the 24-hour time point only, while macrophages showed reduced 
viability at both time points.  No cell death was observed for any cell type at the fourth 
condition of 280 J/cm2, which is above the MECCF.   
 The results of the cumulative fluence experiments at 1197 nm are shown in Figure 
5.3.  However, since the output of the Raman laser was lower than the 1064 nm pump laser, 
the cumulative fluences used for each condition are correspondingly lower.  Again, the 
ANOVA or Brown-Forsythe tests indicated significant between group differences for each 
combination of cell type and wavelength at some time points.  Death of the macrophages 
irradiated at 1197 nm occurred below the MECCF.  All cell types were still viable after 
irradiation at 70 J/cm2, but macrophages showed reduced viability at 140 J/cm2 as did the 
SMCs at the 6-hour time point.  The endothelial cells proved more robust, with a decrease 
in fractional cell death only at 210 J/cm2.    
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Figure 5.2 Cell viability for each cell type versus light dosage at 1064 nm. The y-axis 
shows the fraction of live cells, normalized to the cell viability in the nonirradiated 
control group.  The x-axis shows the cumulative fluence dosage applied to cells at 
each condition.  The red vertical line indicates the value of the maximum expected 
clinical cumulative fluence (MECCF) for clinical imaging.  For each condition, n=6.  




Figure 5.3 Cell viability for each cell types versus light dosage at 1197 nm. The y-
axis shows the fraction of live cells, normalized to the cell viability in the 
nonirradiated control group.  The x-axis shows the cumulative fluence dosage 
applied to cells at each condition.  The red vertical line indicates the value of the 
maximum expected clinical cumulative fluence (MECCF) for clinical imaging.  For 
each condition, n=6.  BF: Brown–Forsythe.  Reproduced from Sowers et al.[183]   
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 Results for the single pulse fluence experiments for the macrophages, SMCs, and 
HCAECs are shown in Figure 5.4.  The results are uniform across cell types and 
wavelengths.  No cell death was observed for any of the conditions tested, with the fraction 
of live cells being near 1 in all cases.  This is a positive result, and a strong indication that 
if cell death occurs from IVPA imaging, the likely mechanism will be heat accumulation 




Figure 5.4 Single pulse experimental results for the macrophages, endothelial cells, 
and smooth muscle cells.  The fraction of live cells is reported along the y-axis.  The 
pulse energy out of the optical fiber for each condition in shown on the x-axis.  The 
maximum dosage of 1.2 mJ is 0.4 mJ higher than the highest energy commonly used 
for ex vivo IVPA studies.  For each condition, n=4.  Figure produced using data 
from Sowers et al.[183]    
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5.4 Discussion  
In the first part of this chapter, a maximum expected clinical cumulative fluence was 
determined that comprised the highest expected total fluence a region of tissue would be 
expected to experience in a clinical setting based on common IVPA imaging parameters in 
the literature.  This value, the MECCF, was found to be 200 J/cm2.  Cells were irradiated 
with a range of cumulative fluences above and below this threshold.  The conditions 
covered over 2 orders of magnitude, varying from 14 J/cm2 through 4100 J/cm2 at 1064 nm 
and from 1.4 J/cm2 through 410 J/cm2 at 1197 nm.   
 All three cell types showed cell death at 1400 J/cm2 when irradiated at 1064 nm, 
with the macrophages and HCAECs showing signs of damage at 690 J/cm2, although only 
after 24 hours for the HCAECs.  At 1197 nm, all cell types showed loss of viability at a 
cumulative fluence of 210 J/cm2, with macrophages also showing reduced viability at 
cumulative fluences of 140 J/cm2 as did the SMCs after 6 hours.  The most likely cause of 
the discrepancy at different wavelengths is the difference in the absorption coefficient of 
water [198].  The absorption coefficient of water is about 10 times larger at 1197 nm than at 
1064 nm, leading to greater heat accumulation.  It is not clear why the macrophages were 
more susceptible to damage by irradiation than the SMCs or HCAECs.   
 For both wavelengths and all three cells types, cell damage occurred near the 
MECCF.  This implies that safety will place constraints on the types of imaging protocols 
that can be used clinically.  However, the cumulative fluence during clinical imaging can 
easily be reduced by an order of magnitude below the MECCF by reducing the number of 
A-lines per image and increasing the pullback rate of the catheter, although there will be a 
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consequent reduction in image quality.  In addition, recent in vivo studies have shown the 
ability to image lipid using only 0.08 mJ, which would lower the MECCF by a further 
order of magnitude[55].  However, this requires flushing the vessel with heavy water, which 
has a substantially lower absorption coefficient at wavelengths used for lipid imaging.  The 
heavy water is not toxic, but its clinical usage will require FDA approval and would 
increase the cost of the imaging procedure.  Catheter designs with narrower beam profiles 
and improved overlap with the ultrasound transducer footprint could also make it possible 
to reduce pulse energies without decreasing image quality[48].  Using lower frequency 
transducers may sufficiently increase the sensitivity of catheters such that lipid could be 
detected using much lower pulse energies through blood in vivo, although further studies 
will be needed to confirm this[203] and it will cause an accompanying decrease in spatial 
resolution.  This study indicates that IVPA can be accomplished safely, but that safety will 
put constraints on the types of imaging protocols that can be used.  This result warrants 
further study ex vivo and in vivo.   
 The result of the single pulse fluence experiments was that for all cell types at each 
wavelength, the fraction of live cells was near one.  This was true regardless of wavelength, 
despite much higher absorption coefficients at the longer wavelengths (e.g. 10 times larger 
at 1197 nm and 40 times larger at 1720 nm for water, compared to 1064 nm)[198].  In 
addition, there was no statistical difference in the fraction of live cells between the control 
group and the irradiated cells.  This is a strong indicator that the maximum single pulse 
fluences expected in IVPA imaging will not be a mechanism of cell death.  Instead, future 
studies on the safety of IVPA imaging should focus on heat deposition as the mechanism 
of damage.   
 95 
 There were several limitations to the cumulative fluence studies.  First, cell death 
was evaluated in vitro rather than in the tissue environment in which they would normally 
be found in vivo.  There may be differences in cell behavior between the two environments.  
In particular, there was some indication of higher metabolism or cell growth following 
irradiation with lower cumulative fluences at the 24 hour time point, although the large 
standard deviation at these time points made statistical evidence inconsistent across all the 
experimental conditions tested.  This effect has been found in a multitude of other in vitro 
studies in the literature [204].  Even if present, it is unclear if this effect would transfer to an 
in vivo environment, where cell growth would be regulated by biological factors.   
 In addition, since the mechanism of cell damage appears to be heat accumulation, 
differences in the heat transfer properties of surrounding materials between these 
experiments and the in vivo environment would affect the results.  The thermal properties 
of the 96 well plate and media (similar to water) differ from that of tissue.  The thermal 
diffusivity of blood vessel tissue is 1.3 x 10-7 m2/s[205].  It is roughly 2.0 x 10-7 m2/s for 
polyethylene[206, 207] and 1.49 x 10-7 m2/s for water at 37°C[208].  The similar thermal 
diffusivities imply that the rate of cooling of the cells will be similar in vivo.  However, the 
heat transfer from the cells and media in the experiment may be limited by the insulating 
effect of surrounding air, whereas heat in vivo would continue to be transported by 
conduction through surrounding tissue.  This would make heat transfer more favorable in 
vivo.  Less favorably, irradiation over 12 or 120 seconds was necessary to reach cumulative 
fluences near the MECCF at 1064 nm and 1197 nm, respectively.  Clinical IVPA imaging 
protocols would happen over ~5 seconds, which would result in less time for heat transport 
away from the irradiation site.  Conversely, clinical imaging in vivo will benefit from the 
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cooling effect of flowing blood or saline.  This will cool the tissue both by carrying laser 
energy absorbed by the liquid away and by introducing a convective cooling effect on the 
interior surface of the vessel wall.  Finally, since the smooth muscle cells and macrophages 
are located inside the vessel, the cumulative fluence they experience will be attenuated 
from absorption by any blood or saline that may be between the catheter and vessel wall or 
by any preceding vessel tissue.  Ex vivo and in vivo studies which more accurately mimic 
the heat transfer environment during clinical IVPA imaging should be conducted to take 
these variables into account.   
 Despite these limitations, the experimental data agreed well with the ANSI Z136.1 
standard for irradiation of skin.  There are two sets of guidelines for repeated exposure of 
skin in this standard.  One is that a maximum permissible exposure (MPE) for a single 
pulse must not be exceeded.  The second is that a MPE for the pulse train must not be 
exceeded.  For the single pulse guidelines, the MPE for skin is 0.1 J/cm2 at 1064 and 1210 
nm and 1 J/cm2 at 1720 nm.  Given a 300 µm fiber with an NA of 0.22, the spot size had a 
diameter of 0.7 mm.  Thus, the maximum single pulse fluence tested was 0.31 J/cm2.  The 
MPE is equivalent to roughly 10% of the exposure at which damage should be expected 
50% of the time (EC50).  Since no cell death was detected in these experiments, all that 
can be concluded is that the “measured MPE” for this experiment would be 0.031 J/cm2 or 
greater.   
 For the second ANSI guideline, the MPE for skin under these irradiation conditions 
is 1 W/cm2 at 1064 and 1197 nm.  Partial cell death, which we use as an approximation of 
the EC50, was detected in the cumulative fluence experiments at 690 J/cm2 and 130 J/cm2 
for 1064 nm and 1197 nm, respectively.  The irradiance at these conditions was 17.3 W/cm2 
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and 1.73 W/cm2.  Given the relationship between EC50 and MPE, the “measured MPE” 
for these experiments would thus be 1.73 W/cm2 and 0.173 W/cm2.  Damage from heat 
accumulation would be determined by the amount of heat generated from irradiation, which 
itself is dependent on the absorption coefficient of the tissue being irradiated.  At 1064 nm 
the absorption coefficient of skin is about 2.6 times larger than water, while at 1197 nm it 
is smaller by a factor of 0.35[115, 198].  After adjusting the ANSI standards for skin based on 
this difference, an MPE for mostly water-based tissue would be nearer 2.6 W/cm2 at 1064 
nm and 0.35 W/cm2 at 1197 nm.  The “measured MPEs” for these experiments are lower 
than these values but by less than a factor of two.  This shows strong agreement with the 
ANSI standards, despite the limitations of the in vitro setup.  In vessel tissue, other 
endogenous chromophores, such as fibers and lipid, will be present.  It will be necessary 
to conduct experiments ex vivo to determine if absorption from these components has a 
large effect on the damage threshold.   
 This study indicates that it will be possible for researchers to develop safe imaging 
protocols for clinical IVPA imaging, although safety considerations will play a constraint.  
Further, this work strongly indicates that heat accumulation is the damage mechanism of 
concern for IVPA imaging.  However, future studies are needed ex vivo and in vivo to 
validate these results.  Further experiments should also include the second lipid absorption 
peak at 1720 nm and use both diseased and healthy tissue.    
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5.5 Conclusion  
This was the first study intended to investigate the safety of IVPA imaging.  Cell viability 
in response to a variety of lasing conditions were tested on endothelial cells, 
macrophages, and smooth muscle cells, which are present in healthy and diseased 
vessels.  Irradiation was conducted at 1210 nm and 1720 nm, which correspond to peaks 
in the absorption coefficient of lipid, and at 1064 nm, which could become a common 
wavelength for dual wavelength imaging due to its high accessibility from Nd:YAG 
lasers.  Two sets of experiments were conducted.  In the first, the effect of heat 
accumulation on cell viability was investigated by subjecting cells to various amounts of 
cumulative fluence.  At 1064 nm, cell death was apparent only after irradiation above 280 
J/cm2.  This is above the maximum expected clinical cumulative fluence (MECCF), 
which is an approximation of the highest cumulative fluence that could be expected in 
clinical imaging.  At 1197 nm, cell death was apparent at 210 J/cm2 for the endothelial 
and smooth muscle cells, but at 140 J/cm2 for the macrophages at both time points and 
the SMCs after 6 hours.  This result implies that damage from IVPA imaging is possible 
given current practices, although the cumulative fluence could be lowered two orders of 
magnitude below the MECCF at the cost of imaging quality.  This is a positive result, and 
a strong indication that IVPA imaging can be translated safely.  The second set of 
experiments were designed to determine if cell death during IVPA imaging will occur 
from single pulse fluences (peak optical intensity) or heat accumulation over multiple 
laser pulses.  All three cell types were irradiated with 0.4, 0.8, and 1.2 mJ pulses using an 
optical fiber positioned 1 mm from the cells to replicate the maximum single pulse 
fluences expected during IVPA imaging.  For all cell types and at each pulse energy no 
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cell death was observed, strongly indicating that heat accumulation is the mechanism of 
damage on which future studies should focus.  The studies in this chapter justify further 
investigation of safety concerns around IVPA imaging ex vivo and in vivo.    
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CHAPTER 6: SAFETY OF INTRAVASCULAR PHOTOACOUSTIC 
IMAGING – IN VIVO 
6.1 Introduction 
6.1.1 Abstract 
To the author’s knowledge, this is the first study designed to evaluate the safety of 
intravascular photoacoustic imaging in vivo.  The damage to blood vessel tissue from 
real-time in vivo delivery of light was investigated in the carotid arteries of swine.  
Damage was assessed at 1064 nm and the lipid imaging wavelength of 1720 nm in a dose 
dependent manner.  Damage was assessed by Dr. Serge Rousselle, a trained pathologist 
and co-founder of Alizee Pathology.  He determined that the only dose dependent type of 
damage in the tissue was media necrosis.  This damage was detectable when tissue was 
subjected to a total dosage of 50 J/cm2 or greater at 1720 nm.  There was also damage at 
700 J/cm2 when 1064 nm light was used.  Prior studies have already shown that lipid 
plaque can be imaged using similar or lesser dosages than those showing damage in this 
study.  Moreover, in the opinion of the pathologist, the damage would be expected to 
heal, although additional studies would be needed to prove this conclusively.  The results 
were consistent with the in vitro studies discussed in the prior chapter.  The results are 
also compared to the ANSI Z136.1 standard for skin and it was found that it 
underestimates damage to the carotid arteries.  Thus, the ANSI Z136.1 standard for skin 
may not be appropriate for vessel tissue.  Future work should evaluate the progression of 
damage over longer time points and evaluate any potential increase in blood 
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thrombogenicity from irradiation.  Nonetheless, these studies suggest that it will be 
possible to use IVPA imaging to identify lipid plaque in a clinical setting without 
damaging vessel tissue.   
 
6.1.2 Background 
In the prior chapter, the safety study had two main outcomes.  First, it determined that 
any damage from IVPA imaging would be caused by heat accumulation rather than 
optical breakdown from high pulse energies.  Second, it determined approximate 
thresholds for damage using 1064 nm and 1197 nm light.  At 1064 nm, the damage 
threshold was between 280 and 690 J/cm2.  At 1197 nm, the damage threshold was 
between 70 and 140 J/cm2.  The lower damage threshold at 1197 nm is due to the higher 
absorption coefficient in water, which is a primary component of soft tissues.   
 However, the threshold for tissue damage in IVPA imaging needs to be evaluated 
in a more realistic environment, namely in an in vivo experiment.  Although in vivo real 
time IVPA imaging has been successfully conducted[55-57] with no apparent damage in the 
histological sections used for validation of the imaging results[56], no extensive 
(wavelength and dose dependent) study of tissue damage was found in the literature.  It 
would be useful for researchers developing IVPA to know which energy dosages, and 
thus what imaging protocols, will be safe.  In addition, a demonstration of safety is a 
necessary step to bring IVPA imaging to the clinic.   
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 Thus, I describe here a set of experiments which aimed to evaluate the threshold 
for damage to vessel tissue from light irradiation in a wavelength and dose dependent 
manner.  The experiments were conducted on the carotid arteries of swine in vivo.  The 
carotid arteries were irradiated at 1064 nm and 1720 nm.  At each wavelength, 3 dosages 
were applied to different regions of tissue.  The dosages were chosen based on the 
damage thresholds found in the cell studies.  The samples were sent to a pathologist who 
evaluated them for damage while blinded.  The conclusions from that evaluation are 
shown here and the implications for clinical translation of IVPA imaging are discussed.   
6.2 Materials and Methods 
6.2.1 Laser System and Catheter 
Light irradiation was produced by a high power, high pulse repetition rate (PRF) custom 
made laser (Ekspla, NT200).  The laser consists of a Nd:YAG pumped optical parametric 
oscillator (OPO) capable of producing light in the wavelength range from 1690-1750 nm, 
which contains the lipid absorption peak at 1720 nm.  The light from the Nd:YAG at 
1064 nm could also be recovered from a side port in the laser.  The laser had a maximum 
PRF of 3840 Hz.  The power output of the laser varied from experiment to experiment.  
At the maximum PRF, it could roughly emit 8 mJ out of the laser at 1064 nm, although 
most of this was discarded before exiting the catheter.  It could emit close to 0.6 mJ at the 
wavelengths near 1720 nm.  All wavelengths were optically coupled into the same 300 
µm optical fiber, although this coupling resulted in some energy loss.  Upon exiting the 
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catheter, the maximum light emission was near 0.55 mJ per pulse at 1064 nm and 0.22 




Figure 6.1 a) A picture of the operating room with the laser system.  The laser 
system is present at the back-right corner of the room.  The catheter, spindle, water 
injection, and other components are present on the bedside system.  b) A picture of 
the laser system with the optical components to deliver the laser light into the optical 
fiber.  c) A picture of the bedside system.  The catheter extends off the front of the 
system toward the swine.   
 
 
 Because of the large size of the laser and optics, the system was split into two 
parts (Figure 6.1a).  The first part (Figure 6.1b) consisted of the laser, the optical 
components to couple all wavelengths into the optical fiber, and the computational 
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hardware for running the laser and imaging system.  The second part (Figure 6.1c) 
included a spindle which was used to rotate the catheter.  The spindle electrically and 
optically connected the catheter to the computer system, electrical hardware, and laser on 
the non-bedside portion of the system.  This second part was small enough that it could 
be placed next to the surgical table.  The light from the laser was delivered to the bedside 
portion of the system through the 300 µm optical fiber.    
 The light was delivered to the vessel tissue through a catheter.  The catheter 
consisted of a torque cable (Asahi Intecc USA, Inc.) containing a 300 µm optical fiber.  
The end of the optical fiber was polished to 37 degrees.  This resulted in side-firing 
delivery of light from the catheter due to total internal reflection of the light on the inside 
angled surface of the optical fiber.  The optical fiber was covered with a glass cap that 
was epoxied in place.  This was done to prevent water from coming into contact with the 
surface of the optical fiber, which would have prevented total internal reflection of the 
laser light due to the higher index of refraction of water.  A coaxial cable also ran through 
the torque cable, and was connected to an ultrasound transducer (20 MHz) at the end of 
the catheter for ultrasound imaging and acquisition of the photoacoustic signal.   
 The torque cable of the catheter was inserted into a polyethylene (BD Medical, 
63018-781) sheath to prevent damage to vessel tissue from catheter rotation.  The 
polyethylene sheath was connected to the torque cable with a 7 Fr introducer sheath 
(Terumo Pinnacle) normally used to deliver catheters into vessels during surgery.  The 
presence of the introducer sheath also allowed liquid to be pushed through the catheter 
into the blood vessel.  This liquid could displace blood in the lumen, pushing it into and 
through a port in the introducer and out of the blood vessel.    
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6.2.2 Animal Model and Procedure 
Two Yorkshire swine were used for the safety study.  The swine was put under anesthesia 
using 5% isoflurane in 100% oxygen and placed in the supine position on the operating 
table.  Anesthesia was maintained at 1.5-2% isoflurane thereafter, supplemented with 
Propofol as needed.  The laser irradiation was conducted on the inside of the carotid 
artery of each swine.  Therefore, once the pig was anesthetized, a longitudinal neck 
incision was performed and tissue was dissected until about 10 cm of the carotid artery 
was exposed.  A 7 Fr introducer was advanced into the superior (near the head) side of 
the vessel.  The IVPA catheter was inserted into the vessel via the introducer.    
 Before irradiation, blood had to be removed from the lumen of the carotid artery.  
This is because blood has a high absorption coefficient near 1720 nm.  As a result, much 
of the light dosage would be absorbed by blood instead of by tissue if blood were present.  
To prevent this, the inferior end of the carotid artery was ligated.  With the artery segment 
isolated, heavy water (deuterium) was used to flush blood from the artery.  Heavy water is 
a form of water with two neutrons in the hydrogen atoms.  It is used instead of water 
because it has a low absorption coefficient at 1720 nm[209].  It is also non-toxic.  The artery 
was first cleared with a 50 ml bolus flush of heavy water.  Then, during the full length of 
the safety studies, heavy water was continuously flushed into the artery at a rate of 400 
ml/hr.  As explained previously, the water entered the catheter through the introducer used 
to mate the catheter torque cable and sheath.  The blood/water mixture was able to exit the 
artery through the outlet port of the introducer used to deliver the catheter into the carotid 
artery.  In the first swine, only the right carotid artery was irradiated.  In the second pig, 
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both carotid arteries were irradiated.  After irradiation, the pigs were euthanized using KCl 
or Euthasol while under deep anesthesia.   
 
 
Table 6.1 Table of wavelength and light dosage conditions with sample sizes for each 
condition.   
Condition Number Wavelength [nm] Fluence [J/cm2] Sample Number 




C2 100 7 




C5 50 10 
C6 200 4 
 
 
 Tissues were irradiated with 6 wavelength and dosage combinations.  The 
wavelengths used were 1064 and 1720 nm.  Wavelength near 1720 nm are used for lipid 
imaging.  Tissue has a higher absorption coefficient at this wavelength than at 1210 nm, so 
it represents the conservative case out of the two wavelengths generally used for lipid 
imaging using IVPA with regard to safety.  The 1064 nm wavelength was chosen because 
it is commonly available with the Nd:YAG laser, thus making it desirable for dual 
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wavelength imaging.  Three dosages were chosen for each wavelength (Table 6.1).  Each 
condition also had a unique sample size, dependent on the pullback distance of the catheter 
for each condition.  Due to the spring-like nature of the torque cable in the catheter, the 
sample size could not be controlled precisely, although it was possible to record the true 
pullback distance using fluoroscopy.  The dosages were chosen using the damage 
thresholds found in the in vitro studies in the prior chapter as a guidance.  The dosages 
were chosen such that the highest would be expected to cause damage, while the lowest 
would be well below the expected damage threshold.  Each segment of tissue was irradiated 
with only one wavelength and at one dosage as the catheter was rotated and retracted during 







Figure 6.2  a-d) Sequential images showing the length the catheter was pulled 




Figure 6.3 a) fluoroscopy image showing the two clips used to relate the pixel length 
in the fluoroscopy images to a physical distance.  The bottom clip is partially 
obstructed by surgical equipment lying on the top of the swine.  The bottom clip is 
more clearly visible in (b), although the top clip had not been added at that time.   
 
 
 Ultimately, the regions irradiated by each dosage needed to be identified after 
removal so they could be evaluated for damage.  However, the torque cable in the 
catheter had a spring-like behavior.  By this, it is meant that if the catheter was retracted 
by pulling it back a given distance using the bedside system, the tip of the catheter in the 
vessel wouldn’t always move by the same distance.  This made it necessary to track the 
catheter to determine the regions of the artery that were irradiated with each dosage.  To 
achieve this, fluoroscopy images were taken before and after each dosage was applied to 
the vessel wall (Figure 6.2).  Clips were placed in the image at a known distance (Figure 
6.3).  These points were used as a calibration length to convert the distance the catheter 
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moved between applied dosages (in pixels) to a physical unit of length (mm) in the 
fluoroscopy images.  The clips were also placed at both ends of the carotid arteries.  They 
acted as reference points to measure the length of the artery in vivo before the artery 
shrunk after being removed from the swine.   
 All surgeries were conducted in accordance with the IACUC protocol EM78P 
from T3 labs.  Approval for off campus animal work was given by the IACUC at Georgia 
Institute of Technology.   
 
6.2.3 Tissue Preparation and Pathology 
The carotid arteries were removed after euthanasia and immediately placed in 10% 
neutral buffered formalin for fixation.  The artery from the first pig was not stretched to 
its original size, so it shrank upon removal.  To account for this, it was assumed that the 
artery shrank uniformly when registering locations on the vessel with a given dosage 
condition.  The two carotid arteries irradiated in the second pig were stretched and pinned 
to a board of cork at their original length (determined using the known distance between 
the metal clips).  The arteries were shipped in 10% neutral buffered formalin to Alizee 
Pathology in accordance with Georgia Tech’s environmental health and safety policies.  
They were received in good condition, meaning the seals were intact and there was no 
damage to the containers.   
 The tissues were evaluated by Serge Rousselle at Alizee Pathology.  Several steps 
had to be made to ensure meaningful results.  First, the pathologist had to be blinded to 
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the wavelength and dosage applied to the tissue being evaluated.  Second, we had to be 
sure that we could determine where a given tissue slice was located within the artery, 
since that would be necessary to correlate it with a given wavelength and dosage.  To 
achieve both these objectives, each artery was cut into 16 segments of roughly equal 
length before shipment to the pathologist.  Using the fluoroscopy images and metal clips, 
it was determined before shipment which wavelength and dosage was applied to each of 
the segments.  The segments were labeled with an anonymous identifier (a number to 
designate the artery number and a letter to designate the segment), so the pathologist was 
blinded.   
 All samples were processed in a series of alcohol and xylene and embedded in 
paraffin wax for sectioning.  Each segment was sectioned approximately at the center.  
Two sections were produced for each segment, each with a tissue thickness of 5 µm.  One 
section was stained with Hemotoxylin & Eosin (H&E) and the other was stained with 
Gomori’s Elastin Trichrome (GET).  Hemotoxylin stains cell nuclei blue or purple while 
the eosin turns the extracellular matrix and cytoplasm pink.  Thus, the H&E stain gives 
an overall picture of a tissue’s layout.   Gomori’s Elastin Trichrome is meant to stain 
connective tissue and fibers.  It stains connective and collagen tissue green or blue.  
Muscle, keratin, and cytoplasm will appear red.  Nuclei will stain dark blue to black.   
 Multiple types of damage were evaluated using these stains.  These damage types 
are recorded in the official pathology report (Appendix C).  The pathologist produced raw 
data tables with evaluations of damage for each segment individually.  After the raw data 
tables were generated, the pathologist was sent information that matched each segment 
with a wavelength and dosage.  The results based on wavelength and dosage were 
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compiled and reported by the pathologist.  Damage types were evaluated for trends with 
respect to wavelength and dosage.  The level of background damage in negative controls 
(not irradiated) were also considered by the pathologist when evaluating the tissue.  The 
results were compiled in a pathology report (Appendix C).   
 A written set of questions was also sent to the pathologist after receiving a written 
report.  These were returned with written answers.  The contents of the questions and 
answers (Appendix D) are used to contribute to the content of the results and discussion 
sections of this chapter.    
 
6.2.4 Statistics 
The initial evaluation by the pathologist was done on a categorical scale.  Thus, the data 
was tested for significance using Brown-Forsythe with Games-Howell as the post hoc.  
Each wavelength (1064 nm and 1720 nm) is tested separately.  To compensate for the 
increased likelihood of type I errors, the significance threshold is reduced by a factor of 2 
(p < 0.025).  All statistical tests were performed in IBM SPSS Statistics.   
6.3 Results 
Multiple damage types were evaluated by the pathologist.  The different morphologies of 
damage were marked using a numeral categorization that ranged from 0 to 4 (Table 6.2) 
for each tissue segment (see Tabulated Microscopic Data in Appendix C).  All the damage 
morphologies which received a non-zero damage score in at least some of the samples are 
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shown in Table 6.3.  Examples of the types of damage that were indicative of these damage 
morphologies can be found in Table 6.4 with an accompanying definition and explanation 
of potential causes.   
 
 
Table 6.2 Scoring method used by the pathologist.   
Score Description 
0 Finding not present.  
1 Present, but minimal feature.  
2 Notable feature; mild.  
3 Prominent feature; moderate.  








Table 6.3  Damage morphologies identified by the pathologist with non-zero damage 
scores in at least some of the histological images.   
Damage Grouping Damage Endpoint 
Injury 
Mural Acute Thermal Injury 
Media Necrosis 








Endothelium Erosion (terminal or artifact) 







Table 6.4  Damage types found in the tissue specimens with a description taken from 
the pathologist report (Appendix C).  
Damage Type Description 
Endothelial Cell loss Most sensitive endpoint. Endothelial cells are highly 
susceptible to any mechanical shear stress or thermal effect 
and are typically the first cell type to be lost. 
Hypereosinophilic 
Smooth Muscle Cells 
Acute cell injury in the media. The staining alteration 
indicates generally a change in cytoplasmic homeostasis. 
This can be an artifact of tissue handling or fixation if 
fixation conditions are not optimal or can be a very early 
sign of peracute mural damage. Interpretation is based on 
comparison between control and treated vessels as well as 





Concentric change characterized by sheets of smooth muscle 
cells showing hypereosinophilia and pyknotic to 
karyorrhectic nuclei to cytolysis (loss of cellular features) 
leaving the vessel wall matrix intact. This change can be 
radial to circumferential and is always concentric (inside 
out). 
Contraction bands Alternating bands of hypereosinophilic and contracted 
smooth muscle cells alternating with pale hypocellular or 
acellular areas. This change indicates excessive 




Individual cell necrosis; may present as hypereosinophilia, 
pyknosis, karyorrhexis, cell debris and/or apoptotic body 
Collagen denaturation Loss of fine fibrillar texture with collagenous areas showing 
hyalinization (homogenous thick bundles typically 
hypereosinophilic and sometimes picking up hematoxylin 
stain (purple) to varying degrees). This change indicates heat 









Figure 6.4 Segment 1C (H&E).  C0 (No activation).  The region M contains intact 
outer media with the black dotted line separating the region from an inner media 
area showing necrotic smooth muscle cells (clear arrowheads; hypereosinophilic and 








Figure 6.5 Segment 2D (H&E).  C1 (1064 nm - 8.3 J/cm2). The black dotted line 
defines a boundary between the intact outer media (M) and the inner affected media 
showing hypereosinophilic smooth muscle cells (arrowheads) and clear spaces of 
smooth muscle cell effacement and loss (clear arrows).  Clear double arrows 
indicate areas in the innermost media showing pyknosis in smooth muscle cell nuclei 







Figure 6.6 Segment 1I (H&E).  C2 (1064 nm - 100 J/cm2).  The black dotted line 
defines the boundary between the intact outer media and the inner affected media 
showing hypereosinophilic smooth muscle cells (clear arrowheads) and increased 
interstitial clear spaces.  The blue double arrow indicate region in the innermost 
media showing pyknosis in smooth muscle cell nuclei (generally consistent with 
compressive necrosis).  The blue arrows point to clear spaces in the inner media 








Figure 6.7 Segment 1L (H&E).  C3 (1064 nm - 700 J/cm2).  The black dotted line 
marks the boundary between the intact inner media (clear double arrow) and the 
outer affected media showing hypereosinophilic smooth muscle cells (clear 
arrowheads) and increased interstitial clear spaces (clear arrows).  The blue arrows 








Figure 6.8 Segment 3C (H&E).  C4 (1720 nm – 8.3 J/cm2). The black asterisk marks 
collagen denaturation in the adventitia, likely caused by electrocauterization during 









Figure 6.9 Segment 3L (H&E).  C5 (1720 nm – 50 J/cm2).  The black dotted lines 
mark the boundary between the intact outer and mid media (M) and the affected 
media showing hypereosinophilic and contracted smooth muscle cells (clear 
arrowheads) and increased interstitial clear spaces (clear arrows).  The innermost 
media (clear double arrow) shows pyknotic nuclei and hypereosinophilic smooth 





Figure 6.10 Segment 1P (GET).  C6 (1720 nm – 200 J/cm2).  Section showing 
widespread media necrosis (circular green double arrow) and a short segment of 
intact media (M, delineated by green dotted line).  The clear arrows point to radial 
clusters of hyperchromatic and shrunken smooth muscle cells evoking contraction 
bands.   
 
 Twenty-six images of the 48 tissue segments are shown in the report with 
annotations and a description of any damage written by the pathologist (Appendix C).  
One of these images is shown for each light dosage condition as an example (Figure 6.4 - 
Figure 6.10), with the annotation from the pathologist edited for formatting consistency 
only.  In other words, the substance of the annotations was not changed.  Damage is 
present at the lowest conditions, including the control.  Compressive necrosis, collagen 
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denaturization in the adventitia, and endothelial cell loss were present at all conditions.  
With increasing severity, hypereosinophilic smooth muscle cells, cell effacement, and 
necrotic/apoptotic cells were present in the tissue as the irradiation dosage increased.  At 
the highest dosage at 1720 nm, compression bands were also present.   
 
 
Table 6.5 Damage morphologies for endothelialization and media necrosis.  The 
damage for endothelialization was significant for all conditions, which is common 
for all catheterization procedures.  The media necrosis score showed increased 









C0 None 0 4.0 0.7 
C1 
1064 
8.3 4.0 1.1 
C2 100 4.0 0.7 
C3 700 4.0 1.4 
C4 
1720 
8.3 4.0 0.5 
C5 50 4.0 2.2 
C6 200 4.0 3.3 
 
 
 The pathologist determined that damage was present in the tissue at clearly 
detectable levels for only two of the damage morphologies listed in Table 6.3: 
endothelialization and media necrosis.  The average pathologist scores for each of these 
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damage morphologies are shown in Table 6.5.  Endothelialization was scored at the highest 
possible severity (4.0) for every tissue condition.  The scores for media necrosis ranged 
from 0.5 to 3.3.   
 Although some media necrosis was present at all conditions, the severity and 
extent of the damage increased at higher dosages.  Media necrosis was determined by the 
pathologist to clearly exceed the baseline damage found in the controls for C5 and C6.  
Damage was also found to exceed the baseline damage threshold in the controls for C3, 
although it was noted that the damage was more equivocal (a trend) when compared with 
the negative controls.   
 The statistical analysis yielded similar results.  For the 1720 nm wavelength, the 
Brown-Forsythe test indicated significant between group differences (p < 0.001).   The 
post hoc test between the control and treatment groups indicated a significant difference 
between the control and C5 (p = 0.0017) and C6 (p = 0.00027), but not C4 (p = 0.989).  
At 1064 nm, the Brown-Forsythe test did not indicate significance between group 
differences (p = 0.240).  The Games-Howell post hoc showed a p value of 0.198 between 
C0 and C3, indicating no significant difference.   
6.4 Discussion 
The pathologist identified endothelialization and media necrosis as the only two damage 
morphologies with a large enough severity to be caused by the treatment.  
Endothelialization was scored at the highest severity of 4.0 for each sample.  This was 
expected.  Catheterization regularly causes endothelialization due to the shear stress of 
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moving the catheter along the vessel wall.  This is an effect of all surgical catheterization 
procedures and would heal after surgery.  Thus, it does not present a safety concern that 
would inhibit the use of IVPA imaging in the clinic.  The second damage morphology 
that was deemed significant was media necrosis.  The necrosis was found in smooth 
muscle cells in the vessel media.  The severity of necrosis increased as the irradiation 
dosage increased (Table 6.5).  The pathologist observed a clear treatment effect at 
conditions C5 and C6 (1720 nm: 50 and 200 J/cm2).  A more equivocal treatment effect 
(trend) was also observed for condition C3 (1064 nm: 700 J/cm2).  The pathologist 
determined that all damage observed would be expected to heal, although it would take 
long time point (1-2 months) studies to prove this conclusively.   
 The results of the statistical tests were mostly consistent with this result.  
Significant differences in media necrosis compared to the control condition was clear for 
C5 (p = 0.0017) and C6 (p = 0.00027).  However, a significant difference was not 
identified (p = 0.240) between the control and tissue irradiated at 1064 nm.  At C3, the 
pathologist reported some damage, although he wrote in the report that the observation 
was somewhat equivocal (indicative of a trend) because of the level of background 
damage in the control tissue.  The p value between C0 and C3 was 0.198.  Given the low 
sample size (n for C3 = 5), a non-significant result could be a result of low power.  Since 
this is a safety study meant to determine damage, type I errors are preferable to type II 
errors.  Thus, for the remainder of the discussion it is assumed that increased media 
necrosis was identified for condition C3.  However, future studies with higher power 
would be necessary to determine with higher certainty.   
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 There were several limitations and assumptions that affect the interpretation of 
this study.  First, the control groups had multiple sources of damage.  These sources 
include catheterization (endothelialization and compressive trauma due to catheter bulk 
and rigidity), electrocauterization to clear tissue during surgery, the effects of tissue 
removal and handling, and cutting the tissues into segments after removal.  In addition, 
the time length from tissue irradiation to tissue removal and fixation was only a few 
hours, meaning there was relatively little time for damage to manifest.  All these factors 
made it more difficult for the pathologist to identify damage as having been caused by 
irradiation rather than from the procedure.  Nonetheless, the pathologist was still able to 
draw conclusions.  Second, the amount of time it took to deliver the dosage varied for 
each condition.  The amount of time one location in the tissue was irradiated is equivalent 
to the total time it took to apply the dose multiplied by the quotient of the spot size of the 
laser on the tissue in the axial direction and the total length over which the dosage was 
applied.  Both the total time length and the physical length over which the dosage was 
applied were recorded during the experiment.  The spot size can be calculated using 
geometry.  Assume that the length of the optical fiber in the axial direction or the artery is 
0.6 mm.  Also, the half angle of light exiting the optical fiber would be ~12 degrees, 
based on the NA of the optical fiber.  Given a maximum artery radius of 2.5 mm 
measured during the experiment, the spot size was approximately 1.66 mm in the axial 
direction along the artery.  Using these parameters, the amount of time it took to apply 
each dosage to a region of tissue for C1-C6 were approximately 1, 13, 89, 3, 19, and 76 
seconds, respectively.  Time periods of 20 seconds or less (C1, C2, C4, C5) would be 
unlikely to affect damage since it is not a significant time length for heat transfer.  
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However, it is possible that the level of damage at conditions C3 and C6 were 
underestimated due to the length of time it took to apply these dosages in tissue.  Future 
work could address this, although it would require higher power lasers than any that have 
been currently reported for real-time IVPA imaging[55-57].  Third, although the vessel was 
isolated and flushed, it is likely that at least some residual blood was present in the blood 
vessel.  This would have lowered the actual light dosage that reached the tissue.  It should 
be noted that despite this our experiment would still overestimate damage, since vessel 
isolation and flushing would not be conducted during clinical IVPA imaging.  The vessel 
would instead be filled with pure blood.  Finally, during clinical IVPA imaging the blood 
would be flowing.  This would exert a convective cooling effect on the blood vessel, 
potentially decreasing damage from heat.   
 These damage thresholds for media necrosis compare favorably with our 
previously published work on cells[183] that is described in the prior chapter.  In those 
studies, some cell types first showed statistically significant loss of viability at 690 J/cm2 
when irradiated with light at 1064 nm.  This is consistent with the results of this in vivo 
safety study, in which damage was detected at 1064 nm for dosages of 700 J/cm2.  The 
IVPA lipid imaging wavelength used in that study was 1197 nm.  At this condition, cell 
death was first apparent for some cell types at 140 J/cm2.  In this study, damage was clear 
at 50 J/cm2, but not at 8.3 J/cm2.  If you assume that the midpoint between these values is 
the true transition point for the damage, then you get a damage threshold near 30 J/cm2.  
This is 4.7x smaller than the in vitro threshold of 140 J/cm2.  However, the absorption 
coefficient of water and vessel tissue is anywhere from 2-5x larger at 1720 nm than at 
1197 nm[115, 198, 210], so a lower damage threshold at 1720 nm would be expected since 
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more heat would be absorbed given the same light dosage.  These results are in good 
agreement considering the large differences between the in vitro and in vivo heat transfer 
environments.   
 It is also worth comparing these results to the ANSI Z136.1 guideline for the safe 
use of lasers.  Although this standard applies to the skin and eyes, we can compare our 
results to the requirements for skin to determine if the results seem reasonable.  The 
maximum permissible exposure (MPE) as defined by the standard varies for each 
wavelength depending on the time length of irradiation.  For time lengths below 10 
seconds, it is defined in terms of the fluence applied to the tissue.  For time lengths above 
10 seconds, it is defined in terms of the irradiance applied over that time.  The actual 
fluence dosage applied in our experiments is already given for each condition in Table 6.1.  
The irradiance can be calculated by dividing the fluence at each dosage by the length of 




Table 6.6 A comparison of the MPE predicted by ANSI Z136.1 for skin to our 
experimental results on blood vessel tissue.  Note that the ANSI Z136.1 standard 
defines the MPE as 10x smaller than the dosage that will cause damage 50% of the 
time (EC50).  Thus, the MPE must be multiplied by 10 before comparing it to the 
































C1 1064  8.3 N/A 5.5 N/A N N 
C2 1064  N/A 7.8 N/A 1 N N 
C3 1064  N/A 7.8 N/A 1 N Y 
C4 1720 8.3 N/A 1 N/A N N 
C5 1720 N/A 2.6 N/A 0.1 Y Y 
C6 1720 N/A 2.6 N/A 0.1 Y Y 
 
 
 A comparison of the experimentally applied fluence, experimentally applied 
irradiance, and the MPE for each condition are shown in Table 6.6.  Table 6.6 also shows 
if the ANSI standard would predict damage for each condition.  Remember from the prior 
chapter that the MPE has a safety factor of 10, so the MPE must be multiplied by 10 to 
determine where damage would first be detectable.  The prediction of damage using the 
ANSI standard is compared to our experimental results, in which damage was identified 
by the pathologist.  These results are all in agreement, except that our experiments 
identified damage at condition C3 that was not predicted based on the MPE.  This 
underestimate of damage based on the MPE is not unexpected, since the standard applies 
to skin.  The absorption coefficient of vessel tissue is higher than skin at both 
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wavelengths[115, 198, 210], so damage at lower dosages should be expected.  Also, damage at 
condition C3 was considered by the pathologist to be more equivocal.  The statistical test 
yielded no significance, albeit with low sample size.  Nonetheless, these results substantiate 
that the ANSI standards for skin may not be adequate for determining if damage can be 
expected to vessel tissue.   
 Our experimental results indicate a damage threshold between 8.3 and 50 J/cm2 at 
1720 nm.  Assuming that the true threshold for damage is the average of these conditions, 
the transition point would be at 30 J/cm2.  Reducing by the safety factor of 10 gives an 
MPE near 3 J/cm2 at 1720 nm.  An IVPA imaging protocol that used 128 A-lines per 
frame, 0.1 mJ per pulse, and a 2 mm/s pullback in a 2 mm diameter (occluded) artery 
would be near this MPE, at 3.13 J/cm2.  Recent real-time in vivo studies have successfully 
imaged plaque lipid using imaging protocols that used equivalent or lower exposures[55-
57].  This indicates that it will be possible to use IVPA imaging for lipid identification 
safely.  It should also be noted that the true limits for safe IVPA imaging may be higher 
than the thresholds identified in this study if future work shows that the damage from 
irradiation found in this study would heal over time.   
 To the author’s knowledge, this is the first experimental study to investigate the 
safety of IVPA imaging in depth in vivo.  We found that damage to vessels from heat 
accumulation is unlikely to inhibit the use of IVPA imaging clinically due to safety 
concerns.  However, the study could be improved in several ways.  First, repeating the 
study but with termination of the swine at 3-7 days after irradiation would make it easier 
to differentiate between damage caused by catheterization and light irradiation.  Second, 
conducting a study in which damage was evaluated 1-2 months after irradiation would 
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make it possible to determine if the vessels would heal from the type of damage found in 
our histological specimens.  It should be noted, however, that such a study would involve 
some practical difficulties.  We found during the course of the imaging studies that it is 
difficult to completely flush blood from the artery in a survival surgery, because methods 
of isolating the vessel will still allow some blood to flow in over time.  During a terminal 
surgery, this can be dealt with by flushing large volumes of water.  However, the amount 
of liquid that can be injected into the swine during survival is limited.  Besides 
attenuating the light, static blood in the vessel could coagulate which would absorb 
almost all the light emitted from the catheter and potentially prove fatal to the pig after 
the surgery.  Finally, this study did not examine the effect of irradiation on blood.  Future 
studies would be needed to assess the effect of these irradiation dosages on blood cells 
and any consequent increase in thrombogenicity.   
6.5 Conclusions 
To the author’s knowledge, this is the first study designed to evaluate the safety of IVPA 
in vivo.  The damage to blood vessel tissue from real-time in vivo delivery of light was 
investigated in the carotid arteries of swine.  Damage was assessed at 1064 nm and the 
lipid imaging wavelength of 1720 nm in a dose dependent manner.  Damage was 
assessed by a trained pathologist.  The pathologist determined that the only dose 
dependent type of damage in the tissue was media necrosis.  There was clear damage to 
the tissue when subjected to 50 J/cm2 at 1720 nm.  There was also damage at 700 J/cm2 
when 1064 nm light was used, although the pathologist stated the damage was more 
equivocal when compared to the controls.  An MPE defined by the damage results at 
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1720 nm could be met with an imaging protocol using 128 A-lines, 0.1 mJ per pulse, and 
a pullback rate of 2 mm/s in a 2 mm diameter occluded artery.  Prior studies have already 
shown that lipid plaque can be imaged using similar or lesser dosages.  Moreover, in the 
opinion of the pathologist, the damage that was detected at the higher dosages would be 
expected to heal, although additional studies will be needed to prove this conclusively.  
The results were consistent with the in vitro studies discussed in the prior chapter.  We 
found that the ANSI Z136.1 standard for skin underestimates the damage compared to 
our experimental results.  We conclude that this standard may not be appropriate for 
vessel tissue.  Future work should evaluate the progression of damage over longer time 
points (1-2 months) and evaluate any potential increase in blood thrombogenicity.  
Regardless, these studies suggest that it will be possible to use IVPA imaging to identify 
lipid in plaque in a clinical setting without damaging the vessel tissue.    
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APPENDIX A:  Fluence versus Depth for all Monte Carlo Simulations 
Summary: This appendix contains the fluence as a function of depth along the center of the 





Figure_Apx A-1 Simulation results using 100% fatty tissue with light at 700 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-2 Simulation results using 100% fatty tissue with light at 800 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-3 Simulation results using 100% fatty tissue with light at 900 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-4 Simulation results using 100% fatty tissue with light at1064 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-5 Simulation results using 100% fibrous tissue with light at 700 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-6 Simulation results using 100% fibrous tissue with light at 800 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-7  Simulation results using 100% fibrous tissue with light at 900 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-8 Simulation results using 100% fibrous tissue with light at 1064 nm.  
The plots show the fluence versus depth at the center of the imaging plane for mice 
(left) and humas (right).  The two plots on top show simulations at multiple optical 
fiber angles and the distance held constant at 7.5 mm, while the bottom two plots 
show simulations conducted at multiple fiber bundle to imaging plane distances and 
angle held constant at 45 degrees.  The optical properties of the skin and bulk tissue 
as well as the ratio of maximum fluence between simulations conducted with mice 




Figure_Apx A-9 Simulation results using 20% fatty and 80% fibrous tissue with 
light at 800 nm.  The plots show the fluence versus depth at the center of the 
imaging plane for mice (left) and humas (right).  The two plots on top show 
simulations at multiple optical fiber angles and the distance held constant at 7.5 
mm, while the bottom two plots show simulations conducted at multiple fiber 
bundle to imaging plane distances and angle held constant at 45 degrees.  The 
optical properties of the skin and bulk tissue as well as the ratio of maximum 
fluence between simulations conducted with mice skin thickness and human skin 




Figure_Apx A-10 Simulation results using 40% fatty and 60% fibrous tissue with 
light at 800 nm.  The plots show the fluence versus depth at the center of the 
imaging plane for mice (left) and humas (right).  The two plots on top show 
simulations at multiple optical fiber angles and the distance held constant at 7.5 
mm, while the bottom two plots show simulations conducted at multiple fiber 
bundle to imaging plane distances and angle held constant at 45 degrees.  The 
optical properties of the skin and bulk tissue as well as the ratio of maximum 
fluence between simulations conducted with mice skin thickness and human skin 




Figure_Apx A-11  Simulation results using 60% fatty and 40% fibrous tissue with 
light at 800 nm.  The plots show the fluence versus depth at the center of the 
imaging plane for mice (left) and humas (right).  The two plots on top show 
simulations at multiple optical fiber angles and the distance held constant at 7.5 
mm, while the bottom two plots show simulations conducted at multiple fiber 
bundle to imaging plane distances and angle held constant at 45 degrees.  The 
optical properties of the skin and bulk tissue as well as the ratio of maximum 
fluence between simulations conducted with mice skin thickness and human skin 




Figure_Apx A-12 Simulation results using 80% fatty and 20% fibrous tissue with 
light at 800 nm.  The plots show the fluence versus depth at the center of the 
imaging plane for mice (left) and humas (right).  The two plots on top show 
simulations at multiple optical fiber angles and the distance held constant at 7.5 
mm, while the bottom two plots show simulations conducted at multiple fiber 
bundle to imaging plane distances and angle held constant at 45 degrees.  The 
optical properties of the skin and bulk tissue as well as the ratio of maximum 
fluence between simulations conducted with mice skin thickness and human skin 
thickness are shown at the top.    
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APPENDIX B:  Effective Attenuation coefficient versus position for 
multiple tissue combinations for all 4 wavelengths (700, 800, 900, 
1064 nm) simulated.   
 
 
Figure_Apx B-1 Plot of the effective attenuation coefficient as a function of the 
depth at which the exponential fit was applied for fluence versus depth in 
simulations conducted at 700 nm for various tissue compositions.  The fit was 
applied over 4 mm segments in increments of 1 mm.  The depth at which the fit is 
the true rate of decay occurs once the effective attenuation coefficient becomes 
roughly constant, usually 4-5 data points from the left.  The variation in the effective 
attenuation seen at the right is due to probabilistic variation in the simulation 
results, which arises from the small number of photons reaching deep into the 




Figure_Apx B-2 Plot of the effective attenuation coefficient as a function of the 
depth at which the exponential fit was applied for fluence versus depth in 
simulations conducted at 800 nm for various tissue compositions.  The fit was 
applied over 4 mm segments in increments of 1 mm.  The depth at which the fit is 
the true rate of decay occurs once the effective attenuation coefficient becomes 
roughly constant, usually 4-5 data points from the left.  The variation in the effective 
attenuation seen at the right is due to probabilistic variation in the simulation 
results, which arises from the small number of photons reaching deep into the 




Figure_Apx B-3 Plot of the effective attenuation coefficient as a function of the 
depth at which the exponential fit was applied for fluence versus depth in 
simulations conducted at 900 nm for various tissue compositions.  The fit was 
applied over 4 mm segments in increments of 1 mm.  The depth at which the fit is 
the true rate of decay occurs once the effective attenuation coefficient becomes 
roughly constant, usually 4-5 data points from the left.  The variation in the effective 
attenuation seen at the right is due to probabilistic variation in the simulation 
results, which arises from the small number of photons reaching deep into the 




Figure_Apx B-4 Plot of the effective attenuation coefficient as a function of the 
depth at which the exponential fit was applied for fluence versus depth in 
simulations conducted at 1064 nm for various tissue compositions.  The fit was 
applied over 4 mm segments in increments of 1 mm.  The depth at which the fit is 
the true rate of decay occurs once the effective attenuation coefficient becomes 
roughly constant, usually 4-5 data points from the left.  The variation in the effective 
attenuation seen at the right is due to probabilistic variation in the simulation 
results, which arises from the small number of photons reaching deep into the 
tissue.    
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APPENDIX C:  Pathology Report 
 
The following is a copy of the pathology report, emailed to us by Alizee Pathology on 
August 7th, 2020.  The formatting has been changed to fit the requirements of this 











The objective of this study was to histologically evaluate the local response of Intravascular 
Photoacoustic Imaging (IVPA) on swine carotid arteries.     
 
Methods 
The histology and pathology portions of Alizée Project Number HJC13-339 conducted at 
Alizée Pathology were neither intended nor required to be in compliance with United States 
Food and Drug Administration GLP regulations set forth in Title 21 Code of Federal 
Regulations (CFR) Part 58. As such, quality assurance inspections and oversight were not 
performed. However, all study conduct performed at Alizée was completed in accordance 
with the technical memo, study protocol, Alizée Standard Operating Procedures (SOP) and 
sound scientific judgment. The results from analysis provided in this report have undergone 
a thorough quality control review. In addition to the hard copy, an electronic copy of this 
report in portable document format (PDF) will be provided to Georgia Institute of 
Technology. The PDF is a representation of the pathology report hard copy; however, only 
the signed hard copy of the pathology report is considered raw data. Digital images 
appearing in this report are for illustrative purposes only. All pathologic diagnoses were 
derived from the original histological preparations. 
 
This pathology executive summary report by Alizée presents the results of microscopic 
assessment of a total of forty eight (48) carotid artery segments (16 segments per artery) 
153 
 
from swine when treated with laser irradiation at several dosages for Georgia Institute of 
Technology, Atlanta, GA.  This study, including all surgical procedures and tissue harvests, 
was conducted at the Georgia Institute of Technology, under the direction of Tim Sowers. 
Histological processing was performed at Alizée Pathology, Thurmont, MD. Resulting 
slides were evaluated, in a manner blinded to treatment, via light microscopy at Alizée by 
Serge D. Rousselle, DVM, DACVP, Study Pathologist. 
 
According to the protocol and client communication, a total of 3 carotid arteries from swine 
were assigned to this study, in which there were seven total conditions (treatments). These 
consisted of two wavelengths of laser light (1064 nm and 1720 nm) with 3 different dosages 
of light at each wavelength, as well a negative control which was not irradiated with any 
light. The wavelength number and light dosage (fluence) are given for each condition, as 
shown in Table A. After laser irradiation at several dosages, each artery was dissected into 
sixteen segments and placed in containers filled with 10% neutral buffered formalin. All 
collected samples were sent to Alizée for histology and microscopic evaluation. 
 
A total of sixteen (16) segments each from 3 carotid arteries (Artery 1, Artery 2 and Artery 
3, respectively) were received at Alizée, fixed in 10% neutral buffered formalin. Samples 
were received in good condition, defined as all seals intact with no damage to containers 













None 0 1A, 1B, 1C, 1D, 2A, 2B, 2P, 3A, 3B 
C1 1064 8.3 1E*, 1F*, 1G, 1H, 2C, 2D, 2E, 2F, 2G 
C2 1064 100 1I, 1J, 2H, 2I, 2J, 2K, 2L 
C3 1064 700 1K, 1L, 2M, 2N, 2O 
C4 1720 8.3 1M, 3C, 3D, 3E 
C5 1720 50 1N, 1O, 3F, 3G, 3H, 3I, 3J, 3K, 3L, 3M 
C6 1720 200 1P, 3N, 3O, 3P 
* = Treatment applied to ~¼ of vessel circumference. 
 
 
The pre-trimmed carotid artery segments were processed in a series of graded alcohols and 
xylene and paraffin wax embedded. The resulting paraffin blocks were sectioned twice 
serially, with an effort to capture the center of each segment, at an approximate 5 µm 
thickness and mounted to slide. One slide was stained with hematoxylin and eosin (H&E) 
and the other with Gomori’s Elastin Trichrome (GET). Microscopic evaluation of the 
resulting slides was conducted by Serge Rousselle, DVM, DACVP. Tabulated microscopic 
data are presented in Appendix A. 





Table_Apx C-2 Scoring table for damage morphology parameters 
Score Description 
0 Finding not present. 
1 Present, but minimal feature. 
2 Notable feature; mild. 
3 Prominent feature; moderate. 
4 Overwhelming feature; severe. 
 
 
Definitions and causes of damage types: 
Endothelial Cell Loss: Most sensitive endpoint. Endothelial cells are highly susceptible to 
any mechanical shear stress or thermal effect and are typically the first cell type to be lost. 
 
Hypereosinophilic Smooth Muscle Cells: Acute cell injury in the media. The staining 
alteration indicates generally a change in cytoplasmic homeostasis. This can be an artifact 
of tissue handling or fixation if fixation conditions are not optimal or can be a very early 
sign of peracute mural damage. Interpretation is based on comparison between control and 
treated vessels as well as pattern and distribution of the change and associated changes 
(context). 
 
Compressive/Pressure Necrosis/Cell Effacement (loss): Concentric change characterized 
by sheets of smooth muscle cells showing hypereosinophilia and pyknotic to karyorrhectic 
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nuclei to cytolysis (loss of cellular features) leaving the vessel wall matrix intact. This 
change can be radial to circumferential and is always concentric (inside out). 
 
Contraction bands: Alternating bands of hypereosinophilic and contracted smooth muscle 
cells alternating with pale hypocellular or acellular areas. This change indicates excessive 
vasoconstrictive stress and may lead to necrosis or regeneration. 
 
Necrotic/Apoptotic Cells: Individual cell necrosis; may present as hypereosinophilia, 
pyknosis, karyorrhexis, cell debris and/or apoptotic body. 
 
Collagen denaturation: Loss of fine fibrillar texture with collagenous areas showing 
hyalinization (homogenous thick bundles typically hypereosinophilic and sometimes 
picking up hematoxylin stain (purple) to varying degrees). This change indicates heat 




Results & Discussion 
Microscopic scoring of the local response of a total of forty-eight (48) segments from 3 
swine carotid arteries when treated with laser irradiation at several dosages showed the 
following: 
 
Table_Apx C-3 Histopathology Group Summary 
HJC19-
339 















































































































































































n 9 9 9 9 9 9 9 9 9 9 9 
Mean 0.0 0.7 0.3 0.1 0.0 0.4 0.4 4.0 1.8 0.8 0.1 
StDev 0.0 0.7 0.7 0.2 0.2 0.5 0.5 0.0 1.1 0.7 0.3 
C1 
n 9 9 9 9 9 9 9 9 9 9 9 
Mean 0.0 1.1 0.1 0.2 0.0 0.7 0.7 4.0 1.3 0.9 0.6 
StDev 0.0 0.6 0.3 0.2 0.2 0.5 0.5 0.0 0.5 0.3 0.7 
C2 
n 7 7 7 7 7 7 7 7 7 7 7 
Mean 0.0 0.7 0.0 0.1 0.0 0.1 0.1 4.0 0.4 0.7 0.0 
StDev 0.0 1.0 0.0 0.2 0.2 0.4 0.4 0.0 0.5 0.5 0.0 
C3 
n 5 5 5 5 5 5 5 5 5 5 5 
Mean 0.0 1.4 0.0 0.2 0.0 0.6 0.6 4.0 1.2 1.0 0.0 
StDev 0.0 0.5 0.0 0.2 0.2 0.5 0.5 0.0 0.4 0.0 0.0 
C4 
n 4 4 4 4 4 4 4 4 4 4 4 
Mean 0.0 0.5 0.5 0.4 0.5 0.8 0.8 4.0 0.8 0.3 0.0 
StDev 0.0 1.0 1.0 0.3 0.3 0.5 0.5 0.0 0.5 0.5 0.0 
C5 
n 10 10 10 10 10 10 10 10 10 10 10 
Mean 0.2 2.2 0.0 0.2 0.2 0.6 0.6 4.0 1.9 0.6 0.0 
StDev 0.4 0.8 0.0 0.2 0.2 0.5 0.5 0.0 0.9 0.5 0.0 
C6 
n 4 4 4 4 4 4 4 4 4 4 4 
Mean 0.0 3.3 0.0 0.0 0.0 0.0 0.0 4.0 3.5 1.0 0.0 




General Perspective on Acute Vascular Changes Associated with Energy Delivery: 
 
Energy delivery produce non-specific microscopic changes in tissues essentially 
characterized by degeneration and necrosis sometimes accompanied by evidence of 
extracellular protein matrix denaturation. In vessels, these changes target endothelial cells 
and media smooth muscle cells primarily. Extracellular matrix (ECM) can be affected by 
mechanical or energy delivery and cause laceration or tears (mechanical stress) or 
coagulation (radiative energy).  Spurious factors can and frequently do complicate 
interpretation of vascular histology. Vascular histology can be significantly influenced by 
experimental conditions in-vivo and at tissue harvest (tissue handling and fixation). 
Catheterization of a target vessel alone can and typically erodes the endothelial surface 
through mechanical shear stress. Catheter bulk and relative rigidity can also impart 
localized compressive trauma sufficient to bruise the vessel wall and cause cell death in 




Tissue collection can also produce changes that mimic necrosis unless the tissue is fixed 
in-situ prior to dissection and excision/trimming. Tissue handling and pulling during 
dissection as well as trimming of target segments can also cause tissue damage that mimics 
compressive injury (crushing). Use of cauterizing scalpel can cause coagulation necrosis 
and denaturation of ECM.  
 
Morphologically, the resulting effect on vascular cells include vacuolization, shrinkage and 
hypereosinophilia of the cytoplasm, pyknosis, localized cellular effacement or stretch tears 
in cellular sheets.  Effect on ECM includes lacerations and coagulation/hyalinization (heat-
induced denaturation). Interpreting the significance and cause of acute vascular changes 






Microscopic Finding Ascribable to Treatment: 
 
Table_Apx C-4 Average Severity of Media Necrosis 











In this study, the only change that was clearly dose-related consisted of media necrosis. 
This change is characterized by areas of media hypereosinophilia with pyknosis and/or 
karyorrhexis. It was observed at low severity in control segments (C0) and showed a clear 
increase in severity, incidence and circumferential extension at highest doses (C5 and C6). 
In group C3, there was a slight increase in incidence and circumferential extent that was of 
equivocal significance biologically (possible trend) considering the level of background 
noise in the controls. The changes observed at lower doses (C1, C4) were consistent with 
background noise.  
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C0 (NO ACTIVATION) 
 
Figure_Apx C-1 Segment 2A (H&E). C0 (No activation). Clear arrowheads = rare 
contracted and hyper eosinophilic smooth muscle cells in the media (media 
necrosis score ‘1’); blue double arrows = inner media showing compressed smooth 




Figure_Apx C-2 Segment 1C (H&E). C0 (No activation). Clear double arrow 
inside dotted line = inner media showing smooth muscle cells with pyknotic nuclei 
and variably hypereosinophilic and contracted cytoplasm; solid arrow = slight 




C0 (NO ACTIVATION) (CONTINUED) 
 
Figure_Apx C-3 Segment 1C (H&E). C0 (No activation). M = intact outer media; 
black dotted line = outline of inner media area showing necrotic smooth muscle 
cells (clear arrowheads = hypereosinophilic and contracted smooth muscle cells); 





Figure_Apx C-4 Segment 1C (GET). C0 (No activation). M = intact inner media; 
green dotted line = outline of deep media area showing necrotic smooth muscle 






C0 (NO ACTIVATION) (CONTINUED) 
 
Figure_Apx C-5 Segment 2A (GET). C0 (No activation). Green asterisk = focal 








Figure_Apx C-6 Segment 3B (GET). C0 (No activation). Green asterisks = locally 
extensive collagen denaturation of the adventitia (consistent with focal 





C1 (1064 nm - 8.3 J/cm2) 
 
Figure_Apx C-7 Segment 1H (GET). C1 (1064 nm - 8.3 J/cm2). Green dotted line 
= boundary between the intact inner media (M) and the outer affected media 





Figure_Apx C-8 Segment 1H (H&E). C1 (1064 nm - 8.3 J/cm2). Black dotted line 
= boundary between the intact inner media (M) and the outer affected media 





C1 (1064 nm - 8.3 J/cm2) (CONTINUED) 
 
Figure_Apx C-9 Segment 1H (GET). C1 (1064 nm - 8.3 J/cm2). Green dotted line 
= outline of deep media area showing necrotic smooth muscle cells; green 
arrowheads = hyperchromatic and contracted smooth muscle cells (necrosis); 





Figure_Apx C-10 Segment 1H (H&E). C1 (1064 nm - 8.3 J/cm2). Black dotted line 
= outline of deep media area showing necrotic smooth muscle cells; clear 
arrowheads = hyperchromatic and contracted smooth muscle cells (necrosis); 
clear arrows = clear spaces between smooth muscle cells (edema and/or smooth 
muscle cell dissociation and loss); clear double arrow = inner media appearing 





C1 (1064 nm - 8.3 J/cm2) (CONTINUED) 
 
Figure_Apx C-11 Segment 2D (H&E). C1 (1064 nm - 8.3 J/cm2). Black dotted line 
= boundary between the intact outer media (M) and the inner affected media 
showing hypereosinophilic smooth muscle cells (arrowheads) and clear spaces of 
smooth muscle cell effacement and loss (clear arrows); clear double arrows = 
innermost media showing pyknosis in smooth muscle cell nuclei (generally 





Figure_Apx C-12 Segment 2D (GET). C1 (1064 nm - 8.3 J/cm2). Green asterisk 
bounded by dotted line = focal collagen denaturation of the adventitial collagen 






C2 (1064 nm – 100 J/cm2) 
 
Figure_Apx C-13 Segment 2J (H&E). C2 (1064 nm - 100 J/cm2). Clear double 
arrow = media (M) showing no evident necrosis; blue dotted line and blue double 









Figure_Apx C-14 Segment 1I (H&E). C2 (1064 nm - 100 J/cm2). Black dotted line 
= boundary between the intact outer media and the inner affected media showing 
hypereosinophilic smooth muscle cells (clear arrowheads) and increased 
interstitial clear spaces; blue double arrow = innermost media showing pyknosis 
in smooth muscle cell nuclei (generally consistent with compressive necrosis); blue 
arrows = clear spaces in the inner media (smooth muscle cell loss) denoting 





C2 (1064 nm – 100 J/cm2) (CONTINUED) 
 
Figure_Apx C-15 Segment 1I (H&E). C2 (1064 nm - 100 J/cm2). Solid arrows = 
minimal inflammation in the adventitia (neutrophils); clear arrowhead = necrotic 






C3 (1064 nm – 700 J/cm2) 
 
Figure_Apx C-16 Segment 2N (H&E). C3 (1064 nm - 700 J/cm2). Clear double 
arrow inside dotted line = media showing no evident treatment-induced necrosis. 
There is concentric hypereosinophilia and pyknosis typically consistent with 





Figure_Apx C-17 Segment 1L (H&E). C3 (1064 nm - 700 J/cm2). Black dotted line 
= boundary between the intact inner media (clear double arrow) and the outer 
affected media showing hypereosinophilic smooth muscle cells (clear arrowheads) 
and increased interstitial clear spaces (clear arrows); blue arrows = clear spaces 





C4 (1720 nm - 8.3 J/cm2) 
 
Figure_Apx C-18 Segment 3C (H&E). C4 (1720 nm – 8.3 J/cm2). Black asterisk = 





Figure_Apx C-19 Segment 1M (H&E). C4 (1720 nm – 8.3 J/cm2). Black dotted 
line = boundary between the intact (albeit possibly compressed) inner media 
(solid double arrow) and the outer affected media showing hypereosinophilic and 
contracted smooth muscle cells (clear arrowheads) and increased interstitial clear 






C4 (1720 nm - 8.3 J/cm2) (CONTINUED) 
 
Figure_Apx C-20 Segment 3C (GET). C4 (1720 nm – 8.3 J/cm2). Green asterisks = 
locally extensive collagen denaturation of the adventitia (consistent with focal 





C5 (1720 nm - 50 J/cm2) 
 
Figure_Apx C-21 Segment 1N (H&E). C5 (1720 nm – 50 J/cm2). Affected media 
showing hypereosinophilic and contracted smooth muscle cells (clear arrowheads) 
and increased interstitial clear spaces (clear arrow); solid arrows = 
hypereosinophilic smooth muscle cells with pyknotic nuclei in the inner media 





Figure_Apx C-22 Segment 3H (H&E). C5 (1720 nm – 50 J/cm2). Media inside 
dotted line = affected media showing hypereosinophilic and contracted smooth 
muscle cells (clear arrowheads) and increased interstitial clear spaces (clear 




C5 (1720 nm - 50 J/cm2) (CONTINUED) 
 
Figure_Apx C-23 Segment 3L (H&E). C5 (1720 nm – 50 J/cm2). Black dotted lines 
= boundary between the intact outer and mid media (M) and the affected media 
showing hypereosinophilic and contracted smooth muscle cells (clear arrowheads) 
and increased interstitial clear spaces (clear arrows), the innermost media (clear 
double arrow) shows pyknotic nuclei and hypereosinophilic smooth muscle cells 






C6 (1720 nm - 200 J/cm2) 
 
Figure_Apx C-24 Segment 1P (GET). C6 (1720 nm – 200 J/cm2). Section showing 
widespread media necrosis (circular green double arrow) and a short segment of 
intact media (M, delineated by green dotted line); clear arrows = radial clusters of 





Figure_Apx C-25 Segment 1P (H&E). C6 (1720 nm – 200 J/cm2). Black dotted 
line = radial boundary between the intact media (M) and the affected media 
showing widespread hypereosinophilic and contracted smooth muscle cells (clear 





C6 (1720 nm - 200 J/cm2) (CONTINUED) 
 
Figure_Apx C-26 Segment 3O (H&E). C6 (1720 nm – 200 J/cm2). Black dotted 
line = boundary between the intact outer and mid media (M) and the affected 
media showing widespread hypereosinophilic and contracted smooth muscle cells 
(clear arrowheads) and increased interstitial clear spaces (clear arrows); the 
innermost media (clear double arrow) shows pyknotic nuclei and 







Changes induced by treatment overlap with changes induced by catheterization +/- 
vasospasm (i.e., compressive necrosis and stretch necrosis). Outer media necrosis 
characterized by smooth muscle cell hypereosinophilia and contraction is most 
characteristic. Treatment effect was clear in C3 (1064 nm; 700 J/cm2) and C5 < C6 (1720 
nm; 50, 200 J/cm2, respectively). Possible treatment effects sporadically at lower doses 
(C1, C2 and C4). The tissue damage at these levels are not considered life threatening and 
are expected to heal. While nothing in this study represents a safety concern, a chronic time 



















































APPENDIX D:  Pathologist Q&A 
 
The following gives a series of questions for the pathologist with answers.  The questions 
were originally answered in a phone call and answered verbally.  However, the 
pathologist also returned the questions with written answers while sending us the final 




Definitions and Causes of Damage Types:  
Please clarify the meaning of the following types of damage:  
 Hypereosinophilic (smooth muscle cells) 
 Compressive/pressure necrosis 
 Contraction bands 
Is there a hierarchy of damage severity for the damage types you describe (shown below)?  
Can you categorize these in terms of their potential causes (mechanical catheter damage, 
heat accumulation, heavy water flushing) 
 Hypereosinophilic (SMCs) 
 Collagen denaturation 
 Necrotic/apoptotic cells 
 Cell effacement 
 Contraction bands 
 Endothelialization  
Pathologist Response: Added clarification for the above in the Executive Summary 
Pathology Report. 
Is there a primary damage mechanism we should be looking at?  
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Can you categorize these types of damage in terms of their potential causes?  In terms of 
our experiments, possibilities include:  
(a) mechanical damage from catheter  
(b) heat accumulation from laser  
(c) heavy water injection (possible higher pressure for extended periods)  
(d) cutdown via electrocauterization (the cardiologist knew the purpose of the 
experiment, and thus should have avoided direct contact with the artery, but I don’t 
think we should rule out some local damage remaining)  
(e) lack of nutrients/oxygen delivery from blood flushing (1-2 hours from blood 
flushing to tissue fixation)  
Pathologist Response: There is not a morphological change that is specific or 
pathognomonic for the type of energy that you are delivering. What makes your modality 
different is the mode of delivery and hence to distribution of these changes. Recognizing 
it requires experience with your treatment and experimental settings and comparison 
between control and test. Reducing background noise and artifacts will help sharpen up 
the acute signal.  
Conditions/Image Specific Questions:  
Slide 11, Figure 16 – “area has no evident necrosis but also hypereosinophilia and pyknosis 
consistent with compression necrosis”.  Seems to contradict.  Can you explain?   
Is collagen denaturization tabulated anywhere?   
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Pathologist Response: Clarified caption for Figure 16 – please see Executive Summary 
Pathology Report. For collagen denaturation, please see collagen injury subheading in 
data table, namely hyalinized collagen. 
Analysis/Interpretation Questions:  
Certain types of damage (compression necrosis, focal cauterization of collagen in 
adventitia) are present at all conditions.  Why is it that damage at higher dosages was rated 
as more severe?   
Pathologist Response: Reading was done blind, so severity scores reflect extent seen at 
time of evaluation. 
Was there an increase in intensity in collagen denaturization between conditions types (this 
feature was present in controls)?  
Pathologist Response: I can’t account for presence in controls except for cauterization 
during dissection. 
At lower dosages, the outer media seems affected while the internal media is intact.  At 
higher dosages, damage is present in the internal layer and sometime the outer layers.  What 
is your interpretation of this?   
Pathologist Response: Variations in energy delivery with dose. Some amount is 
background noise so I would refrain from trying to over analyze this until you produce 




Big Picture Questions:  
Are there specific conditions where more samples would be informative, or would it be 
better to test other intermediate conditions between the energy levels already chosen?  If 
so, please specify which.   
Pathologist Response: Highest order of priority is to decrease background noise as stated 
above. 
Will the tissue at these damage levels heal? Do expect any of these types of damage to be 
life threatening?  
Pathologist Response: Yes, they will heal and no, they are not life threatening. 
Would a chronic study (injury then sacrifice two month later) be useful?   
Pathologist Response: Yes and will be required to demonstrate healing and lack of 
adverse changes. 
What does the FDA usually require to ensure the safety of a device like this?  Is there 
anything you can suggest to make our experiments meet their expected requirements more 
closely?   
Pathologist Response: See above: reach a steady state of recovery and healing and no 
permanent damage that impact function (i.e. stenosis). 
In more laymen's terms, how do the histological types of damage found in this analysis 
relate to the safety/well-being of an animal or patient undergoing imaging?  
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Pathologist Response: Nothing seen here represents a safety concern but a chronic time 
period (4 weeks) would be required to confirm that healing is uneventful. 
What conditions or changes to protocol should be made to the next set of experiments?   
Pathologist Response: Optimize tissue harvest conditions: no cauterization, perfusion 
fixation prior to tissue extraction, contention of tissue on a rigid support to avoid 






1. Wang, L.V. and J. Yao, A practical guide to photoacoustic tomography in the life 
sciences. Nat Methods, 2016. 13(8): p. 627-38. 
2. Xu, M.H. and L.H.V. Wang, Photoacoustic imaging in biomedicine. Review of 
Scientific Instruments, 2006. 77(4). 
3. Bell, A.G., Upon the production of sound by radiant energy. 1881, Washington,: 
Gibson brothers, printers. 45 p. incl. plates. 
4. Gusev, V.E. and A.A. Karabutov, Laser optoacoustics. 1993, New York: 
American Institute of Physics. xvii, 271 p. 
5. Oraevsky, A.A., S.L. Jacques, and F.K. Tittel, Measurement of tissue optical 
properties by time-resolved detection of laser-induced transient stress. Appl Opt, 
1997. 36(1): p. 402-15. 
6. Emelianov, S.Y., et al., Synergy and Applications of Combined Ultrasound, 
Elasticity, and Photoacoustic Imaging. 2006 Ieee Ultrasonics Symposium, Vols 1-
5, Proceedings, 2006: p. 405-+. 
7. Diot, G., A. Dima, and V. Ntziachristos, Multispectral opto-acoustic tomography 
of exercised muscle oxygenation. Opt Lett, 2015. 40(7): p. 1496-9. 
8. Erpelding, T.N., et al., Sentinel lymph nodes in the rat: noninvasive photoacoustic 
and US imaging with a clinical US system. Radiology, 2010. 256(1): p. 102-10. 
9. Li, R., et al., Assessing breast tumor margin by multispectral photoacoustic 
tomography. Biomedical Optics Express, 2015. 6(4): p. 1273-1281. 
10. Luke, G.P., D. Yeager, and S.Y. Emelianov, Biomedical Applications of 
Photoacoustic Imaging with Exogenous Contrast Agents. Annals of Biomedical 
Engineering, 2012. 40(2): p. 422-437. 
11. Pramanik, M. and L.V. Wang, Thermoacoustic and photoacoustic sensing of 
temperature. J Biomed Opt, 2009. 14(5): p. 054024. 
12. Sowers, T. and S. Emelianov, Exogenous imaging contrast and therapeutic agents 
for intravascular photoacoustic imaging and image-guided therapy. Physics in 
Medicine and Biology, 2018. 63(22). 
13. Wang, B., et al., Intravascular Photoacoustic Imaging. Ieee Journal of Selected 
Topics in Quantum Electronics, 2010. 16(3): p. 588-599. 
14. Zackrisson, S., S.M.W.Y. van de Ven, and S.S. Gambhir, Light In and Sound Out: 
Emerging Translational Strategies for Photoacoustic Imaging. Cancer Research, 
2014. 74(4): p. 979-1004. 
15. Oraevsky, A.A., et al., Clinical optoacoustic imaging combined with ultrasound 
for coregistered functional and anatomical mapping of breast tumors. 
Photoacoustics, 2018. 12: p. 30-45. 
16. Haisch, C., et al., Combined optoacoustic/ultrasound system for tomographic 
absorption measurements: possibilities and limitations. Anal Bioanal Chem, 2010. 
397(4): p. 1503-10. 
17. Niederhauser, J.J., et al., Combined ultrasound and optoacoustic system for real-
time high-contrast vascular imaging in vivo. IEEE Trans Med Imaging, 2005. 
24(4): p. 436-40. 
203 
 
18. Kim, C., et al., Deeply penetrating in vivo photoacoustic imaging using a clinical 
ultrasound array system. Biomedical Optics Express, 2010. 1(1): p. 278-284. 
19. Sivasubramanian, K., V. Periyasamy, and M. Pramanik, Non-invasive sentinel 
lymph node mapping and needle guidance using clinical handheld photoacoustic 
imaging system in small animal. Journal of Biophotonics, 2018. 11(1). 
20. Organization, W.H. Cardiovascular diseases (CVDs). 2017  [cited 2017 Feb 
2018]; Available from: http://www.who.int/mediacentre/factsheets/fs317/en/. 
21. Libby, P., Inflammation in atherosclerosis. Nature, 2002. 420(6917): p. 868-74. 
22. Fischman, D.L., et al., A randomized comparison of coronary-stent placement and 
balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis 
Study Investigators. N Engl J Med, 1994. 331(8): p. 496-501. 
23. Kolodgie, F.D., et al., Pathologic assessment of the vulnerable human coronary 
plaque. Heart, 2004. 90(12): p. 1385-1391. 
24. van der Wal, A.C. and A.E. Becker, Atherosclerotic plaque rupture--pathologic 
basis of plaque stability and instability. Cardiovasc Res, 1999. 41(2): p. 334-44. 
25. Virmani, R., et al., Lessons from sudden coronary death - A comprehensive 
morphological classification scheme for atherosclerotic lesions. Arteriosclerosis 
Thrombosis and Vascular Biology, 2000. 20(5): p. 1262-1275. 
26. Farb, A., et al., Coronary plaque erosion without rupture into a lipid core - A 
frequent cause of coronary thrombosis in sudden coronary death. Circulation, 
1996. 93(7): p. 1354-1363. 
27. Quillard, T., et al., Mechanisms of erosion of atherosclerotic plaques. Current 
Opinion in Lipidology, 2017. 28(5): p. 434-441. 
28. Skeoch, S. and I.N. Bruce, Atherosclerosis in rheumatoid arthritis: is it all about 
inflammation? Nature Reviews Rheumatology, 2015. 11(7): p. 390-400. 
29. Glass, C.K. and J.L. Witztum, Atherosclerosis. the road ahead. Cell, 2001. 104(4): 
p. 503-16. 
30. Libby, P., et al., Atherosclerosis. Nat Rev Dis Primers, 2019. 5(1): p. 56. 
31. Rafieian-Kopaei, M., et al., Atherosclerosis: process, indicators, risk factors and 
new hopes. Int J Prev Med, 2014. 5(8): p. 927-46. 
32. Doradla, P., et al., Biomechanical Stress Profiling of Coronary Atherosclerosis: 
Identifying a Multifactorial Metric to Evaluate Plaque Rupture Risk. JACC 
Cardiovasc Imaging, 2020. 13(3): p. 804-816. 
33. Li, S., et al., Circulating microRNAs as potential biomarkers for coronary plaque 
rupture. Oncotarget, 2017. 8(29): p. 48145-48156. 
34. Libby, P., et al., Reassessing the Mechanisms of Acute Coronary Syndromes. 
Circ Res, 2019. 124(1): p. 150-160. 
35. Otsuka, F., et al., Pathology of coronary atherosclerosis and thrombosis. 
Cardiovasc Diagn Ther, 2016. 6(4): p. 396-408. 
36. Davies, M.J., Stability and instability: two faces of coronary atherosclerosis. The 
Paul Dudley White Lecture 1995. Circulation, 1996. 94(8): p. 2013-20. 
37. Narula, J., et al., Histopathologic characteristics of atherosclerotic coronary 
disease and implications of the findings for the invasive and noninvasive 
detection of vulnerable plaques. J Am Coll Cardiol, 2013. 61(10): p. 1041-51. 
38. Van der Wal, A.C., et al., Site of Intimal Rupture or Erosion of Thrombosed 
Coronary Atherosclerotic Plaques Is Characterized by an Inflammatory Process 
204 
 
Irrespective of the Dominant Plaque Morphology. Circulation, 1994. 89(1): p. 36-
44. 
39. Libby, P. and G. Pasterkamp, Requiem for the 'vulnerable plaque'. Eur Heart J, 
2015. 36(43): p. 2984-7. 
40. Naghavi, M., et al., From vulnerable plaque to vulnerable patient: a call for new 
definitions and risk assessment strategies: Part II. Circulation, 2003. 108(15): p. 
1772-8. 
41. Stone, G.W., et al., A prospective natural-history study of coronary 
atherosclerosis. N Engl J Med, 2011. 364(3): p. 226-35. 
42. Waksman, R., et al., Identification of patients and plaques vulnerable to future 
coronary events with near-infrared spectroscopy intravascular ultrasound 
imaging: a prospective, cohort study. Lancet, 2019. 394(10209): p. 1629-1637. 
43. Libby, P. and P. Theroux, Pathophysiology of coronary artery disease. 
Circulation, 2005. 111(25): p. 3481-8. 
44. Jansen, K., et al., Photoacoustic imaging of human coronary atherosclerosis in 
two spectral bands. Photoacoustics, 2014. 2(1): p. 12-20. 
45. Sowers, T. and S. Emelianov, Exogenous imaging contrast and therapeutic agents 
for intravascular photoacoustic imaging and image-guided therapy. Phys Med 
Biol, 2018. 63(22): p. 22TR01. 
46. Karpiouk, A.B., B. Wang, and S.Y. Emelianov, Development of a catheter for 
combined intravascular ultrasound and photoacoustic imaging. Review of 
Scientific Instruments, 2010. 81(1). 
47. Sethuraman, S., et al., Intravascular photoacoustic imaging using an IVUS 
imaging catheter. Ieee Transactions on Ultrasonics Ferroelectrics and Frequency 
Control, 2007. 54(5): p. 978-986. 
48. Cao, Y.C., et al., High-sensitivity intravascular photoacoustic imaging of lipid-
laden plaque with a collinear catheter design. Scientific Reports, 2016. 6. 
49. Wang, B. and S. Emelianov, Thermal intravascular photoacoustic imaging. 
Biomed Opt Express, 2011. 2(11): p. 3072-8. 
50. Jansen, K., et al., Intravascular photoacoustic imaging of human coronary 
atherosclerosis. Opt Lett, 2011. 36(5): p. 597-9. 
51. Jansen, K., et al., Spectroscopic intravascular photoacoustic imaging of lipids in 
atherosclerosis. J Biomed Opt, 2014. 19(2): p. 026006. 
52. Sethuraman, S., et al., Spectroscopic intravascular photoacoustic imaging to 
differentiate atherosclerotic plaques. Opt Express, 2008. 16(5): p. 3362-7. 
53. Yeager, D., et al., Intravascular photoacoustic imaging of exogenously labeled 
atherosclerotic plaque through luminal blood. Journal of Biomedical Optics, 
2012. 17(10). 
54. VanderLaan, D., et al., Real-Time Intravascular Ultrasound and Photoacoustic 
Imaging. IEEE Trans Ultrason Ferroelectr Freq Control, 2017. 64(1): p. 141-
149. 
55. Wu, M., et al., Real-time volumetric lipid imaging in vivo by intravascular 




56. Kole, A., et al., Comparative Quantification of Arterial Lipid by Intravascular 
Photoacoustic-Ultrasound Imaging and Near-Infrared Spectroscopy-Intravascular 
Ultrasound. J Cardiovasc Transl Res, 2019. 12(3): p. 211-220. 
57. Iskander-Rizk, S., et al., In vivo intravascular photoacoustic imaging of plaque 
lipid in coronary atherosclerosis. EuroIntervention, 2019. 15(5): p. 452-456. 
58. Vancraeynest, D., et al., Imaging the vulnerable plaque. J Am Coll Cardiol, 2011. 
57(20): p. 1961-79. 
59. Falk, E., Plaque rupture with severe pre-existing stenosis precipitating coronary 
thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal 
occlusive thrombi. Br Heart J, 1983. 50(2): p. 127-34. 
60. Takano, M., et al., Mechanical and structural characteristics of vulnerable 
plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll 
Cardiol, 2001. 38(1): p. 99-104. 
61. Thieme, T., et al., Angioscopic evaluation of atherosclerotic plaques: validation 
by histomorphologic analysis and association with stable and unstable coronary 
syndromes. J Am Coll Cardiol, 1996. 28(1): p. 1-6. 
62. Ueda, Y., et al., Assessment of plaque vulnerability by angioscopic classification 
of plaque color. Am Heart J, 2004. 148(2): p. 333-5. 
63. DeMaria, A.N., et al., Imaging vulnerable plaque by ultrasound. J Am Coll 
Cardiol, 2006. 47(8 Suppl): p. C32-9. 
64. Di Mario, C., et al., Detection and characterization of vascular lesions by 
intravascular ultrasound: an in vitro study correlated with histology. J Am Soc 
Echocardiogr, 1992. 5(2): p. 135-46. 
65. Choudhury, R.P., V. Fuster, and Z.A. Fayad, Molecular, cellular and functional 
imaging of atherothrombosis. Nat Rev Drug Discov, 2004. 3(11): p. 913-25. 
66. Huang, D., et al., Optical coherence tomography. Science, 1991. 254(5035): p. 
1178-81. 
67. Jang, I.K., et al., Visualization of coronary atherosclerotic plaques in patients 
using optical coherence tomography: comparison with intravascular ultrasound. J 
Am Coll Cardiol, 2002. 39(4): p. 604-9. 
68. Myerburg, R.J., et al., Frequency of sudden cardiac death and profiles of risk. Am 
J Cardiol, 1997. 80(5B): p. 10F-19F. 
69. Packard, R.R. and P. Libby, Inflammation in atherosclerosis: from vascular 
biology to biomarker discovery and risk prediction. Clin Chem, 2008. 54(1): p. 
24-38. 
70. Regar, E., et al., Optical coherence tomography. Cardiovasc Radiat Med, 2003. 
4(4): p. 198-204. 
71. Sawada, T., et al., Feasibility of combined use of intravascular ultrasound 
radiofrequency data analysis and optical coherence tomography for detecting thin-
cap fibroatheroma. Eur Heart J, 2008. 29(9): p. 1136-46. 
72. Stamper, D., N.J. Weissman, and M. Brezinski, Plaque characterization with 
optical coherence tomography. J Am Coll Cardiol, 2006. 47(8 Suppl): p. C69-79. 
73. Schneiderman, J., et al., Diagnosis of thin-cap fibroatheromas by a self-contained 
intravascular magnetic resonance imaging probe in ex vivo human aortas and in 
situ coronary arteries. J Am Coll Cardiol, 2005. 45(12): p. 1961-9. 
206 
 
74. Toussaint, J.F., et al., Water diffusion properties of human atherosclerosis and 
thrombosis measured by pulse field gradient nuclear magnetic resonance. 
Arterioscler Thromb Vasc Biol, 1997. 17(3): p. 542-6. 
75. Caplan, J.D., et al., Near-infrared spectroscopy for the detection of vulnerable 
coronary artery plaques. J Am Coll Cardiol, 2006. 47(8 Suppl): p. C92-6. 
76. Chapman, I., Relationships of recent coronary artery occlusion and acute 
myocardial infarction. J Mt Sinai Hosp N Y, 1968. 35(2): p. 149-54. 
77. Constantinides, P., Pathogenesis of cerebral artery thrombosis in man. Arch 
Pathol, 1967. 83(5): p. 422-8. 
78. Friedman, M. and G.J. Van den Bovenkamp, Role of thrombus in plaque 
formation in the human diseased coronary artery. Br J Exp Pathol, 1966. 47(6): p. 
550-7. 
79. Wang, J., et al., Near-infrared spectroscopic characterization of human advanced 
atherosclerotic plaques. J Am Coll Cardiol, 2002. 39(8): p. 1305-13. 
80. Yeager, D., et al., Intravascular photoacoustic imaging of gold-nanorod labeled 
atherosclerotic plaques. Photons Plus Ultrasound: Imaging and Sensing 2012, 
2012. 8223. 
81. Lee, H.Y., J.P. Despres, and K.K. Koh, Perivascular adipose tissue in the 
pathogenesis of cardiovascular disease. Atherosclerosis, 2013. 230(2): p. 177-84. 
82. McKenney-Drake, M.L., et al., Epicardial Adipose Tissue Removal Potentiates 
Outward Remodeling and Arrests Coronary Atherogenesis. Ann Thorac Surg, 
2017. 103(5): p. 1622-1630. 
83. Verhagen, S. and F. FVisseren, Perivascular adipose tissue as a cause of 
atherosclerosis. Atherosclerosis, 2010. 214(1): p. 3-10. 
84. Abran, M., et al., Development of a photoacoustic, ultrasound and fluorescence 
imaging catheter for the study of atherosclerotic plaque. IEEE Trans Biomed 
Circuits Syst, 2014. 8(5): p. 696-703. 
85. Dai, X.J., et al., Miniature Endoscope for Multimodal Imaging. Acs Photonics, 
2017. 4(1): p. 174-180. 
86. Mathews, S.J., et al. All-optical intravascular probe for dual-mode photoacoustic 
imaging and optical coherence tomography (Conference Presentation). in Proc. 
SPIE 10494, Photons Plus Ultrasound: Imaging and Sensing 2018. 2018. San 
Francisco, CA. 
87. Castano, A.P., T.N. Demidova, and M.R. Hamblin, Mechanisms in photodynamic 
therapy: part one-photosensitizers, photochemistry and cellular localization. 
Photodiagnosis and Photodynamic Therapy, 2004. 1(4): p. 279-293. 
88. Lucky, S.S., K.C. Soo, and Y. Zhang, Nanoparticles in Photodynamic Therapy. 
Chemical Reviews, 2015. 115(4): p. 1990-2042. 
89. Huang, Z., A review of progress in clinical photodynamic therapy. Technol 
Cancer Res Treat, 2005. 4(3): p. 283-93. 
90. Woodburn, K.W., et al., Phototherapy of cancer and atheromatous plaque with 
texaphyrins. J Clin Laser Med Surg, 1996. 14(5): p. 343-8. 
91. Hayase, M., et al., Photoangioplasty with local motexafin lutetium delivery 
reduces macrophages in a rabbit post-balloon injury model. Cardiovasc Res, 
2001. 49(2): p. 449-55. 
207 
 
92. Waksman, R., et al., PhotoPoint photodynamic therapy promotes stabilization of 
atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol, 2008. 
52(12): p. 1024-32. 
93. Cheung, J., et al., Longer term assessment of photodynamic therapy for intimal 
hyperplasia: a pilot study. Journal of Photochemistry and Photobiology B-
Biology, 2004. 73(3): p. 141-147. 
94. Kereiakes, D.J., et al., Phase I drug and light dose-escalation trial of motexafin 
lutetium and far red light activation (phototherapy) in subjects with coronary 
artery disease undergoing percutaneous coronary intervention and stent 
deployment - Procedural and long-term results. Circulation, 2003. 108(11): p. 
1310-1315. 
95. Letourneur, D. and P.N. Trohopoulos, Atherosclerotic disease and management 
challenges with nanomedicine: EU FP7 NMP funded "NanoAthero" and 
"CosmoPHOS-nano" large-scale projects. European Journal of Nanomedicine, 
2014. 6(2): p. 115-119. 
96. Kosuge, H., et al., Near infrared imaging and photothermal ablation of vascular 
inflammation using single-walled carbon nanotubes. J Am Heart Assoc, 2012. 
1(6): p. e002568. 
97. Gao, W., et al., Copper sulfide nanoparticles as a photothermal switch for TRPV1 
signaling to attenuate atherosclerosis. Nature Communications, 2018. 9. 
98. Yeager, D., et al., Intravascular photoacoustics for image-guidance and 
temperature monitoring during plasmonic photothermal therapy of atherosclerotic 
plaques: a feasibility study. Theranostics, 2013. 4(1): p. 36-46. 
99. Kharlamov, A.N., et al., Silica-gold nanoparticles for atheroprotective 
management of plaques: results of the NANOM-FIM trial. Nanoscale, 2015. 
7(17): p. 8003-8015. 
100. Sowers, T., H. Yoon, and S. Emelianov, Investigation of light delivery geometries 
for photoacoustic applications using Monte Carlo simulations with multiple 
wavelengths, tissue types, and species characteristics. J Biomed Opt, 2020. 25(1): 
p. 1-16. 
101. Beard, P., Biomedical photoacoustic imaging. Interface Focus, 2011. 1(4): p. 602-
31. 
102. Oraevsky, A.A., et al., Laser-Based Optoacoustic Imaging in Biological Tissues. 
Laser-Tissue Interaction V, Proceedings Of, 1994. 2134: p. 122-128. 
103. Sun, T. and G.J. Diebold, Generation of Ultrasonic-Waves from a Layered 
Photoacoustic Source. Nature, 1992. 355(6363): p. 806-808. 
104. Xia, W., et al., Handheld Real-Time LED-Based Photoacoustic and Ultrasound 
Imaging System for Accurate Visualization of Clinical Metal Needles and 
Superficial Vasculature to Guide Minimally Invasive Procedures. Sensors (Basel), 
2018. 18(5). 
105. Li, D.S., et al., Polypyrrole-Coated Perfluorocarbon Nanoemulsions as a Sono-
Photoacoustic Contrast Agent. Nano Letters, 2017. 17(10): p. 6184-6194. 
106. Yoon, H., et al., Super-Resolution Imaging With Ultrafast Ultrasound Imaging of 
Optically Triggered Perfluorohexane Nanodroplets. IEEE Trans Ultrason 
Ferroelectr Freq Control, 2018. 65(12): p. 2277-2285. 
208 
 
107. Wang, G.H., et al., Simulation of light delivery for photoacoustic breast imaging 
using the handheld probe. Chinese Optics Letters, 2014. 12(5). 
108. Sivasubramanian, K., et al., Optimizing light delivery through fiber bundle in 
photoacoustic imaging with clinical ultrasound system: Monte Carlo simulation 
and experimental validation. Journal of Biomedical Optics, 2017. 22(4). 
109. Sangha, G.S., N.J. Hale, and C.J. Goergen, Adjustable photoacoustic tomography 
probe improves light delivery and image quality. Photoacoustics, 2018. 12: p. 6-
13. 
110. Fang, Q. and D.A. Boas, Monte Carlo simulation of photon migration in 3D 
turbid media accelerated by graphics processing units. Opt Express, 2009. 17(22): 
p. 20178-90. 
111. Fang, Q.Q., Mesh-based Monte Carlo method using fast ray-tracing in Plucker 
coordinates. Biomedical Optics Express, 2010. 1(1): p. 165-175. 
112. Yu, L.M., et al., Scalable and massively parallel Monte Carlo photon transport 
simulations for heterogeneous computing platforms. Journal of Biomedical 
Optics, 2018. 23(1). 
113. Filatova, S.A., I.A. Shcherbakov, and V.B. Tsvetkov, Optical properties of animal 
tissues in the wavelength range from 350 to 2600 nm. J Biomed Opt, 2017. 22(3): 
p. 35009. 
114. Marquez, G., et al., Anisotropy in the absorption and scattering spectra of chicken 
breast tissue. Appl Opt, 1998. 37(4): p. 798-804. 
115. Bashkatov, A.N., et al., Optical properties of human skin, subcutaneous and 
mucous tissues in the wavelength range from 400 to 2000 nm. Journal of Physics 
D-Applied Physics, 2005. 38(15): p. 2543-2555. 
116. Tuchin, V.V., Tissue Optics: Light Scattering Methods and Instruments for 
Medical Diagnosis. TT38 ed. Vol. TT38. 2000, Washington: SPIE Press. 
117. Jacques, S.L., Optical properties of biological tissues: a review (vol 58, pg R37, 
2013). Physics in Medicine and Biology, 2013. 58(14): p. 5007-5008. 
118. Schmitt, J.M. and G. Kumar, Optical scattering properties of soft tissue: a discrete 
particle model. Applied Optics, 1998. 37(13): p. 2788-2797. 
119. Wang, R.K.K., Modelling optical properties of soft tissue by fractal distribution of 
scatterers. Journal of Modern Optics, 2000. 47(1): p. 103-120. 
120. Sabino, C.P., et al., The optical properties of mouse skin in the visible and near 
infrared spectral regions. J Photochem Photobiol B, 2016. 160: p. 72-8. 
121. Calabro, K., et al., Gender variations in the optical properties of skin in murine 
animal models. Journal of Biomedical Optics, 2011. 16(1). 
122. Joshi, N., C. Donner, and H.W. Jensen, Noninvasive measurement of scattering 
anisotropy in turbid materials by nonnormal incident illumination. Opt Lett, 2006. 
31(7): p. 936-8. 
123. Ramakrishna, S.A. and K.D. Rao, Estimation of light transport parameters in 
biological media using coherent backscattering. Pramana-Journal of Physics, 
2000. 54(2): p. 255-267. 
124. Stocker, S., et al., Broadband Optical Properties of Milk. Applied Spectroscopy, 
2017. 71(5): p. 951-962. 
125. Walstra, P., et al., Dairy Technology: Principles of Milk Properties and 
Processes, ed. I. Marcel Dekker. 1999, New York. 
209 
 
126. Cook, J.R., R.R. Bouchard, and S.Y. Emelianov, Tissue-mimicking phantoms for 
photoacoustic and ultrasonic imaging. Biomedical Optics Express, 2011. 2(11): p. 
3193-3206. 
127. Hale, G.M. and M.R. Querry, Optical Constants of Water in the 200-nm to 200-
microm Wavelength Region. Appl Opt, 1973. 12(3): p. 555-63. 
128. Yoon, H. and S. Emelianov, Combined multi-wavelength photoacoustic and 
plane-wave ultrasound imaging for probing dynamic phase-change contrast 
agents. IEEE Trans Biomed Eng, 2018. 66(2): p. 595-598. 
129. Yoon, H., et al., Design and Demonstration of a Configurable Imaging Platform 
for Combined Laser, Ultrasound, and Elasticity Imaging. IEEE Trans Med 
Imaging, 2018. 38(7): p. 1622-1632. 
130. Ranasinghesagara, J.C., Y. Jiang, and R.J. Zemp, Reflection-mode multiple-
illumination photoacoustic sensing to estimate optical properties. Photoacoustics, 
2014. 2(1): p. 33-8. 
131. Ranasinghesagara, J.C. and R.J. Zemp, Combined photoacoustic and oblique-
incidence diffuse reflectance system for quantitative photoacoustic imaging in 
turbid media. J Biomed Opt, 2010. 15(4): p. 046016. 
132. Kruizinga, P., et al., Photoacoustic imaging of carotid artery atherosclerosis. 
Journal of Biomedical Optics, 2014. 19(11). 
133. Held, G., et al., Effect of irradiation distance on image contrast in epi-
optoacoustic imaging of human volunteers. Biomed Opt Express, 2014. 5(11): p. 
3765-80. 
134. Xie, Z.X., L.H.V. Wang, and H.F. Zhang, Optical fluence distribution study in 
tissue in dark-field confocal photoacoustic microscopy using a modified Monte 
Carlo convolution method. Applied Optics, 2009. 48(17): p. 3204-3211. 
135. Periyasamy, V. and M. Pramanik, Monte Carlo simulation of light transport in 
tissue for optimizing light delivery in photoacoustic imaging of the sentinel lymph 
node. J Biomed Opt, 2013. 18(10): p. 106008. 
136. Frenz, M. and M. Jaeger, Optimization of tissue irradiation in optoacoustic 
imaging using a linear transducer: theory and experiments - art. no. 68561Y. 
Photons Plus Ultrasound: Imaging and Sensing 2008: The Ninth Conference on 
Biomedical Thermoacoustics, Optoacoustics, and Acoustic-Optics, 2008. 6856: p. 
Y8561-Y8561. 
137. Li, M.C., et al., Linear array-based real-time photoacoustic imaging system with a 
compact coaxial excitation handheld probe for noninvasive sentinel lymph node 
mapping. Biomedical Optics Express, 2018. 9(4): p. 1408-1422. 
138. Montilla, L.G., et al., Real-time photoacoustic and ultrasound imaging: a simple 
solution for clinical ultrasound systems with linear arrays. Physics in Medicine 
and Biology, 2013. 58(1): p. N1-N12. 
139. Wang, Y., et al., Optimizing the light delivery of linear-array-based photoacoustic 
systems by double acoustic reflectors. Sci Rep, 2018. 8(1): p. 13004. 
140. Wang, L.D., et al., Video-rate functional photoacoustic microscopy at depths. 
Journal of Biomedical Optics, 2012. 17(10). 
141. Jaeger, M., J.C. Bamber, and M. Frenz, Clutter elimination for deep clinical 
optoacoustic imaging using localised vibration tagging (LOVIT). Photoacoustics, 
2013. 1(2): p. 19-29. 
210 
 
142. Jaeger, M., M. Frenz, and D. Schweizer, Iterative reconstruction algorithm for 
reduction of echo background in optoacoustic images. Photons Plus Ultrasound: 
Imaging and Sensing 2008: The Ninth Conference on Biomedical 
Thermoacoustics, Optoacoustics, and Acoustic-Optics, 2008. 6856. 
143. Jaeger, M., et al., Deformation-compensated averaging for clutter reduction in 
epiphotoacoustic imaging in vivo. Journal of Biomedical Optics, 2012. 17(6). 
144. Jaeger, M., et al., Improved contrast deep optoacoustic imaging using 
displacement-compensated averaging: breast tumour phantom studies. Physics in 
Medicine and Biology, 2011. 56(18): p. 5889-5901. 
145. Jaeger, M., et al., Improved contrast optoacoustic imaging of deep breast tumors 
using displacement-compensated averaging: Phantom studies. Photons Plus 
Ultrasound: Imaging and Sensing 2010, 2010. 7564. 
146. Jaeger, M., et al., Reduction of background in optoacoustic image sequences 
obtained under tissue deformation. Journal of Biomedical Optics, 2009. 14(5). 
147. Zhao, L.Y., et al., Optical fluence compensation for handheld photoacoustic 
probe: An in vivo human study case. Journal of Innovative Optical Health 
Sciences, 2017. 10(4). 
148. Nie, L.M., et al., Photoacoustic tomography through a whole adult human skull 
with a photon recycler. Journal of Biomedical Optics, 2012. 17(11). 
149. Wang, Z., S. Ha, and K. Kim, A new design of light illumination scheme for deep 
tissue photoacoustic imaging. Opt Express, 2012. 20(20): p. 22649-59. 
150. Yu, J., et al., A Light Illumination Enhancement Device for Photoacoustic 
Imaging: In Vivo Animal Study. IEEE Trans Ultrason Ferroelectr Freq Control, 
2017. 64(8): p. 1205-1211. 
151. Sangha, G.S., E.H. Phillips, and C.J. Goergen, In vivo photoacoustic lipid 
imaging in mice using the second near-infrared window. Biomedical Optics 
Express, 2017. 8(2): p. 736-742. 
152. Ash, C., et al., Effect of wavelength and beam width on penetration in light-tissue 
interaction using computational methods. Lasers Med Sci, 2017. 32(8): p. 1909-
1918. 
153. Cox, B., et al., Quantitative spectroscopic photoacoustic imaging: a review. J 
Biomed Opt, 2012. 17(6): p. 061202. 
154. Lutzweiler, C. and D. Razansky, Optoacoustic imaging and tomography: 
reconstruction approaches and outstanding challenges in image performance and 
quantification. Sensors (Basel), 2013. 13(6): p. 7345-84. 
155. Zhou, X., et al., Evaluation of Fluence Correction Algorithms in Multispectral 
Photoacoustic Imaging. Photoacoustics, 2020. 19: p. 100181. 
156. Hochuli, R., et al., Quantitative photoacoustic tomography using forward and 
adjoint Monte Carlo models of radiance. J Biomed Opt, 2016. 21(12): p. 126004. 
157. Jacques, S.L., Coupling 3D Monte Carlo light transport in optically heterogeneous 
tissues to photoacoustic signal generation. Photoacoustics, 2014. 2(4): p. 137-42. 
158. Liu, Y., H. Jiang, and Z. Yuan, Two schemes for quantitative photoacoustic 
tomography based on Monte Carlo simulation. Med Phys, 2016. 43(7): p. 3987. 
159. Zhu, C. and Q. Liu, Review of Monte Carlo modeling of light transport in tissues. 
J Biomed Opt, 2013. 18(5): p. 50902. 
211 
 
160. Bhatt, M., K.R. Ayyalasomayajula, and P.K. Yalavarthy, Generalized Beer-
Lambert model for near-infrared light propagation in thick biological tissues. J 
Biomed Opt, 2016. 21(7): p. 76012. 
161. Duncan, A., et al., Measurement of cranial optical path length as a function of age 
using phase resolved near infrared spectroscopy. Pediatr Res, 1996. 39(5): p. 889-
94. 
162. Duncan, A., et al., Optical pathlength measurements on adult head, calf and 
forearm and the head of the newborn infant using phase resolved optical 
spectroscopy. Phys Med Biol, 1995. 40(2): p. 295-304. 
163. Hiraoka, M., et al., A Monte Carlo investigation of optical pathlength in 
inhomogeneous tissue and its application to near-infrared spectroscopy. Phys Med 
Biol, 1993. 38(12): p. 1859-76. 
164. Kocsis, L., P. Herman, and A. Eke, The modified Beer-Lambert law revisited. 
Phys Med Biol, 2006. 51(5): p. N91-8. 
165. Kohl, M., et al., Determination of the wavelength dependence of the differential 
pathlength factor from near-infrared pulse signals. Phys Med Biol, 1998. 43(6): p. 
1771-82. 
166. Sassaroli, A. and S. Fantini, Comment on the modified Beer-Lambert law for 
scattering media. Phys Med Biol, 2004. 49(14): p. N255-7. 
167. Bauer, A.Q., et al., Quantitative photoacoustic imaging: correcting for 
heterogeneous light fluence distributions using diffuse optical tomography. J 
Biomed Opt, 2011. 16(9): p. 096016. 
168. Daoudi, K., et al., Correcting photoacoustic signals for fluence variations using 
acousto-optic modulation. Opt Express, 2012. 20(13): p. 14117-29. 
169. Hussain, A., et al., Quantitative blood oxygen saturation imaging using combined 
photoacoustics and acousto-optics. Opt Lett, 2016. 41(8): p. 1720-3. 
170. Kumavor, P.D., et al., Target detection and quantification using a hybrid hand-
held diffuse optical tomography and photoacoustic tomography system. J Biomed 
Opt, 2011. 16(4): p. 046010. 
171. Rajian, J.R., P.L. Carson, and X. Wang, Quantitative photoacoustic measurement 
of tissue optical absorption spectrum aided by an optical contrast agent. Opt 
Express, 2009. 17(6): p. 4879-89. 
172. Harrison, T., P. Shao, and R.J. Zemp, A least-squares fixed-point iterative 
algorithm for multiple illumination photoacoustic tomography. Biomed Opt 
Express, 2013. 4(10): p. 2224-30. 
173. Held, K.G., et al., Multiple irradiation sensing of the optical effective attenuation 
coefficient for spectral correction in handheld OA imaging. Photoacoustics, 2016. 
4(2): p. 70-80. 
174. Ranasinghesagara, J.C., et al., Photoacoustic technique for assessing optical 
scattering properties of turbid media. J Biomed Opt, 2009. 14(4): p. 040504. 
175. Shao, P., B. Cox, and R.J. Zemp, Estimating optical absorption, scattering, and 
Grueneisen distributions with multiple-illumination photoacoustic tomography. 
Appl Opt, 2011. 50(19): p. 3145-54. 
176. Shao, P., T. Harrison, and R.J. Zemp, Iterative algorithm for multiple illumination 
photoacoustic tomography (MIPAT) using ultrasound channel data. Biomed Opt 
Express, 2012. 3(12): p. 3240-9. 
212 
 
177. Shao, P., T.J. Harrison, and R.J. Zemp, Consecutively reconstructing absorption 
and scattering distributions in turbid media with multiple-illumination 
photoacoustic tomography. J Biomed Opt, 2014. 19(12): p. 126009. 
178. Zemp, R.J., Quantitative photoacoustic tomography with multiple optical sources. 
Appl Opt, 2010. 49(18): p. 3566-72. 
179. Troy, T.L., D.L. Page, and E.M. Sevick-Muraca, Optical properties of normal and 
diseased breast tissues: prognosis for optical mammography. J Biomed Opt, 1996. 
1(3): p. 342-55. 
180. Fung, Y.C., Biomechanics : mechanical properties of living tissues. 2nd ed. 1993, 
New York: Springer-Verlag. xviii, 568 p. 
181. Chan, E.K., et al., Effects of Compression on Soft Tissue Optical Properties. 
IEEE Journal of Selected Topics in Quantum Electronics, 1996. 2: p. 943-950. 
182. Liu, Y., Measurement of tissue optical properties during mechanical compression 
using swept source optical coherence tomography, in Biomedical Engineering. 
2009, Virginia Polytechnic Institute and State University: Blacksburg, VA. p. 55. 
183. Sowers, T., et al., Laser threshold and cell damage mechanism for intravascular 
photoacoustic imaging. Lasers Surg Med, 2018. 
184. Kolodgie, F.D., et al., Pathologic assessment of the vulnerable human coronary 
plaque. Heart, 2004. 90(12): p. 1385-91. 
185. Virmani, R., et al., Lessons from sudden coronary death: a comprehensive 
morphological classification scheme for atherosclerotic lesions. Arterioscler 
Thromb Vasc Biol, 2000. 20(5): p. 1262-75. 
186. Kolodgie, F.D., et al., Intraplaque hemorrhage and progression of coronary 
atheroma. N Engl J Med, 2003. 349(24): p. 2316-25. 
187. Kolodgie, F.D., et al., Intraplaque hemorrhage and progression of coronary 
atheroma. New England Journal of Medicine, 2003. 349(24): p. 2316-2325. 
188. Falk, E., P.K. Shah, and V. Fuster, Coronary Plaque Disruption. Circulation, 
1995. 92(3): p. 657-671. 
189. Ma, T., et al., A Review of Intravascular Ultrasound-based Multimodal 
Intravascular Imaging: The Synergistic Approach to Characterizing Vulnerable 
Plaques. Ultrasonic Imaging, 2016. 38(5): p. 314-331. 
190. Ochijewicz, D., et al., Intravascular imaging of coronary artery disease: recent 
progress and future directions. Journal of Cardiovascular Medicine, 2017. 18(10): 
p. 733-741. 
191. Bourantas, C.V., et al., Hybrid Intravascular Imaging. Journal of the American 
College of Cardiology, 2013. 61(13): p. 1369-1378. 
192. Bourantas, C.V., et al., Hybrid intravascular imaging: recent advances, technical 
considerations, and current applications in the study of plaque pathophysiology. 
European Heart Journal, 2017. 38(6): p. 400-U32. 
193. Jansen, K., G. van Soest, and A.F.W. van der Steen, Intravascular Photoacoustic 
Imaging: A New Tool for Vulnerable Plaque Identification. Ultrasound in 
Medicine and Biology, 2014. 40(6): p. 1037-1048. 
194. Bai, X., et al., Intravascular optical-resolution photoacoustic tomography with a 
1.1 mm diameter catheter. PLoS One, 2014. 9(3): p. e92463. 
213 
 
195. Qin, H., et al., Inflammation-targeted gold nanorods for intravascular 
photoacoustic imaging detection of matrix metalloproteinase-2 (MMP2) in 
atherosclerotic plaques. Nanomedicine, 2016. 12(7): p. 1765-1774. 
196. Shang, S., et al., Simultaneous imaging of atherosclerotic plaque composition and 
structure with dual-mode photoacoustic and optical coherence tomography. Opt 
Express, 2017. 25(2): p. 530-539. 
197. Denton, M.L., et al., Spatially correlated microthermography maps threshold 
temperature in laser-induced damage. Journal of Biomedical Optics, 2011. 16(3). 
198. Hale, G.M. and M.R. Querry, Optical Constants of Water in the 200-nm to 200-
micron Wavelength Region. Appl Opt, 1973. 12(3): p. 555-63. 
199. Khan, A. and G.D. Tayner, Robustness to Non-Normality of Common Tests for 
the Many-Sample Location Problem. Journal of Applied Mathematics and 
Decision Sciences, 2003. 7(4): p. 187-206. 
200. Hartung, J., D. Argac, and K.H. Makambi, Small sample properties of tests on 
homogeneity in one-way Anova and Meta-analysis. Statistical Papers, 2002. 
43(2): p. 197-235. 
201. Olejnik, S.F. and J. Algina, Type I Error Rates and Power Estimates of Selected 
Parametric and Nonparametric Tests of Scale. Journal of Educational and 
Behavioral Statistics, 1987. 12(1): p. 45-61. 
202. Ramsey, P.H., Testing Variances in Psychological and Educational Research. 
Journal of Educational and Behavioral Statistics, 1994. 19(1): p. 23-42. 
203. Daeichin, V., et al., Frequency Analysis of the Photoacoustic Signal Generated by 
Coronary Atherosclerotic Plaque. Ultrasound Med Biol, 2016. 42(8): p. 2017-25. 
204. Bayat, M., et al., Comparison of the in vitro effects of low-level laser therapy and 
low-intensity pulsed ultrasound therapy on bony cells and stem cells. Prog 
Biophys Mol Biol, 2017. 
205. Hasgall, P.A., et al., IT'IS Database for thermal and electromagnetic parameters 
of biological tissues. 2015: Online. 
206. Kalaprasad, G., et al., Thermal conductivity and thermal diffusivity analyses of 
low-density polyethylene composites reinforced with sisal, glass and intimately 
mixed sisal/glass fibres. Composites Science and Technology, 2000. 60(16): p. 
2967-2977. 
207. Kamal, M.R., V. Tan, and F. Kashani, The thermal conducitvity and diffusivity of 
polyethylene solids and melts. Advances in Polymer Technology, 1983. 3(2): p. 
89-98. 
208. Incropera, F.P., et al., Introduction to Heat Transfer. 5th ed. 2006, United States 
of America. 
209. Waggener, W.C., Absorbance of Liquid Water and Deuterium Oxide between 0.6 
and 1.8 Microns. Analytical Chemistry, 1958. 30: p. 1569-1570. 
210. Keijzer, M., et al., Fluorescence spectroscopy of turbid media: Autofluorescence 
of the human aorta. Appl Opt, 1989. 28(20): p. 4286-92. 
 
